Protein crystal structure

Abstract

Disclosed is a crystal comprising at least a catalytically active portion of a SET 7/9 histone methyltransferase, and various uses thereof, and ligands for SET 7/9.

Description

FIELD OF THE INVENTION

This invention relates to a protein crystal structure, various methods of utilising the structure and/or information derivable therefrom, and altered proteins.

BACKGROUND OF THE INVENTION

In eukaryotic cells, DNA is maintained in a highly ordered and condensed in association with small, basic histone proteins. This packaged DNA is termed chromatin. Generally speaking, there are two forms of chromatin: heterochromatin which is tightly compacted and highly refractory to processes such as gene transcription; and euchromatin, which has a more open conformation and tends to be amenable to transcription.

The basic unit of chromatin is the nucleosome, which consists of approximately two turns of DNA around a histone core octamer comprising two monomers each of histones H2A, H2B, H3 and H4. The N terminal tails of the core histones protrude out of the core structure and make contact with adjacent nucleosomes.

The basic N terminal tails of the core histones are known to be subject to many different covalent modifications including acetylation and, in particular, methylation of lysine residues.

It is generally believed that modification of the histone tails affects chromatin structure and thereby has an impact on expression of genes within the DNA in the modified nucleosome. Thus it is widely held that histone modification provides a layer of epigenetic control of gene expression, although the details of the mechanisms involved have not yet been fully elucidated.

A number of enzymes which methylate histones (histone methyltransferases, or HMTs) are known. They tend to be highly specific e.g. a particular HMT will normally methylate only a particular lysine residue of a particular histone molecule (say, for example, the lysine residue at position 9 of histone H3). HMTs almost exclusively belong to the “SET” family of proteins, that is they contain a conserved methyltransferase domain called a SET domain (so called because the domain was first identified in the Drosophila protein Suvar)3-9, (Enhancer-of-zeste, Ttrithorax); (Su(var) is an abbreviation for “suppressor of variegation”).

It has been postulated that deregulation of SET domain function in SET proteins may be involved in the causation of many types of cancer (Schneider et al, 2002 TRENDS in Biochemical Sciences 27, 396-402) and, given the likely role of HMTs in regulation of gene expression, one can appreciate the basis for such a postulation.

The first example of an enzyme that specifically methylates lysine-4 of histone H3 in humans was independently characterised by two groups and separately named SET7 (Wang et al, 2001 Mol. Cell. 8, 1207-1217) and SET9 (Nishioka et al, 2002 Genes Dev. 16, 479-489). Accordingly the protein is now known as SET 719). This protein is among the smallest shown to possess HMTase activity and it also lacks SET domain-associated cysteine-rich regions.

The results of X-ray crystallographic analysis of the enzyme in isolation, or in complex with a reaction product, have been published (Wilson et al, 2002 Cell 777, 105-115; Jacobs et al, 2002 Nat. Struct. Biol. 9, 833-838). However; the crystal used for analysis by Wilson et al lacked a C-terminal segment of the enzyme (which is critical for catalytic activity) since no useful crystals could be obtained of the complete enzyme, due to the flexibility of the C terminal.

The SET 7/9 HMT comprises a conserved SET domain (i.e. the SET 7/9 domain) and flanking pre- and post-SET domains. Analysis by Rea et al, (2000 Nature 406, 593-599) suggested that, at least for SuV39H1, both the pre-SET and post-SET domains were required for HMTase activity. However, the function of the pre-SET and post-SET domains is still unclear. A variety of different sequences are found adjacent to the C terminus of SET domains across the family of HMTs, and this might reflect important differences in the precise specificity of the various enzymes.

The present inventors have now been able to prepare a crystal of a catalytically competent portion of the enzyme, in a complex with both its co-factor and a lysine-containing peptide substrate. This complex has allowed determination of the structure of the SET domain, including the essential C-terminal segment, to a surprisingly high resolution.

This information has, in turn, led the inventors to make a number of other inventions, described and exemplified below.

SUMMARY OF THE INVENTION

In a first aspect the invention provides a crystal comprising at least a catalytically active portion of a SET 7/9 histone methyltransferase (HMT). In a preferred embodiment the crystal comprises SET 7/9 HMT in complex with a lysine-containing protein or peptide substrate and/or a methyl group-donating co-factor. It should be noted that the crystal complex may be formed before or (more preferably) after the enzyme-catalysed methylation reaction takes place, so the co-factor, if present, may be methylated or demethylated and, conversely, the substrate (if present) may be unmethylated or methylated.

In a preferred embodiment the invention provides a crystal comprising SET 7/9 HMT, optionally in a complex with a lysine-containing substrate and/or a (methyl group-donating) co-factor, which diffracts X-rays so as to allow for the determination of atomic co-ordinates of SET 7/9 HMT to a resolution of 1.7 Å or better.

A crystal in accordance with the invention typically has the space group P2₁, and unit cell dimensions of a=52.7 Å, b=75.4 Å, c=69.1 Å and β=94.2°.

In particular, a crystal in accordance with the invention comprises at least residues 117-366 of SET 7/9 HMT, which portion is catalytically active.

One crystal in accordance with the invention has the relative atomic co-ordinates set out in Annex 1, and these will generally be applicable for other crystals in accordance with the invention. However, those skilled in the art will appreciate that minor deviation from these precise co-ordinates will not significantly affect the structure, either in terms of its dominant characteristics or its usefulness in, for example, rational drug design (as discussed further below). Accordingly, for the purposes of the present specification, a crystal having a structure in which the atomic co-ordinates set out in Annex 1 may vary by up to 0.2 Å (more preferably no more than 0.1 Å) in any direction is considered as being a crystal in accordance with the present invention.

By way of explanation, Annex 1 shows (from left to right): the atom number and type, the residue type and number, the x, y and z co-ordinates of the atom (in Å); “OCC” is the occupancy and B is the B factor (in Ų). Atoms 1-3813 belong to the SET 7/9 domain. Atoms 3814-3855 belong to the S-AdoHomocysteine cofactor. Atoms 3859-4039 belong to the substrate peptide.

Using the data provided by the atomic co-ordinates, the inventors have identified residues of the SET 7/9 domain which are believed to interact with residues of the substrate. Thus in one particular embodiment the invention provides a crystal comprising a complex of SET 7/9 with a lysine-containing substrate peptide comprising at least the amino acid sequence ARTKQT, and wherein the complex involves one or more (preferably two or more, more preferably three or more, and most preferably four or more) of the interactions set out in Table 1 below. (The relative substrate residue numbering makes the lysine residue to be methylated position 0, with residues to the N terminal side being negative and residues to the C terminal side being positive):

TABLE 1
SET 7/9
Residue interacts with: Relative Substrate Residue
Trp 260                 −3 (e.g. Ala)
His 252                 −2 (e.g. Arg)
Asp 256                 −2 (e.g. Arg)
Ser 268                 −1 (e.g. Thr)
Thr 266                 Lys 0
Ser 268                 Lys 0
Ser 268                 +1 (e.g. Gln)
Val 355                 +1 (e.g. Gln)
Lys 317                 +2 (e.g. Thr)

Those skilled in the art will readily appreciate that determination of the three dimensional ternary structure of SET 7/9 HMT in complex with its cofactor and/or a substrate provides the basis for the rational design of molecules which interact specifically with SET 7/9 HMT (alone, or in complex with its cofactor and/or a substrate). Such molecules may be referred to, for present purposes, as ligands. Of particular interest are ligands which will modulate the methyltransferase activity of SET 7/9 HMT. Such modulation may include inhibiting or enhancing the methylstransferase activity, altering its substrate specificity, and stabilising or destabilising the interaction between SET 7/9 HMT and its cofactor and/or a histone substrate. For present purposes, “destabilising” encompasses inhibition of the formation of a complex of SET 7/9 HMT with a substrate and/or its cofactor.

By way of explanation, SET 7/9 HMT requires a source of methyl groups for transfer to the lysine residue of the substrate to be methylated. The source of methyl groups is provided by a methyl group-donating cofactor. The natural cofactor for SET 7/9 is referred to as S-AdoMet (or AdoMet), in essence an adenosinylated methionine molecule. During the SET 7/9 HMT-catalysed reaction, the methyl group is transferred from S-AdoMet to the lysine residue of the substrate. The resulting demethylated cofactor is referred to as S-AdoHomocysteine (abbreviated as S-AdoHcy or AdoHcy). The structures of AdoMet and AdoHcy are shown in FIGS. 1a and 1b respectively.

In particular, there are several computer modelling packages commercially available which can facilitate the rational design of ligand molecules which are likely to modulate the methyltransferase activity of SET 7/9 HMT. Examples include computer programs such as GRAM, DOCK and AUTODOCK (Walters et al, 1998 Drug Discovery Today 3, 160-178; Dunbrack et al, 1997 Folding and Design 2, 2742) which can be employed, with knowledge of the ternary structure a complex comprising SET 7/9, to design potential reversible or irreversible SET 7/9 HMT inhibitors.

Alternatively a computer program may be employed to analyse the active site of SET 7/9 HMT and predict the structure of chemical moieties which will interact with the active site. An example of one such program is GRID (described by Goodford, 1985 J. Med. Chem. 28, 849-857).

In addition, the likely forces of attraction and repulsion, and the degree of any steric hindrance, between SET 7/9 HMT and a prospective ligand, can be estimated using computer programs. In general, the greater the forces of attraction (and the lower the forces of repulsion), the closer the fit and the fewer the number of steric hindrances, the tighter will be the interaction between SET 7/9 HMT and the ligand. In addition, the greater the specificity of binding of the ligand, the lower the likelihood of any adverse reactions from undesired interactions with other proteins.

Thus, in a further aspect, the invention provides a method of selecting or designing a ligand for SET 7/9, which method comprises use of at least part of the atomic co-ordinate data contained in Annex 1 (preferably a substantial part of the data i.e. the data relating to at least 50% of the atoms identified in Annex 1, more preferably most of the data i.e. the data relating to at least 75% of the atoms, and most preferably substantially all of the data i.e. the data relating to at least 95% of the atoms), or data derivable therefrom. Data derivable from the atomic co-ordinate data presented in Annex 1 include structure factor data (see Blundell et al, in “Protein Crystallography” Academic Press, New York, London and San Francisco (1976)). Where less than the complete data set is used for the modelling or designing method of the invention, it is preferred at least to include data relating to that part of the SET domain which constitutes the active site. In particular the inventors believe the following residues to be important to the catalytic activity of the SET 7/9 HMT:

Tyr 245, His 252, Hsp 256, Asn 263, Gly 264, Thr 266, Leu 267, Ser 268, Gly 292, His 293, Ala 295, Tyr 305, Lys 317, Tyr 335, and Tyr 337.

Accordingly, preferred methods of selecting or designing potential ligands will typically comprise use of atomic co-ordinate data for at least some of the atoms present in one or more (preferably most, more preferably all) of the residues identified immediately above.

Typically the method of this aspect of the invention comprises the step of modelling all or part of the structure of SET 7/9 HMT using a computer and identifying a potential ligand by designing or selecting a molecule based on its likely ability to interact with the modeled structure.

A potential ligand may be a new chemical entity, although this has the disadvantage that a method of synthesising the entity must be devised if the compound is to be tested in vitro. More preferably therefore, the potential ligand is a compound which is already available. Commercially available libraries of compound structures, such as the Cambridge Structural Database, allow for computer-based high throughput screening of compounds in order to identify and select potential ligands.

Potential ligands which have been designed or selected on the basis of computer modelling or otherwise may then be synthesised or, more preferably, obtained from commercial sources for in vitro testing. The potential ligand may be tested, for example, for any enhancing or inhibitory effect on the methyltransferase activity of SET 7/9 HMT. An assay of HMT activity is described herein and may readily be modified to investigate the effect of the ligand e.g. by contacting a preparation comprising SET 7/9 HMT with a suitable lysine-containing peptide or protein substrate and a suitable cofactor in the presence or absence of the potential ligand.

An assay of methyltransferase activity has the advantage of indicating not only whether a ligand binds to SET 7/9 HMT but also whether such binding has a modulating effect on the catalytic activity of the enzyme. However, other in vitro screening or analytical methods might usefully be employed as an alternative or as an adjunct to enzyme activity assays.

For example, the potential ligand could be labelled, conveniently with a fluorophore. Many suitable fluorophores are commercially available and include inter alia, fluorescein and rhodamine. Binding of the labelled potential ligand to SET 7/9 (alone or in complex with a substrate and/or cofactor) could then be readily detected and assayed (e.g. in a fluorescence polarization assay—see, for instance, Sokham et al, 1999 Anal. Biochem. 275, 156-161).

If desired, any complex resulting from interaction of the potential ligand with SET 7/9 HMT can be analysed to obtain detailed structural information about the binding of the (potential) ligand to SET 7/9. This allows for the structure of the selected or designed ligand to be altered in a rational way in order to optimise affinity and/or specificity of binding of the ligand to SET 7/9. In particular, if desired, a complex comprising SET 7/9 HMT and the ligand may be crystallised and subject to X-ray crystallography in order to obtain data to “fine tune” the interaction between the ligand and SET 7/9 HMT. The interaction may be optimised, for example, by adding or removing groups from the ligand, substituting groups or otherwise altering the overall shape of the ligand.

It will be appreciated that the process of computer modelling and in vitro testing and/or analysis could be performed in an iterative manner, if desired.

In another aspect the invention provides a computer readable medium comprising either (a) at least part of the atomic co-ordinate data contained within Annex 1, or (b) structure factor data derivable from at least part of the atomic co-ordinate data contained within Annex 1.

The invention also provides a computer system for the purpose of modelling structures and/or performing rational drug design of a potential ligand for the SET 7/9 HMT (alone or in complex with a substrate and/or cofactor), the system comprising either (a) at least part of the atomic co-ordinate data contained within Annex 1, or (b) structure factor data derivable from at least part of the atomic co-ordinate data contained within Annex 1.

Preferably the computer readable medium and/or computer system comprises positional data relating to, or derivable from, at least 50%, more preferably at least 75%, and most preferably at least 95% of the atoms detailed in Annex 1.

In yet another aspect the invention provides a method of obtaining a crystal comprising at least a catalytically active portion of a SET 7/9 domain, the method comprising the steps of:

• (i) forming a complex comprising at least a catalytically active portion of a SET 7/9 domain with a lysine-containing substrate peptide or protein, and/or with a cofactor; and
• (ii) forming a crystal comprising the complex.

More especially, the inventors have surprisingly found that optimal results are obtained if the lysine residue of the substrate which interacts with the active site of the SET 7/9 domain in the complex is methylated (especially, mono-methylated), and such represents a preferred feature of the invention. In addition, it is also preferred that the cofactor, if present in the complex, is in unmethylated form (e.g. AdoHcy).

The inventors have found that, in preferred embodiments, a crystal may be formed from a complex of a methylated lysine-containing substrate peptide or protein, a SET 7/9 domain, and an unmethylated cofactor (such as AdoHcy), which crystal diffracts X-rays so as to allow determination of the atomic co-ordinates of the SET 7/9 domain to a resolution of 1.7 Å or better.

In yet another aspect the invention provides a method of obtaining a crystal comprising at least a catalytically active portion of a SET 7/9 domain, the method comprising the steps of:

• (i) forming a complex comprising at least a catalytically active portion of a SET 7/9 domain and a ligand therefor (the ligand being an inhibitor of SET 7/9 HMT activity); and
• (ii) forming a crystal comprising the complex.

In the crystal-forming method aspects of the invention, the complex will typically comprise at least residues 108-366 of the SET domain, which portion is catalytically active.

In a further aspect, the invention provides a ligand for a SET 7/9 domain which modulates the methyltransferase activity thereof, said ligand having been selected or designed by analysis or modelling using at least part of the atomic co-ordinate data contained within Annex 1 or structure factor data obtainable therefrom. More specifically the ligand is typically selected or designed by analysis or modelling using data from at least 50%, more preferably at least 75% and most preferably at least 95% of the atoms detailed in Annex 1.

The ligand may, for example, be one which interacts with one or more of the residues of the SET 7/9 domain which the inventors believe to be important for the HMTase activity of the SET 7/9 domain, namely:

Tyr 245, His 252, Hsp 256, Asn 263, Gly 264, Thr 266, Leu 267, Ser 268, Gly 292, His 293, Ala 295, Tyr 305, Lys 317, Tyr 335, and Tyr 337.

Alternatively, or additionally the ligand may interact with one or more of the SET 7/9 residues identified in Table 1 above as interacting with the substrate. Preferred ligands will comprise or consist of a hydrophobic moiety which can occupy the highly hydrophobic lysine access channel, identified by the inventors in the SET 7/9 domain. Some examples of suitable ligands are given in Example 3.

Once ligands have been identified with acceptable binding specificity and affinity, they can be investigated for use as potential drugs as modulators of SET HMT activity (particularly as inhibitors). Thus, in a further aspect the invention provides a pharmaceutical composition comprising a modulator of SET HMT activity in admixture with a physiologically acceptable diluent, excipient or carrier, the modulator being a compound in accordance with general formula I or II (defined in Example 3) and/or being a modulator selected or designed by analysis or modelling using at least part of the atomic co-ordinate data contained within Annex 1 or structure factor data obtainable therefrom.

The invention also provides for use of a ligand molecule e.g. in accordance with general formula I or II, and/or selected or designed by the method of the invention as a modulator of SET HMT activity, (particularly as an inhibitor thereof). The invention additionally provides for use of a modulator of SET HMT activity to prepare a pharmaceutical composition for modulating the methylation of histones.

In addition, the data obtained by the inventors has enabled identification of key amino acid residues in the SET HMT protein which are essential to the histone methyltransferase activity of the enzyme or its specificity. Alteration of one or more of these key residues may affect the HMT properties in a useful way.

Those skilled in the art are readily able to make point mutations in proteins, provided the relevant nucleic acid sequencing encoding the protein to be mutated is available. Thus, for example, site directed mutagenesis and/or PCR could be used to introduce one or more mutations into the SET HMT protein at desired locations. Particular residues which are susceptible to mutation so as to alter HMTase activity include residues 245, 305 and 335 of the SET domain. The invention thus affords a method providing SET HMTases with altered enzyme activity, and altered SET HMTases obtained by the method.

The invention will now be further described by way of illustrative example and with reference to the accompanying drawings in which:

FIGS. 1A and 1B illustrate the structure of the SET 7/9 cofactor in its methylated (S-AdoMet) and demethylated (S-AdoHcy) states respectively;

FIG. 2 a(i) and 2a(ii) are two orthogonal views of the ternary structure of the SET 7/9 domain in complex with AdoHcy and a substrate peptide;

FIG. 2 b(i) and 2b(ii) are two views of the SET domain using surface representation (views (i) and (ii) are related by a two-fold rotation about a vertical axis);

FIG. 2 c(i)-(iv) are stereographic representations of selected active site residues of the SET 7/9 domain;

FIG. 2 d(i) and (ii) are two representations of the electron density (2fo-2fc) over a small part of the active site of the SET 7/9 domain;

FIG. 3 is a bar chart showing the results of HMT assays of SET 7/9 and two point mutants thereof, for unmethylated or monomethylated lysine-containing peptide substrates;

FIG. 4 a is a schematic representation of various interactions made by the histone substrate peptide in complex with SET 7/9;

FIG. 4 b shows the sequence of various portions of histone proteins which are known to be subject to methylation, aligned according to the position of the target lysine residues. The numbers at the top refer to the relative position of the residues with respect to the target lysine (K) residue. The numbers at the sides are the absolute positions of the residues within the various histone proteins;

FIGS. 5 and 6 show examples of the structure of potential ligands for SET 7/9 proposed by the inventors; and

FIG. 7 is a schematic representation of a proposed synthesis scheme for preparing a further ligand of SET 7/9.

EXAMPLES

Example 1.1

Protein Constructs

A truncated form of the SET 7/9 HMT protein lacking the first 51 residues of the N terminal portion, referred to as ΔSET7/9 (residues 52-366), was expressed as a GST-fusion in pGEX 6P1 in E. coli BL21. The GST was removed by overnight treatment with PreScission™ Protease (Amersham) prior to gel filtration. Preparation of ΔSETT7/9 in D₂O for nmr studies resulted in a series of N-terminal degradation products which were still catalytically active. Subsequently a further truncated form of the protein, ΔΔSET7/9 (residues 108-366), was prepared as above and found to be stable for growth in D₂O and was consequently used for further nmr and crystallography experiments. Site-directed alanine mutations were introduced using the Stratagene Quikchange Mutagenesis kit, mutations were confirmed by DNA sequencing and electrospray mass spectrometry. Synthetic peptides were prepared using conventional in vitro techniques. AdoHcy was obtained from Fluka, Switzerland.

Example 1.2

HMTase Activity Measurements

The methyltransferase activity of SET7/9 and the various mutant constructs described in the text were determined in a reaction volume of 20 μl containing 3 μM AdoMet supplemented with [methyl-³H] AdoMet (4 μCi) (Amersham Biosciences, UK) and 750 μM purified methylase in reaction buffer (50 mM Tris pH 8.5, 100 mm NaCl, 1 mM EDTA, 1 mM DTT) with 50 μM histone peptide (see below). Following incubation at 37° C. for 60 min the reaction was vacuum blotted onto membrane (Hybond-C, Amersham Biosciences, UK) washed and activity measured by scintillation counting.

Example 1.3

Analytical Analysis of Histone Methylation

The histone methyltransferase assay for analytical purposes was carried out under slightly different conditions than those described in Example 1.2. For analytical purposes the reaction was performed at 37° C. in 50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM DTT, with 300 μM AdoMet (Fluka, Switzerland), 100 μM H3 20mer peptide (ARTKQTARKSTGGKAPRKQY), and with 1.5 μM enzyme. At desired time intervals an aliquot of the reaction was removed and quenched in 8 M urea and acidified with glacial acetic acid. The reaction products were separated by reverse phase HPLC (Jasco (UK) Ltd) on a Zorbax 300SB-C18 column (Rockland Technologies, Inc. USA) using a gradient from 0 to 40% acetonitrile in the presence of 0.05% trifluoroacetic acid at 55° C. Fractions from the peptide peak were analysed using a Reflex III MALDI time-of-flight mass spectrometer (Bruker Daltonik, GmbH, Germany) to obtain positive ion mass spectra.

Example 1.4

NMR

NMR spectra were recorded at 25° C. on a Varian Inova spectrometer operating at ¹H frequencies of 600 MHz and 800 MHz. Protein samples, 0.5 nM, were prepared in 50 mM Tris-HCl, 0.2 mM TCEP (Trialkylphosphine Tris (2-carboxyethyl)phosphine—a reducing agent), 10% D₂O, pH 6.5.

Example 1.5

Crystallography

Protein stock solution was prepared at 100 mg/ml in 50 mM Tris, pH 7.0, 100 mM NaCl, and then incubated with a two-fold molar excess of mono-methylated Lys-410-mer peptide (ARTKQTARKS) and AdoHcy. Crystals were grown by vapour diffusion at room temperature as hanging drops. Drops were prepared by mixing equal volumes of protein complex with reservoir solution containing 0.1M Tris, pH 7.8 and 22% PEG3350.

Crystals were first transferred into mother liquor augmented with an additional 5% PEG 400, prior to plunging into liquid nitrogen. Data were collected from flash cooled crystals at 100K on an Raxis-II detector mounted on a Rigaku RU200 generator. Diffraction data were integrated and scaled using DENZO and SCALEPACK (Otwinoski & Minor in “Data Collection and Processing” (eds. Sawyer, Isaacs & Bailey) p 556-562 (SERC Daresbury Laboratory, Warrington 1993)). The crystals belong to the spacegroup P2₁, with a=52.7 Å, b=75.4 Å, c=69.1 Å and β=94.2°. The upper resolution of data collection was limited only by the minimum crystal-detector distance, for all data 20-1.75 Å the merging R factor is 0.052 with 90% completeness (0.20 and 52% for the bin, 1.8-1.75 Å); overall the data is 1-fold redundant. The structure was solved by molecular replacement using our previous model (1H3I.brk) with AMORE. Subsequent refinement was done using REFMAC5 (1994, Collaborative Computational Project 4, Acta Crystallogr. D50 p 760-763) and manual model building in 0 (Jones et al, 1991 Acta Crystallogr. A47 p 110-119). The final model comprises one AdoHcy molecule and residues 117-366 of the protein for both complexes in the asymmetric unit, for the A molecule residues 1-6 of the peptide are ordered while all 10 residues are ordered in the B molecule because of the contacts with another molecule in the lattice. At the current stage of refinement, using all data from 20-1.75 Å, there are 480 water molecules and R_work=0.21, R_free=0.24 and rms bonds=0.008.

Example 2

Example 2.1

Preliminary NMR Studies

Preliminary studies were performed using a complex comprising an unlabelled SET 7/9 domain (residues 52-366 of SET 7/9HMT) and a 20 amino acid residue peptide corresponding to the N terminal of histone H3, specifically labelled with ¹³C and ¹⁵N terminal of histone H3, specifically labelled with ¹³C and ¹⁵N in the lysine residue at position 4. Slightly sub-stoichiometric amounts (0.8 equivalents) of labelled peptide were used. Spectra were recorded at 25° C. using a Varian Inova spectrometer operating at ¹H frequency of 600 MHz. Studies were performed with or without overnight incubation with 5.0 equivalents of AdoMet cofactor, so as to allow comparison of methylated product and unmethylated substrate complexes.

The spectrum of the methylated product complex (data omitted for brevity) exhibited marked differences from that of the unmodified peptide, most notably a reversal of the relative populations of the Lysine-4 side-chain conformers. The relative intensities of the new peaks appearing on methylation (at 2.87, 51.4 and 2.63, 42.0 ppm) indicated that the methylated peptide is more stably bound than the unmethylated substrate and the predominant species (>90%) appeared to have an environment dissimilar to that of the free peptide. A small proportion of the H3 peptide remained unmodified.

Example 2.2

Structural Determinations

Since the preliminary NMR studies suggested that a histone peptide containing monomethylated lysine-4 was better ordered in complex with SET 7/9 than unmodified peptide, the inventors used the products of the normal HMT reaction for crystallisation experiments (methylated lysine peptide and AdoHcy). In particular the inventors used a catalytically active construct that contains the complete C-terminal segment of the SET 7/9 domain. Well-ordered crystals of the ternary complex of SET 7/9 were obtained (using the methodology described in Example 1 and by Wilson et al, 2002 Cell 111, 105-115) that diffracted to at least 1.7 Å spacing and the structure was readily solved by molecular replacement. The C-terminal segment, the AdoHcy cofactor and most of the substrate peptide are well defined in the resulting electron density maps, as are all the important residues around the active site. The overall structure of the ternary complex of SET 7/9 is shown in two orthogonal views in FIG. 2a (i) and (ii).

FIG. 2 a shows two orthogonal views [(i) and (ii)] of the SET 7/9 ternary complex using ribbon representation. The N- and C-terminals of the SET 7/9 domain are labelled “N-term” and “C-term” respectively. The side chain of the methylated lysine residue at position 4 in the substrate peptide is labelled with reference numeral 2. The demethylated AdoHcy cofactor is labelled with reference numeral 4. Elements of the secondary structure of the SET 7/9 domain are labelled (β16 etc). FIG. 2b shows two views [(I) and (ii)] of the SET 7/9 domain using surface representation, and the circular inset panel (iii) shows a magnified view of the lysine access channel (see description below) accommodating the methylated lysine side chain, as seen from the AdoHcy binding site.

FIG. 2 b(i) shows the AdoHcy cofactor (2), and FIG. 2b(ii) shows the substrate peptide (4). FIG. 2b(iii) shows the lysine access channel, labelled with reference numeral 6, accommodating the lysine side chain.

The most stirring feature of the catalytic structure is that the AdoHcy and the peptide substrate are located on opposite sides of the SET domain and that there is a narrow channel (the “lysine access channel”) passing through the enzyme that connects the peptide and cofactor binding surfaces. The target lysine residue of the substrate (Lys-4) is inserted into this channel so that its amine can access the methyl donor (AdoMet). The packing of the C-terminal segment against the SET domain is required to form the lysine access channel explaining why this feature has not been observed in previous HMTase structures which did not include the C terminal segment of the SET domain (Wilson et al, 2002 Cell 111, 105-115).

The C-terminal segment (residues 345-366) is organised into two structural features; residues 337-349, belonging mainly to the SET domain, form an approximate β-hairpin structure that protrudes at a right angle to the surface of the enzyme. This is followed by three residues that accommodate a sharp bend in the polypeptide chain before the final stretch of the protein which adopts an α-helical conformation (FIG. 2a). Tyr-335 and Tyr-337, located just before the C-segment, are both important for the formation of the lysine access channel. The arrangements of the P-hairpin is such that it stabilises the conformation of these two tyrosine residues whilst also contributing to one of the sides of the groove into which the peptide binds. The second side of the peptide-binding groove is made up by residues 255-268 (including β-17). The α-helix at the end of the C-terminal segment packs against P-19, particularly Phe-299 (located just beyond the conserved NHS signature motif (Rea et al, 2000 Nature 406, 593-599), and makes hydrophobic packing interactions with the AdoHcy cofactor through Trp-352.

The mode of cofactor binding in the present structure is such that the methyl group to be transferred from the AdoMet to the amine is pointing into the lysine binding channel (see FIG. 2b). At the peptide binding site, the channel surface is largely made up by the side chains of Leu-267 and tyrosine residues -305-335 and -337 (FIGS. 2c and 2d). The alkyl component of the lysine side-chain therefore inhabits a hydrophobic environment.

The other end of the channel, where it opens onto the cofactor binding surface, is dominated by four phenoxyl hydorixdes (Tyr-245, and Tyr-305, -335, -337) and five main-chain carbonyl groups, all approximately oriented towards the lysine amine group. There are also several well defined water molecules in the vicinity of the active site, although only one is close to the lysine amine.

FIG. 2C, panels (i)-(iv), are stereographic representations of selected active site residues. The upper panels (i), (ii), show the AdoHcy and residues forming the channel occupied by the alkyl portion of the lysine side-chain. The lower panels (iii), (iv) show the arrangement of five main chain carbonyl groups around the amine group of the lysine side chain.

The arrangement is such that, along most of its length, the lysine access channel is highly hydrophobic, and thus insertion of the alkyl portion of the lysine side-chain into the channel is, energetically, very favourable. In contrast, at the far (co-factor) end, the channel is, relatively speaking, moderately hydrophilic due to the presence of the 5 carbonyl groups and this allows for accommodation of the polar amino group at the end of the lysine side-chain.

The structure, with its catalytic and binding surfaces, explains at last the role of a number of invariant residues, whose mutation to alanine has been shown to essentially abolish HMTase activity without significantly affecting the affinity for substrate or cofactor binding. The aromatic ring of Tyr-335 forms a significant part of the binding cavity for the alkyl portion of the Lys-4 residue while its hydroxyloxygen makes a single hydrogen bond to the main-chain carbonyl of residue 295. The importance of the correct positioning of this tyrosine residue is underscored by the observation that His-297 (of the NHS signature) acts to stabilise its conformation by acting as a hydrogen bond acceptor to its main-chain amide (FIG. 2c).

The electron density for the methyl-Lys-4 is very well defined and clearly shows the location of the single methyl group, FIG. 2d(i) and (ii). Examination of the active site also reveals that the lysine amine group donates hydrogen bonds to both the invariant Tyr-245 and to a tightly bound water molecule (W1). The lysine appears to be acting as a hydrogen bond donor in both cases because of the nature of the other hydrogen bonds made by Tyr-335 and W1 (FIG. 2c). The orientation of the lysine amine group is such that the amine-methyl bond is aligned towards the sulfur atom of the AdoHcy. Moreover, it is directed at sulfur along the tetrahedral vector corresponding to the (S) location of the methyl group in AdoMet (Hoffmann, 1986 Biochemistry 25, 4444-49).

FIG. 2 e shows a schematic representation of the proposed reaction scheme. The structure clearly shows that the lysine has been stripped of all solvent molecules except for the one water used as a hydrogen bond acceptor to orient the amino group. This desolvation will lower the pKa of the lysine amino group and also enhance its nucleophilicity. At the same time, the local orientation of the dipoles of four main-chain carbonyl groups towards the nitrogen will stabilise the developing positive charge on that atom as the methylation reaction proceeds. There is no proximate proton acceptor to provide general base catalysis for the nucleophilic nitrogen. Mechanistically, it thus seems likely that the lysine sidechain enters the active site with difficulty in its protonated form, the passage of this cation through the channel being facilitated by the faces of the flanking tyrosines. In the active site, the desolvated lysine is deprotonated, possibly to one of the flanking tyrosine oxygens. Thereafter the methylation reaction proceeds without general base catalysis, facilitated simply by orientation of orbitals, by desolvation and by stabilisation of charge reorganisation.

The present inventors have further analysed the methylation reaction. Reaction mixtures were set up with unmodified peptide and AdoMet and conditions found where the reaction was driven essentially to completion. HPLC separation of the reaction products (results omitted for brevity) gave a peak which eluted at a different position to the unmodified peptide and MALDI analysis of this material revealed only mono-methylated peptide. These results strongly support the conclusion that SET 7/9 catalyses the addition of a single methyl group to its target lysine. The reason for SET 7/9 acting as a mono-methyltransferase is readily apparent from the crystal structure now presented. The peptide used for crystallization was synthesised using mono-methylated lysine at position 4. In the crystal structure there is very well defined electron density for this methyl group in just one position. The arrangement of the two hydrogen bond acceptor groups (for the lysine amine) provides an immediate explanation for the lack of rotation about the CE-NZ bond; Tyr-245 and W1 not only make favourable interactions that stabilise the observed rotamer, but they also preclude, on steric grounds, a methyl group in any other position. Thus the structure shows that the arrangement of protein side-chains and, indirectly, water molecules at the active site of SET 7/9 is such that it can only catalyse the addition of a single methyl group to the lysine amine.

In the light of the present findings, comparison of the sequence of other SET proteins (Lachner & Jenuwein 2002, Curr. Opinion in Cell Biol. 14, 286-298), in the vicinity of the active site, suggests why many of these enzymes catalyse di- or tri-methylation of their target lysines. Only Tyr-245 and Tyr-335 are invariant across the SET family, many other residues are highly variable. So, for example, Tyr-305 is substituted for a valine residue in SUV39H1 (a tri-methylase) and a proline in G9a (a di-methylase). Both of these substitutions would seem likely to produce a cavity at the active site that could accommodate a methyl substituent on the lysine amine.

It has previously been reported that the Y245>A mutation in SET 7/9 leads to a dramatic reduction in HMTase activity (Wilson et al, 2002 cited above). The inventors have now surprisingly found that although this mutant has greatly reduced activity with respect to an unmodified lysine substrate, it has substantial activity if assayed with mono-methylated Lys-4 substrate (see FIG. 3). All of these results taken together, suggest that it will be possible both to predict from the primary structure whether a particular SET protein has mono-, di- or tri-methylase activity and to engineer altered functionality into these enzymes.

FIG. 3 shows the results of a Histone methyltransferase assay of SET 7/9, and SET 7/9 with either of the point mutations Y245→F, using histone H3 peptide substrate either unmodified or with monomethylation of the lysine residue at position 4.

The histone peptide binds in a largely extended conformation into a shallow groove (as shown in FIG. 2b). The binding is mediated by a network of hydrogen and salt bonds involving both the main-chain and side-chains of the peptide (FIG. 4a). The target Lys-4 residue is located approximately at the centre of the defined peptide and the interactions of non-conserved SET 7/9 residues with the peptide seems to account for the enzyme's specificity. Arg(−2)_PEP (substrate residues are numbered relative to the target lysine) makes a salt bridge with Asp-256 and a hydrogen bond with His-252. Thr(−1)_PEP and Gln(+1)_PEP both form hydrogen bonds with Ser-268, and Thr(+2) hydrogen bonds to the side-chain of Lys-317. Arg(−2)_PEP therefore seems to play a particularly important role in mediating substrate specificity. Moreover, inspection of the various histone target sequences (FIG. 4b) shows that only Lys-4 of histone H3 contains a basic residue in this (−2) position. The others all have a basic residue either at the (−1) or )+1) position. Both activity measurements and peptide affinity measurements, using a peptide in which Arg(−2)_PEP is mutated to an alanine (data not shown), support the notion that this arginine residue contributes significantly to peptide binding to SET 7/9. The structure of the ternary complex of SET 7/9 disclosed herein will provide a good model for assessing the likely substrate specificity of other SET proteins from their primary sequence.

Example 3

Rational Design of Ligands for SET 7/9

The determination of the structure of the SET 7/9 domain (in complex with its substrate) as disclosed herein has allowed the present inventors to identify a number of compounds which may act as ligands for the SET 7/9 domain and thus modulate the methyltransferase activity of HMTs containing the SET 7/9 domain.

In particular the inventors have identified (i) potential ligands which may bind to the SET domain ether in isolation or when the protein is in complex with a histone substrate; (ii) a second group of potential ligands which will bind to the SET domain only when the protein is in isolation. Potential ligands may be envisaged which will bind to the SET domain exclusively by covalent binding, or exclusively by non-covalent binding, or by a mixture of both covalent and non-covalent interactions.

In general, potential ligands may have some elements of structure which are analogous to the AdoMet cofactor. However, detailed knowledge of the SET structure has enabled the inventors to propose specific modifications which should improve binding affinity and/or specificity.

In general it will be desirable for the potential ligand to have a stabilised 5′ thioadenosine moiety. This can be achieved, for example, by replacing the S atom of AdoMet with N.

Such a molecule, AzaAdoMet, has been synthesized previously (1999 J. Org. Chem. 64, 7467). In addition, or as an alternative it may be advantageous to derivatise atoms which (in AdoMet) do not strongly interact with the SET protein. Examples include the 3′-OH of the ribosyl moiety and the —NH₂ group at position 4 of the adenyl moiety. Substitutions at one or more of these positions are likely to have beneficial effects on pharmacokinetics in general and on metabolic stability and/or bioavailability in particular. Examples of potential ligands may conform to the general formula I, wherein R¹, R¹ and R³ are, independently: H, alkyl, haloakyl, aralkyl, acyl, cycloalkyl, alkenyl, or oxa-alkyl and wherein n=0, 1 or 2.

Preferred ligands however will comprise a hydrophobic moiety (e.g. a substituted or unsubstituted alkyl or alkenyl group) which will occupy the lysine access channel normally occupied by the side chain of the lysine residue of the substrate. Occupancy of the lysine access channel by a hydrophobic moiety of a ligand would allow for multiple strong hydrophobic interactions, providing a large binding energy for formation of the ligand/protein complex, which should be reflected in a high binding affinity. The lysine access channel is about 8 Å in diameter and, in principle, any hydrophobic moiety of suitable size might be useful for inclusion in a ligand to make use of this unusual feature of the SET 7/9 domain. Ligands of this type may, for example, conform to the general formula II, wherein R¹-R³ and are as in general formula I, and wherein R⁴ may be selected from any of the following: a linear, cyclic or branched alkyl group comprising 2 or more carbon atoms (preferably 2-6 carbon atoms, more preferably 2-5 carbon atoms); an alkenyl group having one or more double bonds; the alkyl or alkenyl group optionally being substituted at one or more positions (e.g. hydroxylated, halogenated, or aminated) and optionally comprising one or more oxa- aza- or thia-replacements of CH₂ groups.

In particular, potential ligands which might occupy the lysine access channel, and therefore bind to SET-domain containing proteins with high affinity might include 1,1′-bis [2,2,2]-bicyclooctane or 1,4-diphenyl moieties. The structures of proposed sample ligands is shown in FIGS. 5 and 6. For the diphenyl-based ligand (FIG. 6) R¹-R⁴ must be small in size, so that the diphenyl moiety can still be inserted into the lysine access channel. R¹, R¹, R³ and R⁴ will typically therefore each comprise a single atom or a small group. For example R₁-R₄ may be, independently, any one of H, F, Cl, Br, OH, methyl, Omethyl or ethyl.

A further family of potential ligands relate to an 5′-aziridinyl adenosine alkylating agent that becomes activated in the bound state as a result of protonation. The parent aziridine nucleoside has been exemplified for underivatised adenosines by E. Weinhold et al (Angew. Chem. Int. Ed., 1998, 37, 2888). An outline synthetic scheme is shown in FIG. 7. Starting from the compound (1) described in the prior art, desirable modifications (R¹, R²) could be introduced to generate species (2). Next, addition of a modified or alternated “homocysteine” group would require the previous introduction of an aziridine generating group on the 5′-nitrogen (as illustrated in species (3), where X is P, Cl, Br or Omes for example). Lastly, incorporation of the aziridine in the “homocysteine” moiety would restore the concept of drug activation by N-protonation following binding the SET-domain containing HMT. In all cases, one would expect that such a ligand would alkylate the terminal amino group of the lysine side chain of the substrate histone, “locking” it into the active site and causing essentially irreversible inhibition of the HMT.

Ligands which fill the hydrophobic lysine access channel of the SET 7/9 domain may well exhibit binding which is highly specific for histone methyltransferases and exhibiting very little, if any, binding affinity for other methyltransferases which do not possess a similar substrate access channel. Consequently, drugs based on such ligands should be similarly specific.

An alternative (and less preferred) approach would be to try to block or fill the lysine access channel from the “cofactor side” of the SET 7/9 protein, by marketing use of protein/protein interactions (e.g. by using a peptide mimetic approach), based on knowledge of the flanking amino acid residues surrounding the opening of the channel. Such peptides are readily synthesized in vitro in large quantities. Conceivably it might be possible to combine the two approaches by using a peptide mimetic with a hydrophobic moiety to be inserted into the lysine access channel—although this would need to allow for the relatively polar nature of the channel at the co-factor end.

Annex 1
HEADER	TRANSFERASE                   18-DEC-02  1O9S
TITLE	CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF THE HUMAN HISTONE
TITLE	2 METHYLTRANSFERASE SET7/9
COMPND	MOL_ID; 1;
COMPND	2 MOLECULE: HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-4
COMPND	3 SPECIFIC;
COMPND	4 SYNONYM: HISTONE H3-K4 METHYLTRANSFERASE, H3-K4-HMTASE;
COMPND	5 CHAIN: A;
COMPND	6 FRAGMENT: N-DOMAIN, SET-DOMAIN, RESIDUES 108-366;
COMPND	7 EC: 2.1.1.43;
COMPND	8 ENGINEERED: YES;
COMPND	9 MOL_ID: 2;
COMPND	10 MOLECULE: GENE FRAGMENT FOR HISTONE H3;
COMPND	11 CHAIN: K;
COMPND	12 FRAGMENT: RESIDUES 2-11;
COMPND	13 ENGINEERED: YES
SOURCE	MOL_ID: 1;
SOURCE	2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE	3 ORGANISM_COMMON: HUMAN;
SOURCE	4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE	5 MOL_ID: 2;
SOURCE	6 SYNTHETIC: YES;
SOURCE	7 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE	8 ORGANISM_COMMON: HUMAN
KEYWDS	METHYLATION, HISTONE H3, METHYLTRANSFERASE, TRANSFERASE
EXPDTA	X-RAY DIFFRACTION
AUTHOR	B. XIAO, C. JING, J. R. WILSON, P. A. WALKER, N. VASISHT, G. KELLY,
AUTHOR	2 S. HOWELL, I. A. TAYLOR, G. M. BLACKBURN, S. J. GAMBLIN
REVDAT	1  19-DEC-02 1O9S   0
JRNL	AUTH B. XIAO, C. JING, J. R. WILSON, P. A. WALKER, N. VASISHT,
JRNL	AUTH 2 G. KELLY, S. HOWELL, I. A. TAYLOR, G. M. BLACKBURN,
JRNL	AUTH 3 S. J. GAMBLIN
JRNL	TITL STRUCTURE AND CATALYTIC MECHANISM OF THE HUMAN
JRNL	TITL 2 HISTONE METHYLTRANSFERASE SET7/9
JRNL	REF  TO BE PUBLISHED
JRNL	REFN
REMARK	2 RESOLUTION. 1.75 ANGSTROMS.
REMARK	E 501 SAH S-Adenosyl-homocyteine
CRYST1	52.690  75.438  69.099  90.00  94.16  90.00  P 1 21 1   4
ORIGX1	1.000000	0.000000	0.000000	0.00000
ORIGX2	0.000000	1.000000	0.000000	0.00000
ORIGX3	0.000000	0.000000	1.000000	0.00000
SCALE1	0.018979	0.000000	0.001380	0.00000
SCALE2	0.000000	0.013256	0.000000	0.00000
SCALE3	0.000000	0.000000	0.014510	0.00000
	No.	Type	Residue	X	Y	Z	Occ.	B
ATOM	1	N	GLY	A	117	31.852	−2.694	2.451	1.00	13.90	N
ATOM	3	CA	GLY	A	117	30.788	−1.711	2.826	1.00	13.55	C
ATOM	6	C	GLY	A	117	30.367	−1.598	4.276	1.00	13.14	C
ATOM	7	O	GLY	A	117	29.481	−0.788	4.552	1.00	14.03	O
ATOM	10	N	VAL	A	118	30.820	−2.492	5.146	1.00	11.64	N
ATOM	12	CA	VAL	A	118	30.552	−2.429	6.568	1.00	10.23	C
ATOM	14	CB	VAL	A	118	31.408	−3.477	7.277	1.00	10.37	C
ATOM	16	CG1	VAL	A	118	30.860	−3.776	8.647	1.00	10.40	C
ATOM	20	CG2	VAL	A	118	31.444	−4.758	6.440	1.00	10.29	C
ATOM	24	C	VAL	A	118	30.691	−1.045	7.215	1.00	9.12	C
ATOM	25	O	VAL	A	118	31.738	−0.387	7.133	1.00	8.38
ATOM	26	N	CYS	A	119	29.609	−0.620	7.860	1.00	7.88
ATOM	28	CA	CYS	A	119	29.560	0.642	8.582	1.00	7.63
ATOM	30	CB	CYS	A	119	28.553	1.595	7.946	1.00	7.90
ATOM	33	SG	CYS	A	119	28.136	3.044	8.935	1.00	8.87
ATOM	34	C	CYS	A	119	29.191	0.387	10.047	1.00	7.19
ATOM	35	O	CYS	A	119	28.248	−0.351	10.346	1.00	6.63
ATOM	36	N	TRP	A	120	29.963	0.979	10.949	1.00	6.31
ATOM	38	CA	TRP	A	120	29.692	0.897	12.381	1.00	6.30
ATOM	40	CB	TRP	A	120	30.960	0.559	13.183	1.00	6.44
ATOM	43	CG	TRP	A	120	31.500	−0.810	12.987	1.00	6.89
ATOM	44	CD1	TRP	A	120	32.219	−1.265	11.920	1.00	7.26
ATOM	46	NE1	TRP	A	120	32.574	−2.580	12.117	1.00	8.17
ATOM	48	CE2	TRP	A	120	32.088	−2.997	13.327	1.00	8.70
ATOM	49	CD2	TRP	A	120	31.416	−1.902	13.908	1.00	7.94
ATOM	50	CE3	TRP	A	120	30.827	−2.073	15.164	1.00	8.69
ATOM	52	CZ3	TRP	A	120	30.926	−3.312	15.792	1.00	9.60
ATOM	54	CH2	TRP	A	120	31.604	−4.378	15.188	1.00	9.83
ATOM	56	CZ2	TRP	A	120	32.196	−4.240	13.963	1.00	9.55
ATOM	58	C	TRP	A	120	29.190	2.262	12.847	1.00	6.01
ATOM	59	O	TRP	A	120	29.838	3.279	12.602	1.00	5.78
ATOM	60	N	ILE	A	121	28.033	2.284	13.495	1.00	5.92
ATOM	62	CA	ILE	A	121	27.493	3.517	14.047	1.00	6.04
ATOM	64	CB	ILE	A	121	26.105	3.817	13.469	1.00	6.35
ATOM	66	CG1	ILE	A	121	26.154	3.835	11.936	1.00	6.79
ATOM	69	CD1	ILE	A	121	24.786	4.013	11.282	1.00	7.65
ATOM	73	CG2	ILE	A	121	25.600	5.165	13.962	1.00	6.50
ATOM	77	C	ILE	A	121	27.420	3.373	15.574	1.00	5.80
ATOM	78	O	ILE	A	121	26.590	2.634	16.101	1.00	5.54
ATOM	79	N	TYR	A	122	28.304	4.064	16.278	1.00	5.71
ATOM	81	CA	TYR	A	122	28.300	4.007	17.733	1.00	5.65
ATOM	83	CB	TYR	A	122	29.719	4.092	18.288	1.00	5.69
ATOM	86	CG	TYR	A	122	30.466	2.790	18.211	1.00	5.87
ATOM	87	CD1	TYR	A	122	31.219	2.470	17.089	1.00	6.06
ATOM	89	CE1	TYR	A	122	31.900	1.285	17.007	1.00	6.49
ATOM	91	CZ	TYR	A	122	31.842	0.396	18.055	1.00	6.75
ATOM	92	OH	TYR	A	122	32.531	−0.783	17.973	1.00	9.10
ATOM	94	CE2	TYR	A	122	31.106	0.683	19.184	1.00	6.65
ATOM	96	CD2	TYR	A	122	30.420	1.877	19.257	1.00	5.78
ATOM	98	C	TYR	A	122	27.479	5.132	18.319	1.00	5.62
ATOM	99	O	TYR	A	122	27.680	6.304	17.993	1.00	6.01
ATOM	100	N	TYR	A	123	26.551	4.773	19.190	1.00	5.73
ATOM	102	CA	TYR	A	123	25.770	5.769	19.901	1.00	6.09
ATOM	104	CB	TYR	A	123	24.457	5.180	20.405	1.00	6.43
ATOM	107	CG	TYR	A	123	23.532	4.727	19.308	1.00	7.37
ATOM	108	CD1	TYR	A	123	23.343	3.381	19.055	1.00	8.49
ATOM	110	CE1	TYR	A	123	22.488	2.952	18.050	1.00	8.58
ATOM	112	CZ	TYR	A	123	21.815	3.883	17.284	1.00	9.47
ATOM	113	OH	TYR	A	123	20.969	3.448	16.296	1.00	11.11
ATOM	115	CE2	TYR	A	123	21.984	5.234	17.515	1.00	8.85
ATOM	117	CD2	TYR	A	123	22.840	5.648	18.528	1.00	8.33
ATOM	119	C	TYR	A	123	26.603	6.258	21.080	1.00	5.50
ATOM	120	O	TYR	A	123	27.512	5.561	21.556	1.00	5.44
ATOM	121	N	PRO	A	124	26.303	7.453	21.564	1.00	5.04
ATOM	122	CA	PRO	A	124	27.026	8.012	22.709	1.00	4.56
ATOM	124	CB	PRO	A	124	26.311	9.349	22.970	1.00	4.62
ATOM	127	CG	PRO	A	124	25.365	9.565	21.870	1.00	5.23
ATOM	130	CD	PRO	A	124	25.265	8.357	21.059	1.00	5.10
ATOM	133	C	PRO	A	124	26.979	7.113	23.955	1.00	3.98
ATOM	134	O	PRO	A	124	27.880	7.201	24.781	1.00	3.93
ATOM	135	N	ASP	A	125	25.966	6.257	24.066	1.00	3.55
ATOM	137	CA	ASP	A	125	25.821	5.359	25.207	1.00	3.08
ATOM	139	CB	ASP	A	125	24.365	4.953	25.422	1.00	2.63
ATOM	142	CG	ASP	A	125	23.731	4.358	24.181	1.00	2.85
ATOM	143	OD1	ASP	A	125	24.275	3.374	23.635	1.00	2.64
ATOM	144	OD2	ASP	A	125	22.675	4.814	23.706	1.00	3.02
ATOM	145	C	ASP	A	125	26.691	4.110	25.104	1.00	3.21
ATOM	146	O	ASP	A	125	26.774	3.342	26.056	1.00	2.98
ATOM	147	N	GLY	A	126	27.320	3.888	23.955	1.00	3.70
ATOM	149	CA	GLY	A	126	28.228	2.756	23.814	1.00	3.59
ATOM	152	C	GLY	A	126	27.684	1.636	22.955	1.00	3.82
ATOM	153	O	GLY	A	126	28.433	0.769	22.515	1.00	3.55
ATOM	154	N	GLY	A	127	26.371	1.642	22.718	1.00	3.88	N
ATOM	156	CA	GLY	A	127	25.761	0.659	21.840	1.00	4.21
ATOM	159	C	GLY	A	127	26.096	1.018	20.395	1.00	4.61
ATOM	160	O	GLY	A	127	26.593	2.109	20.109	1.00	4.48
ATOM	161	N	SER	A	128	25.825	0.110	19.470	1.00	5.37
ATOM	163	CA	SER	A	128	26.140	0.372	18.070	1.00	5.88
ATOM	165	CB	SER	A	128	27.619	0.028	17.808	1.00	6.36
ATOM	168	OG	SER	A	128	27.904	−1.320	18.139	1.00	6.52
ATOM	170	C	SER	A	128	25.253	−0.376	17.094	1.00	6.17
ATOM	171	O	SER	A	128	24.612	−1.363	17.446	1.00	5.68
ATOM	172	N	LEU	A	129	25.203	0.150	15.870	1.00	6.68
ATOM	174	CA	LEU	A	129	24.546	−0.488	14.742	1.00	7.41
ATOM	176	CB	LEU	A	129	23.546	0.469	14.084	1.00	7.78
ATOM	179	CG	LEU	A	129	22.059	0.098	14.150	1.00	10.11
ATOM	181	CD1	LEU	A	129	21.609	−0.271	15.535	1.00	11.82
ATOM	185	CD2	LEU	A	129	21.209	1.256	13.588	1.00	10.96
ATOM	189	C	LEU	A	129	25.678	−0.852	13.776	1.00	7.31
ATOM	190	O	LEU	A	129	26.581	−0.041	13.520	1.00	7.01
ATOM	191	N	VAL	A	130	25.652	−2.075	13.256	1.00	7.45
ATOM	193	CA	VAL	A	130	26.715	−2.540	12.373	1.00	7.62
ATOM	195	CB	VAL	A	130	27.722	−3.377	13.136	1.00	7.81
ATOM	197	CG1	VAL	A	130	28.953	−3.618	12.265	1.00	7.47
ATOM	201	CG2	VAL	A	130	28.079	−2.689	14.417	1.00	8.87
ATOM	205	C	VAL	A	130	26.200	−3.410	11.245	1.00	7.84
ATOM	206	O	VAL	A	130	25.346	−4.265	11.448	1.00	8.27
ATOM	207	N	GLY	A	131	26.740	−3.196	10.055	1.00	7.83
ATOM	209	CA	GLY	A	131	26.349	−3.988	8.903	1.00	7.72
ATOM	212	C	GLY	A	131	26.744	−3.336	7.597	1.00	8.01
ATOM	213	O	GLY	A	131	27.115	−2.155	7.536	1.00	6.88
ATOM	214	N	GLU	A	132	26.693	−4.139	6.545	1.00	8.56
ATOM	216	CA	GLU	A	132	26.931	−3.650	5.207	1.00	9.76
ATOM	218	CB	GLU	A	132	26.773	−4.795	4.209	1.00	10.61
ATOM	221	CG	GLU	A	132	28.057	−5.375	3.662	1.00	12.77
ATOM	224	CD	GLU	A	132	27.834	−6.071	2.335	1.00	14.90
ATOM	225	OE1	GLU	A	132	26.692	−6.069	1.849	1.00	17.36
ATOM	226	OE2	GLU	A	132	28.804	−6.614	1.768	1.00	16.80
ATOM	227	C	GLU	A	132	25.855	−2.630	4.884	1.00	9.88
ATOM	228	O	GLU	A	132	24.685	−2.877	5.150	1.00	10.33
ATOM	229	N	VAL	A	133	26.231	−1.495	4.310	1.00	10.07
ATOM	231	CA	VAL	A	133	25.234	−0.516	3.848	1.00	10.25
ATOM	233	CB	VAL	A	133	25.797	0.910	3.870	1.00	10.52
ATOM	235	CG1	VAL	A	133	26.278	1.237	5.252	1.00	10.72
ATOM	239	CG2	VAL	A	133	26.920	1.082	2.851	1.00	10.68
ATOM	243	C	VAL	A	133	24.729	−0.853	2.433	1.00	10.42
ATOM	244	O	VAL	A	133	25.398	−1.575	1.695	1.00	9.26
ATOM	245	N	ASN	A	134	23.541	−0.339	2.077	1.00	10.94
ATOM	247	CA	ASN	A	134	22.936	−0.558	0.756	1.00	11.92
ATOM	249	CB	ASN	A	134	21.446	−0.102	0.768	1.00	11.89
ATOM	252	CG	AASN	A	134	20.496	−1.066	0.269	0.50	13.75
ATOM	253	CG	BASN	A	134	21.305	1.409	0.958	0.50	12.62
ATOM	254	OD1	AASN	A	134	20.857	−2.146	−0.162	0.50	15.50
ATOM	255	OD1	BASN	A	134	22.289	2.136	1.015	0.50	13.62
ATOM	256	ND2	AASN	A	134	19.235	−0.632	0.183	0.50	14.57
ATOM	257	ND2	BASN	A	134	20.070	1.880	1.015	0.50	13.29
ATOM	262	C	ASN	A	134	23.704	0.253	−0.293	1.00	12.39
ATOM	263	O	ASN	A	134	24.599	1.030	0.041	1.00	11.91
ATOM	264	N	GLU	A	135	23.340	0.089	−1.563	1.00	13.28
ATOM	266	CA	GLU	A	135	23.973	0.862	−2.630	1.00	14.12
ATOM	268	CB	GLU	A	135	23.433	0.475	−4.026	1.00	14.45
ATOM	271	CG	GLU	A	135	21.955	0.726	−4.294	1.00	15.44
ATOM	274	CD	GLU	A	135	21.568	0.407	−5.735	1.00	16.94
ATOM	275	OE1	GLU	A	135	22.468	0.069	−6.538	1.00	17.74
ATOM	276	OE2	GLU	A	135	20.366	0.501	−6.085	1.00	17.47
ATOM	277	C	GLU	A	135	23.812	2.368	−2.347	1.00	14.41
ATOM	278	O	GLU	A	135	24.527	3.190	−2.918	1.00	14.88
ATOM	279	N	ASP	A	136	22.890	2.713	−1.446	1.00	14.52
ATOM	281	CA	ASP	A	136	22.604	4.105	−1.083	1.00	14.64
ATOM	283	CB	ASP	A	136	21.090	4.344	−1.066	1.00	14.86
ATOM	286	CG	ASP	A	136	20.460	4.271	−2.443	1.00	15.26
ATOM	287	OD1	ASP	A	136	21.185	4.369	−3.456	1.00	15.80
ATOM	288	OD2	ASP	A	136	19.233	4.120	−2.607	1.00	15.74
ATOM	289	C	ASP	A	136	23.153	4.501	0.291	1.00	14.53
ATOM	290	O	ASP	A	136	22.784	5.548	0.825	1.00	14.88
ATOM	291	N	GLY	A	137	24.008	3.666	0.876	1.00	14.11
ATOM	293	CA	GLY	A	137	24.585	3.960	2.179	1.00	13.69
ATOM	296	C	GLY	A	137	23.634	3.851	3.361	1.00	13.26
ATOM	297	O	GLY	A	137	23.916	4.401	4.427	1.00	13.56
ATOM	298	N	GLU	A	138	22.520	3.142	3.197	1.00	12.56
ATOM	300	CA	GLU	A	138	21.573	2.951	4.302	1.00	12.13
ATOM	302	CB	GLU	A	138	20.132	3.043	3.807	1.00	12.20
ATOM	305	CG	GLU	A	138	19.762	4.404	3.243	1.00	13.10
ATOM	308	CD	GLU	A	138	18.564	4.341	2.320	1.00	14.32
ATOM	309	OE1	GLU	A	138	18.166	3.219	1.942	1.00	15.05
ATOM	310	OE2	GLU	A	138	18.026	5.410	1.957	1.00	15.58
ATOM	311	C	GLU	A	138	21.793	1.602	4.988	1.00	11.37
ATOM	312	O	GLU	A	138	22.238	0.648	4.354	1.00	11.03
ATOM	313	N	MET	A	139	21.489	1.528	6.285	1.00	10.72
ATOM	315	CA	MET	A	139	21.592	0.284	7.038	1.00	10.35
ATOM	317	CB	MET	A	139	21.672	0.584	8.529	1.00	11.29
ATOM	320	CG	MET	A	139	22.928	1.315	8.887	1.00	14.10
ATOM	323	SD	MET	A	139	24.340	0.197	8.839	1.00	20.90
ATOM	324	CE	MET	A	139	24.057	−0.735	10.285	1.00	20.60
ATOM	328	C	MET	A	139	20.399	−0.617	6.787	1.00	9.24
ATOM	329	O	MET	A	139	19.541	−0.779	7.652	1.00	8.26
ATOM	330	N	THR	A	140	20.360	−1.203	5.592	1.00	8.20
ATOM	332	CA	THR	A	140	19.276	−2.065	5.171	1.00	7.66
ATOM	334	CB	THR	A	140	18.526	−1.378	4.024	1.00	7.49
ATOM	336	OG1	THR	A	140	18.095	−0.077	4.443	1.00	7.44
ATOM	338	CG2	THR	A	140	17.242	−2.114	3.657	1.00	7.50
ATOM	342	C	THR	A	140	19.836	−3.369	4.643	1.00	7.44
ATOM	343	O	THR	A	140	20.634	−3.367	3.717	1.00	7.48
ATOM	344	N	GLY	A	141	19.409	−4.482	5.222	1.00	7.61
ATOM	346	CA	GLY	A	141	19.866	−5.789	4.789	1.00	7.57
ATOM	349	C	GLY	A	141	19.420	−6.844	5.782	1.00	7.70
ATOM	350	O	GLY	A	141	18.803	−6.509	6.800	1.00	7.59
ATOM	351	N	GLU	A	142	19.767	−8.102	5.513	1.00	7.72
ATOM	353	CA	GLU	A	142	19.361	−9.232	6.356	1.00	8.07
ATOM	355	CB	GLU	A	142	19.056	−10.442	5.475	1.00	8.60
ATOM	358	CG	GLU	A	142	17.878	−10.230	4.541	1.00	10.48
ATOM	361	CD	GLO	A	142	16.545	−10.378	5.242	1.00	12.69
ATOM	362	OE1	GLU	A	142	16.516	−10.311	6.485	1.00	14.31
ATOM	363	OE2	GLU	A	142	15.527	−10.561	4.545	1.00	14.94
ATOM	364	C	GLU	A	142	20.414	−9.641	7.367	1.00	7.91
ATOM	365	O	GLU	A	142	20.180	−10.523	8.193	1.00	7.61
ATOM	366	N	LYS	A	143	21.576	−9.010	7.288	1.00	7.58
ATOM	368	CA	LYS	A	143	22.684	−9.353	8.160	1.00	7.56
ATOM	370	CB	LYS	A	143	23.808	−9.985	7.341	1.00	7.63
ATOM	373	CG	LYS	A	143	23.429	−11.335	6.723	1.00	7.75
ATOM	376	CD	LYS	A	143	24.554	−11.902	5.871	1.00	8.89
ATOM	379	CE	LYS	A	143	24.185	−13.242	5.262	1.00	10.51
ATOM	382	NZ	LYS	A	143	25.306	−13.829	4.466	1.00	11.82
ATOM	386	C	LYS	A	143	23.183	−8.116	8.892	1.00	7.45
ATOM	387	O	LYS	A	143	24.385	−7.887	8.988	1.00	7.79
ATOM	388	N	ILE	A	144	22.256	−7.316	9.407	1.00	7.24	N
ATOM	390	CA	ILE	A	144	22.617	−6.111	10.157	1.00	7.37	C
ATOM	392	CB	ILE	A	144	21.758	−4.926	9.725	1.00	7.95	C
ATOM	394	CG1	ILE	A	144	22.066	−4.586	8.260	1.00	9.50	C
ATOM	397	CD1	ILE	A	144	21.303	−3.432	7.744	1.00	10.75	C
ATOM	401	CG2	ILE	A	144	21.998	−3.722	10.610	1.00	7.98	C
ATOM	405	C	ILE	A	144	22.461	−6.412	11.643	1.00	7.00	C
ATOM	406	O	ILE	A	144	21.740	−7.333	12.008	1.00	6.71	C
ATOM	407	N	ALA	A	145	23.161	−5.675	12.505	1.00	6.55	N
ATOM	409	CA	ALA	A	145	23.060	−5.947	13.924	1.00	6.38	C
ATOM	411	CB	ALA	A	145	24.182	−6.892	14.344	1.00	6.56	C
ATOM	415	C	ALA	A	145	23.103	−4.720	14.822	1.00	6.21	C
ATOM	416	O	ALA	A	145	23.744	−3.709	14.515	1.00	6.27	O
ATOM	417	N	TYR	A	146	22.397	−4.821	15.935	1.00	5.83	N
ATOM	419	CA	TYR	A	146	22.567	−3.855	16.991	1.00	5.75	C
ATOM	421	CB	TYR	A	146	21.278	−3.491	17.680	1.00	5.65	C
ATOM	424	CG	TYR	A	146	21.556	−2.722	18.955	1.00	5.17	C
ATOM	425	CD1	TYR	A	146	21.855	−1.366	18.922	1.00	4.51	C
ATOM	427	CE1	TYR	A	146	22.124	−0.661	20.096	1.00	4.27	C
ATOM	429	CZ	TYR	A	146	22.107	−1.322	21.306	1.00	4.15	C
ATOM	430	OH	TYR	A	146	22.373	−0.623	22.469	1.00	3.48	O
ATOM	432	CE2	TYR	A	146	21.825	−2.671	21.359	1.00	4.42	C
ATOM	434	CD2	TYR	A	146	21.566	−3.364	20.193	1.00	4.81	C
ATOM	436	C	TYR	A	146	23.451	−4.543	18.015	1.00	5.68	C
ATOM	437	O	TYR	A	146	23.214	−5.695	18.365	1.00	5.97	O
ATOM	438	N	VAL	A	147	24.458	−3.845	18.509	1.00	5.56	N
ATOM	440	CA	VAL	A	147	25.326	−4.434	19.509	1.00	5.28	C
ATOM	442	CB	VAL	A	147	26.791	−4.503	19.025	1.00	5.60	C
ATOM	444	CG1	VAL	A	147	27.644	−5.214	20.036	1.00	5.40	C
ATOM	448	CG2	VAL	A	147	26.869	−5.217	17.673	1.00	6.04	C
ATOM	452	C	VAL	A	147	25.213	−3.592	20.781	1.00	4.80	C
ATOM	453	O	VAL	A	147	25.357	−2.370	20.735	1.00	4.27	O
ATOM	454	N	TYR	A	148	24.933	−4.249	21.902	1.00	4.48	N
ATOM	456	CA	TYR	A	148	24.817	−3.575	23.194	1.00	4.13	C
ATOM	458	CB	TYR	A	148	24.291	−4.555	24.243	1.00	3.94	C
ATOM	461	CG	TYR	A	148	22.795	−4.859	24.136	1.00	3.58	C
ATOM	462	CD1	TYR	A	148	22.327	−5.880	23.325	1.00	3.66	C
ATOM	464	CE1	TYR	A	148	20.983	−6.167	23.248	1.00	4.23	C
ATOM	466	CZ	TYR	A	148	20.076	−5.422	23.975	1.00	3.79	C
ATOM	467	OH	TYR	A	148	18.740	−5.721	23.900	1.00	4.39	O
ATOM	469	CE2	TYR	A	148	20.515	−4.400	24.791	1.00	3.42	C
ATOM	471	CD2	TYR	A	148	21.869	−4.132	24.865	1.00	3.02	C
ATOM	473	C	TYR	A	148	26.181	−2.994	23.603	1.00	3.93	C
ATOM	474	O	TYR	A	148	27.193	−3.334	22.992	1.00	4.16	O
ATOM	475	N	PRO	A	149	26.216	−2.117	24.614	1.00	3.52	N
ATOM	476	CA	PRO	A	149	27.463	−1.488	25.059	1.00	3.71	C
ATOM	478	CB	PRO	A	149	26.999	−0.534	26.166	1.00	3.63	C
ATOM	481	CG	PRO	A	149	25.556	−0.323	25.932	1.00	3.10	C
ATOM	484	CD	PRO	A	149	25.068	−1.619	25.385	1.00	3.36	C
ATOM	487	C	PRO	A	149	28.520	−2.429	25.607	1.00	3.72	C
ATOM	488	O	PRO	A	149	29.644	−1.979	25.827	1.00	3.15	O
ATOM	489	N	ASP	A	150	28.195	−3.698	25.820	1.00	4.10	N
ATOM	491	CA	ASP	A	150	29.219	−4.647	26.257	1.00	4.16	C
ATOM	493	CB	ASP	A	150	28.632	−5.834	27.034	1.00	4.16	C
ATOM	496	CG	ASP	A	150	27.697	−6.702	26.218	1.00	4.50	C
ATOM	497	OD1	ASP	A	150	27.395	−6.381	25.041	1.00	4.01	O
ATOM	498	OD2	ASP	A	150	27.199	−7.741	26.711	1.00	4.84	O
ATOM	499	C	ASP	A	150	30.088	−5.102	25.073	1.00	4.57	C
ATOM	500	O	ASP	A	150	31.110	−5.769	25.277	1.00	4.32	O
ATOM	501	N	GLU	A	151	29.710	−4.680	23.863	1.00	4.71	N
ATOM	503	CA	GLU	A	151	30.388	−5.043	22.617	1.00	5.51	C
ATOM	505	CB	GLU	A	151	31.796	−4.464	22.555	1.00	6.19	C
ATOM	508	CG	GLU	A	151	31.809	−2.948	22.701	1.00	7.98	C
ATOM	511	CD	GLU	A	151	33.198	−2.358	22.605	1.00	9.90	C
ATOM	512	OE1	GLU	A	151	33.909	−2.350	23.625	1.00	11.04
ATOM	513	OE2	GLU	A	151	33.570	−1.893	21.510	1.00	12.19
ATOM	514	C	GLU	A	151	30.408	−6.554	22.441	1.00	5.71
ATOM	515	O	GLU	A	151	31.357	−7.117	21.909	1.00	5.94
ATOM	516	N	ARG	A	152	29.336	−7.208	22.872	1.00	5.92
ATOM	518	CA	ARG	A	152	29.271	−8.663	22.846	1.00	6.09
ATOM	520	CB	ARG	A	152	29.723	−9.216	24.206	1.00	6.65
ATOM	523	CG	ARG	A	152	29.715	−10.730	24.288	1.00	7.72
ATOM	526	CD	ARG	A	152	30.177	−11.289	25.644	1.00	9.71
ATOM	529	NE	ARG	A	152	30.019	−12.741	25.683	1.00	11.70
ATOM	531	CZ	ARG	A	152	31.007	−13.605	25.870	1.00	13.50
ATOM	532	NH1	ARG	A	152	32.247	−13.183	26.085	1.00	14.88
ATOM	535	NH2	ARG	A	152	30.753	−14.906	25.867	1.00	14.21
ATOM	538	C	ARG	A	152	27.870	−9.156	22.530	1.00	5.87
ATOM	539	O	ARG	A	152	27.682	−9.962	21.623	1.00	6.13
ATOM	540	N	THR	A	153	26.890	−8.686	23.291	1.00	5.66
ATOM	542	CA	THR	A	153	25.507	−9.066	23.066	1.00	5.27
ATOM	544	CB	THR	A	153	24.656	−8.749	24.274	1.00	5.42
ATOM	546	OG1	THR	A	153	25.280	−9.288	25.445	1.00	6.02
ATOM	548	CG2	THR	A	153	23.311	−9.467	24.197	1.00	5.91
ATOM	552	C	THR	A	153	24.984	−8.289	21.884	1.00	5.05
ATOM	553	O	THR	A	153	25.111	−7.060	21.842	1.00	4.35
ATOM	554	N	ALA	A	154	24.373	−9.010	20.947	1.00	4.76
ATOM	556	CA	ALA	A	154	23.892	−8.413	19.723	1.00	4.85
ATOM	558	CB	ALA	A	154	24.885	−8.678	18.600	1.00	4.69
ATOM	562	C	ALA	A	154	22.514	−8.935	19.326	1.00	4.90
ATOM	563	O	ALA	A	154	22.090	−10.016	19.740	1.00	5.00
ATOM	564	N	LEU	A	155	21.838	−8.137	18.508	1.00	5.04
ATOM	566	CA	LEU	A	155	20.543	−8.475	17.934	1.00	4.96
ATOM	568	CB	LEU	A	155	19.488	−7.453	18.363	1.00	4.60
ATOM	571	CG	LEU	A	155	19.311	−7.227	19.871	1.00	4.30
ATOM	573	CD1	LEU	A	155	18.176	−6.271	20.143	1.00	4.42
ATOM	577	CD2	LEU	A	155	19.082	−8.530	20.607	1.00	3.93
ATOM	581	C	LEU	A	155	20.792	−8.437	16.420	1.00	5.23
ATOM	582	O	LEU	A	155	20.928	−7.370	15.836	1.00	5.43
ATOM	583	N	TYR	A	156	20.866	−9.613	15.805	1.00	5.87
ATOM	585	CA	TYR	A	156	21.312	−9.782	14.422	1.00	6.34
ATOM	587	CB	TYR	A	156	22.454	−10.815	14.445	1.00	6.89
ATOM	590	CG	TYR	A	156	23.081	−11.169	13.117	1.00	8.47
ATOM	591	CD1	TYR	A	156	24.005	−10.336	12.519	1.00	9.81
ATOM	593	CE1	TYR	A	156	24.604	−10.665	11.332	1.00	9.89
ATOM	595	CZ	TYR	A	156	24.300	−11.848	10.728	1.00	10.98
ATOM	596	OH	TYR	A	156	24.892	−12.163	9.533	1.00	11.95
ATOM	598	CE2	TYR	A	156	23.380	−12.703	11.297	1.00	11.43
ATOM	600	CD2	TYR	A	156	22.790	−12.368	12.495	1.00	10.67
ATOM	602	C	TYR	A	156	20.205	−10.268	13.497	1.00	6.17
ATOM	603	O	TYR	A	156	19.532	−11.251	13.798	1.00	5.91
ATOM	604	N	GLY	A	157	20.027	−9.588	12.362	1.00	5.92
ATOM	606	CA	GLY	A	157	19.010	−9.977	11.407	1.00	6.02
ATOM	609	C	GLY	A	157	18.607	−8.857	10.467	1.00	5.97
ATOM	610	O	GLY	A	157	19.444	−8.093	9.979	1.00	5.47
ATOM	611	N	LYS	A	158	17.304	−8.754	10.251	1.00	6.58
ATOM	613	CA	LYS	A	158	16.730	−7.820	9.289	1.00	6.79
ATOM	615	CB	LYS	A	158	15.383	−8.366	8.800	1.00	7.28
ATOM	618	CG	LYS	A	158	14.762	−7.570	7.673	1.00	8.22
ATOM	621	CD	LYS	A	158	13.496	−8.225	7.123	1.00	9.35
ATOM	624	CE	LYS	A	158	12.982	−7.512	5.882	1.00	10.69
ATOM	627	NZ	LYS	A	158	14.055	−7.155	4.906	1.00	11.82
ATOM	631	C	LYS	A	158	16.539	−6.421	9.862	1.00	6.67
ATOM	632	O	LYS	A	158	15.893	−6.245	10.888	1.00	7.00
ATOM	633	N	PHE	A	159	17.132	−5.435	9.199	1.00	6.57
ATOM	635	CA	PHE	A	159	16.961	−4.033	9.558	1.00	6.42
ATOM	637	CB	PHE	A	159	18.244	−3.424	10.113	1.00	6.39
ATOM	640	CG	PHE	A	159	18.557	−3.810	11.527	1.00	6.21
ATOM	641	CD1	PHE	A	159	18.938	−5.105	11.834	1.00	6.41
ATOM	643	CE1	PHE	A	159	19.258	−5.462	13.124	1.00	7.30
ATOM	645	CZ	PHE	A	159	19.205	−4.522	14.141	1.00	7.03
ATOM	647	CE2	PHE	A	159	18.840	−3.225	13.861	1.00	6.65
ATOM	649	CD2	PHE	A	159	18.510	−2.865	12.549	1.00	6.66
ATOM	651	C	PHE	A	159	16.630	−3.272	8.288	1.00	6.42
ATOM	652	O	PHE	A	159	17.075	−3.655	7.206	1.00	6.21
ATOM	653	N	ILE	A	160	15.872	−2.189	8.423	1.00	6.70
ATOM	655	CA	ILE	A	160	15.584	−1.310	7.295	1.00	6.91
ATOM	657	CB	ILE	A	160	14.128	−1.421	6.841	1.00	6.96
ATOM	659	CG1	ILE	A	160	13.857	−2.802	6.238	1.00	6.91
ATOM	662	CD1	ILE	A	160	12.379	−3.105	6.032	1.00	7.38
ATOM	666	CG2	ILE	A	160	13.854	−0.364	5.804	1.00	6.76
ATOM	670	C	ILE	A	160	15.891	0.123	7.731	1.00	7.39
ATOM	671	O	ILE	A	160	15.271	0.635	8.663	1.00	7.44
ATOM	672	N	ASP	A	161	16.870	0.747	7.084	1.00	7.95
ATOM	674	CA	ASP	A	161	17.286	2.105	7.420	1.00	8.37
ATOM	676	CB	ASP	A	161	16.195	3.102	7.053	1.00	8.59
ATOM	679	CG	ASP	A	161	16.708	4.528	6.967	1.00	10.23
ATOM	680	OD1	ASP	A	161	17.935	4.715	6.802	1.00	11.11
ATOM	681	OD2	ASP	A	161	15.951	5.527	7.038	1.00	11.88
ATOM	682	C	ASP	A	161	17.607	2.256	8.905	1.00	8.18
ATOM	683	O	ASP	A	161	17.222	3.248	9.508	1.00	8.44
ATOM	684	N	GLY	A	162	18.292	1.272	9.486	1.00	8.28
ATOM	686	CA	GLY	A	162	18.703	1.321	10.888	1.00	7.95
ATOM	689	C	GLY	A	162	17.660	0.834	11.883	1.00	7.65
ATOM	690	O	GLY	A	162	17.938	0.718	13.080	1.00	7.80
ATOM	691	N	GLU	A	163	16.464	0.540	11.390	1.00	7.22
ATOM	693	CA	GLU	A	163	15.357	0.112	12.228	1.00	7.06
ATOM	695	CB	GLU	A	163	14.042	0.667	11.683	1.00	7.80
ATOM	698	CG	GLU	A	163	12.835	0.348	12.546	1.00	9.55
ATOM	701	CD	GLU	A	163	11.566	0.978	12.014	1.00	12.39	C
ATOM	702	OE1	GLU	A	163	10.581	0.247	11.786	1.00	13.95	O
ATOM	703	OE2	GLU	A	163	11.561	2.208	11.819	1.00	15.05	O
ATOM	704	C	GLU	A	163	15.312	−1.408	12.280	1.00	6.25	C
ATOM	705	O	GLU	A	163	15.342	−2.067	11.245	1.00	6.04	O
ATOM	706	N	MET	A	164	15.232	−1.956	13.488	1.00	4.98	N
ATOM	708	CA	MET	A	164	15.210	−3.396	13.688	1.00	4.77	C
ATOM	710	CB	MET	A	164	15.531	−3.723	15.143	1.00	4.72	C
ATOM	713	CG	MET	A	164	15.774	−5.202	15.382	1.00	4.94	C
ATOM	716	SD	MET	A	164	16.451	−5.533	17.027	1.00	5.80	S
ATOM	717	CE	MET	A	164	15.147	−4.981	17.997	1.00	5.96	C
ATOM	721	C	MET	A	164	13.870	−4.029	13.329	1.00	4.84	C
ATOM	722	O	MET	A	164	12.851	−3.766	13.969	1.00	4.40	O
ATOM	723	N	ILE	A	165	13.880	−4.863	12.296	1.00	5.00	N
ATOM	725	CA	ILE	A	165	12.671	−5.558	11.875	1.00	4.95	C
ATOM	727	CB	ILE	A	165	12.608	−5.633	10.341	1.00	5.00	C
ATOM	729	CG1	ILE	A	165	12.742	−4.223	9.744	1.00	4.62	C
ATOM	732	CD1	ILE	A	165	11.748	−3.208	10.282	1.00	4.68	C
ATOM	736	CG2	ILE	A	165	11.329	−6.307	9.929	1.00	5.38	C
ATOM	740	C	ILE	A	165	12.592	−6.946	12.525	1.00	5.29	C
ATOM	741	O	ILE	A	165	11.558	−7.315	13.093	1.00	4.78	O
ATOM	742	N	GLU	A	166	13.686	−7.705	12.446	1.00	6.00	N
ATOM	744	CA	GLU	A	166	13.785	−9.017	13.085	1.00	6.87	C
ATOM	746	CB	GLU	A	166	13.403	−10.149	12.137	1.00	7.63	C
ATOM	749	CG	GLU	A	166	13.470	−11.533	12.779	1.00	9.02	C
ATOM	752	CD	GLU	A	166	13.503	−12.667	11.766	1.00	12.97	C
ATOM	753	OE1	GLU	A	166	13.377	−12.407	10.552	1.00	15.93	C
ATOM	754	OE2	GLU	A	166	13.626	−13.836	12.185	1.00	14.80
ATOM	755	C	GLU	A	166	15.217	−9.261	13.538	1.00	6.98
ATOM	756	O	GLU	A	166	16.045	−9.709	12.749	1.00	6.92
ATOM	757	N	GLY	A	167	15.508	−8.980	14.803	1.00	7.29
ATOM	759	CA	GLY	A	167	16.842	−9.203	15.325	1.00	7.20
ATOM	762	C	GLY	A	167	16.852	−10.404	16.256	1.00	7.48
ATOM	763	O	GLY	A	167	16.056	−10.456	17.191	1.00	7.66
ATOM	764	N	LYS	A	168	17.728	−11.373	15.984	1.00	7.23
ATOM	766	CA	LYS	A	168	17.818	−12.587	16.781	1.00	7.09
ATOM	768	CB	LYS	A	168	18.026	−13.814	15.888	1.00	7.16
ATOM	771	CG	LYS	A	168	16.896	−14.045	14.883	1.00	8.66
ATOM	774	CD	LYS	A	168	17.128	−15.294	14.041	1.00	10.94
ATOM	777	CE	LYS	A	168	16.025	−15.488	13.017	1.00	12.79
ATOM	780	NZ	LYS	A	168	16.093	−16.800	12.293	1.00	15.02
ATOM	784	C	LYS	A	168	18.996	−12.428	17.710	1.00	6.71
ATOM	785	O	LYS	A	168	19.983	−11.812	17.337	1.00	6.28
ATOM	786	N	LEU	A	169	18.878	−12.976	18.916	1.00	6.73
ATOM	788	CA	LEU	A	169	19.933	−12.900	19.902	1.00	6.40
ATOM	790	CB	LEU	A	169	19.498	−13.607	21.186	1.00	7.01
ATOM	793	CG	LEU	A	169	20.474	−13.428	22.350	1.00	8.27
ATOM	795	CD1	LEU	A	169	20.640	−11.955	22.716	1.00	9.19
ATOM	799	CD2	LEU	A	169	20.033	−14.232	23.569	1.00	9.49
ATOM	803	C	LEU	A	169	21.217	−13.531	19.363	1.00	5.72
ATOM	804	O	LEU	A	169	21.198	−14.661	18.882	1.00	5.15
ATOM	805	N	ALA	A	170	22.333	−12.815	19.490	1.00	5.12
ATOM	807	CA	ALA	A	170	23.604	−13.270	18.952	1.00	4.79
ATOM	809	CB	ALA	A	170	23.813	−12.705	17.565	1.00	4.78
ATOM	813	C	ALA	A	170	24.731	−12.807	19.849	1.00	4.58
ATOM	814	O	ALA	A	170	24.512	−12.012	20.759	1.00	4.70
ATOM	815	N	THR	A	171	25.933	−13.309	19.581	1.00	4.52
ATOM	817	CA	THR	A	171	27.131	−12.873	20.290	1.00	4.42
ATOM	819	CB	THR	A	171	27.756	−14.026	21.085	1.00	4.30
ATOM	821	OG1	THR	A	171	26.837	−14.497	22.083	1.00	4.54
ATOM	823	CG2	THR	A	171	28.977	−13.555	21.899	1.00	3.98
ATOM	827	C	THR	A	171	28.120	−12.395	19.236	1.00	4.51
ATOM	828	O	THR	A	171	28.397	−13.116	18.278	1.00	4.13
ATOM	829	N	LEU	A	172	28.636	−11.184	19.406	1.00	5.15
ATOM	831	CA	LEU	A	172	29.680	−10.673	18.541	1.00	5.83
ATOM	833	CB	LEU	A	172	29.805	−9.159	18.697	1.00	6.13
ATOM	836	CG	LEU	A	172	31.000	−8.525	17.977	1.00	6.72
ATOM	838	CD1	LEU	A	172	30.994	−8.877	16.496	1.00	7.77
ATOM	842	CD2	LEU	A	172	30.991	−7.020	18.167	1.00	7.70
ATOM	846	C	LEU	A	172	30.973	−11.365	18.989	1.00	6.16
ATOM	847	O	LEU	A	172	31.430	−11.155	20.111	1.00	6.30
ATOM	848	N	MET	A	173	31.553	−12.201	18.136	1.00	6.57
ATOM	850	CA	MET	A	173	32.750	−12.965	18.519	1.00	7.57
ATOM	852	CB	MET	A	173	32.727	−14.331	17.850	1.00	7.41
ATOM	855	CG	MET	A	173	31.674	−15.243	18.433	1.00	7.25
ATOM	858	SD	MET	A	173	31.804	−16.910	17.822	1.00	7.63
ATOM	859	CE	MET	A	173	31.392	−16.676	16.148	1.00	8.74
ATOM	863	C	MET	A	173	34.060	−12.277	18.188	1.00	8.46
ATOM	864	O	MET	A	173	34.958	−12.176	19.035	1.00	9.38
ATOM	865	N	SER	A	174	34.182	−11.841	16.943	1.00	9.51
ATOM	867	CA	SER	A	174	35.395	−11.198	16.472	1.00	9.87
ATOM	869	CB	SER	A	174	36.388	−12.243	15.965	1.00	10.03
ATOM	872	OG	SER	A	174	35.897	−12.880	14.801	1.00	10.72
ATOM	874	C	SER	A	174	35.028	−10.268	15.331	1.00	10.19
ATOM	875	O	SER	A	174	33.887	−10.262	14.863	1.00	9.74
ATOM	876	N	THR	A	175	36.002	−9.477	14.899	1.00	10.64
ATOM	878	CA	THR	A	175	35.841	−8.599	13.752	1.00	11.10
ATOM	880	CB	THR	A	175	35.735	−7.125	14.184	1.00	11.03
ATOM	882	OG1	THR	A	175	34.539	−6.915	14.949	1.00	10.19
ATOM	884	CG2	THR	A	175	35.544	−6.209	12.996	1.00	11.00
ATOM	888	C	THR	A	175	37.079	−8.797	12.894	1.00	11.71
ATOM	889	O	THR	A	175	38.192	−8.951	13.420	1.00	11.93
ATOM	890	N	GLU	A	176	36.884	−8.814	11.584	1.00	12.23
ATOM	892	CA	GLU	A	176	37.970	−8.970	10.629	1.00	12.70
ATOM	894	CB	GLU	A	176	37.824	−10.291	9.873	1.00	13.24
ATOM	897	CG	GLU	A	176	38.742	−11.388	10.361	1.00	14.72
ATOM	900	CD	GLU	A	176	40.202	−11.034	10.166	1.00	16.74
ATOM	901	OE1	GLU	A	176	40.678	−11.080	9.006	1.00	18.24
ATOM	902	OE2	GLU	A	176	40.868	−10.699	11.167	1.00	17.70
ATOM	903	C	GLU	A	176	37.920	−7.818	9.635	1.00	12.62
ATOM	904	O	GLU	A	176	36.996	−7.741	8.824	1.00	12.20
ATOM	905	N	GLU	A	177	38.905	−6.924	9.702	1.00	12.51
ATOM	907	CA	GLU	A	177	38.963	−5.770	8.805	1.00	12.61
ATOM	909	CB	GLU	A	177	39.451	−6.189	7.408	1.00	12.77
ATOM	912	CG	GLU	A	177	40.878	−6.739	7.442	1.00	13.92
ATOM	915	CD	GLU	A	177	41.661	−6.565	6.147	1.00	15.14
ATOM	916	OE1	GLU	A	177	41.102	−6.076	5.141	1.00	15.39
ATOM	917	OE2	GLU	A	177	42.865	−6.919	6.154	1.00	15.99
ATOM	918	C	GLU	A	177	37.611	−5.035	8.763	1.00	12.30
ATOM	919	O	GLU	A	177	37.070	−4.742	7.689	1.00	12.20
ATOM	920	N	GLY	A	178	37.061	−4.764	9.948	1.00	11.92
ATOM	922	CA	GLY	A	178	35.806	−4.044	10.081	1.00	11.82
ATOM	925	C	GLY	A	178	34.565	−4.927	10.041	1.00	11.59
ATOM	926	O	GLY	A	178	33.496	−4.517	10.489	1.00	11.30
ATOM	927	N	ARG	A	179	34.710	−6.143	9.526	1.00	11.63
ATOM	929	CA	ARG	A	179	33.580	−7.061	9.384	1.00	11.85
ATOM	931	CB	ARG	A	179	33.790	−7.952	8.166	1.00	12.01
ATOM	934	CG	ARG	A	179	34.275	−7.169	6.958	1.00	13.17
ATOM	937	CD	ARG	A	179	34.204	−7.922	5.656	1.00	14.87
ATOM	940	NE	ARG	A	179	34.631	−7.092	4.533	1.00	16.33
ATOM	942	CZ	ARG	A	179	34.270	−7.297	3.276	1.00	18.07
ATOM	943	NH1	ARG	A	179	33.464	−8.308	2.968	1.00	18.99
ATOM	946	NH2	ARG	A	179	34.708	−6.485	2.318	1.00	18.61
ATOM	949	C	ARG	A	179	33.403	−7.917	10.632	1.00	11.75
ATOM	950	O	ARG	A	179	34.311	−8.634	11.031	1.00	11.24
ATOM	951	N	PRO	A	180	32.221	−7.865	11.232	1.00	11.83
ATOM	952	CA	PRO	A	180	31.961	−8.617	12.453	1.00	11.75
ATOM	954	CB	PRO	A	180	30.799	−7.855	13.092	1.00	11.88
ATOM	957	CG	PRO	A	180	30.346	−6.837	12.066	1.00	12.63
ATOM	960	CD	PRO	A	180	31.036	−7.111	10.800	1.00	11.88
ATOM	963	C	PRO	A	180	31.523	−10.035	12.171	1.00	11.47
ATOM	964	O	PRO	A	180	30.967	−10.320	11.112	1.00	11.35
ATOM	965	N	HIS	A	181	31.752	−10.908	13.140	1.00	10.99
ATOM	967	CA	HIS	A	181	31.373	−12.301	13.021	1.00	10.98
ATOM	969	CB	HIS	A	181	32.644	−13.124	12.855	1.00	11.41
ATOM	972	CG	HIS	A	181	33.479	−12.601	11.733	1.00	12.68
ATOM	973	ND1	HIS	A	181	33.096	−12.732	10.413	1.00	14.33
ATOM	975	CE1	HIS	A	181	33.967	−12.106	9.642	1.00	14.59
ATOM	977	NE2	HIS	A	181	34.878	−11.542	10.417	1.00	14.53
ATOM	979	CD2	HIS	A	181	34.573	−11.806	11.730	1.00	13.34
ATOM	981	C	HIS	A	181	30.538	−12.655	14.237	1.00	10.32
ATOM	982	O	HIS	A	181	30.976	−12.486	15.378	1.00	10.37
ATOM	983	N	PHE	A	182	29.315	−13.102	13.977	1.00	9.47
ATOM	985	CA	PHE	A	182	28.364	−13.389	15.037	1.00	8.95
ATOM	987	CB	PHE	A	182	27.026	−12.691	14.756	1.00	8.73
ATOM	990	CG	PHE	A	182	27.112	−11.193	14.743	1.00	9.26
ATOM	991	CD1	PHE	A	182	27.259	−10.506	13.551	1.00	9.46
ATOM	993	CE1	PHE	A	182	27.338	−9.131	13.540	1.00	10.19
ATOM	995	CZ	PHE	A	182	27.284	−8.423	14.722	1.00	11.01
ATOM	997	CE2	PHE	A	182	27.142	−9.092	15.921	1.00	10.72
ATOM	999	CD2	PHE	A	182	27.053	−10.472	15.926	1.00	10.44
ATOM	1001	C	PHE	A	182	28.094	−14.868	15.172	1.00	8.41
ATOM	1002	O	PHE	A	182	28.181	−15.608	14.200	1.00	7.90
ATOM	1003	N	GLU	A	183	27.779	−15.294	16.390	1.00	7.69
ATOM	1005	CA	GLU	A	183	27.266	−16.632	16.599	1.00	7.89
ATOM	1007	CB	GLU	A	183	28.026	−17.388	17.694	1.00	8.44
ATOM	1010	CG	GLU	A	183	27.883	−16.811	19.074	1.00	9.36
ATOM	1013	CD	GLU	A	183	28.444	−17.736	20.144	1.00	9.99
ATOM	1014	OE1	GLU	A	183	29.224	−18.651	19.813	1.00	11.50
ATOM	1015	OE2	GLU	A	183	28.089	−17.561	21.314	1.00	10.33
ATOM	1016	C	GLU	A	183	25.798	−16.403	16.965	1.00	7.71
ATOM	1017	O	GLU	A	183	25.499	−15.538	17.783	1.00	6.70
ATOM	1018	N	LEU	A	184	24.882	−17.106	16.300	1.00	7.86
ATOM	1020	CA	LEU	A	184	23.455	−16.996	16.617	1.00	8.53
ATOM	1022	CB	LEU	A	184	22.575	−17.474	15.455	1.00	8.98
ATOM	1025	CG	LEU	A	184	21.860	−16.417	14.596	1.00	10.69
ATOM	1027	CD1	LEU	A	184	20.916	−17.109	13.631	1.00	11.63
ATOM	1031	CD2	LEU	A	184	21.077	−15.394	15.406	1.00	11.85
ATOM	1035	C	LEU	A	184	23.182	−17.842	17.847	1.00	8.40
ATOM	1036	O	LEU	A	184	23.577	−19.002	17.892	1.00	8.35
ATOM	1037	N	MET	A	185	22.524	−17.268	18.847	1.00	8.65
ATOM	1039	CA	MET	A	185	22.274	−17.994	20.092	1.00	9.49
ATOM	1041	CB	MET	A	185	22.166	−17.032	21.277	1.00	9.31
ATOM	1044	CG	MET	A	185	23.331	−16.044	21.374	1.00	9.03
ATOM	1047	SD	MET	A	185	24.981	−16.799	21.366	1.00	8.67
ATOM	1048	CE	MET	A	185	24.996	−17.487	22.988	1.00	8.51
ATOM	1052	C	MET	A	185	21.012	−18.834	19.948	1.00	10.44
ATOM	1053	O	MET	A	185	20.171	−18.555	19.085	1.00	10.33
ATOM	1054	N	PRO	A	186	20.881	−19.871	20.767	1.00	11.73
ATOM	1055	CA	PRO	A	186	19.702	−20.733	20.721	1.00	12.82
ATOM	1057	CB	PRO	A	186	20.089	−21.907	21.625	1.00	12.75
ATOM	1060	CG	PRO	A	186	21.528	−21.764	21.891	1.00	12.45
ATOM	1063	CD	PRO	A	186	21.842	−20.322	21.783	1.00	12.03
ATOM	1066	C	PRO	A	186	18.468	−20.025	21.262	1.00	13.67
ATOM	1067	O	PRO	A	186	18.585	−18.993	21.920	1.00	14.31
ATOM	1068	N	GLY	A	187	17.302	−20.592	21.002	1.00	14.68
ATOM	1070	CA	GLY	A	187	16.051	−19.982	21.411	1.00	15.36
ATOM	1073	C	GLY	A	187	15.353	−19.478	20.158	1.00	15.85
ATOM	1074	O	GLY	A	187	15.922	−19.536	19.066	1.00	16.33
ATOM	1075	N	ASN	A	188	14.126	−18.993	20.295	1.00	16.29
ATOM	1077	CA	ASN	A	188	13.382	−18.491	19.142	1.00	16.60
ATOM	1079	CB	ASN	A	188	12.224	−19.425	18.800	1.00	16.84
ATOM	1082	CG	ASN	A	188	12.685	−20.693	18.107	1.00	17.32
ATOM	1083	OD1	ASN	A	188	12.476	−20.872	16.903	1.00	17.36
ATOM	1084	ND2	ASN	A	188	13.311	−21.584	18.869	1.00	17.33
ATOM	1087	C	ASN	A	188	12.851	−17.074	19.338	1.00	16.40
ATOM	1088	O	ASN	A	188	12.059	−16.586	18.529	1.00	16.84
ATOM	1089	N	SER	A	189	13.274	−16.423	20.413	1.00	15.95
ATOM	1091	CA	SER	A	189	12.832	−15.063	20.697	1.00	15.52
ATOM	1093	CB	SER	A	189	13.246	−14.644	22.106	1.00	15.67
ATOM	1096	OG	SER	A	189	12.480	−15.339	23.080	1.00	16.44
ATOM	1098	C	SER	A	189	13.394	−14.078	19.677	1.00	14.61
ATOM	1099	O	SER	A	189	14.597	−13.968	19.484	1.00	15.04
ATOM	1100	N	VAL	A	190	12.501	−13.380	18.998	1.00	13.84
ATOM	1102	CA	VAL	A	190	12.926	−12.357	18.061	1.00	12.46
ATOM	1104	CB	VAL	A	190	12.127	−12.417	16.747	1.00	12.81
ATOM	1106	CG1	VAL	A	190	12.524	−13.627	15.919	1.00	13.83
ATOM	1110	CG2	VAL	A	190	10.629	−12.440	17.024	1.00	13.36
ATOM	1114	C	VAL	A	190	12.671	−11.017	18.737	1.00	10.30
ATOM	1115	O	VAL	A	190	11.856	−10.935	19.651	1.00	9.90
ATOM	1116	N	TYR	A	191	13.365	−9.978	18.297	1.00	7.89
ATOM	1118	CA	TYR	A	191	13.065	−8.632	18.748	1.00	6.57
ATOM	1120	CB	TYR	A	191	14.196	−8.097	19.599	1.00	6.34
ATOM	1123	CG	TYR	A	191	14.589	−9.048	20.680	1.00	5.06
ATOM	1124	CD1	TYR	A	191	15.581	−9.990	20.460	1.00	5.67
ATOM	1126	CE1	TYR	A	191	15.982	−10.870	21.483	1.00	4.58
ATOM	1128	CZ	TYR	A	191	15.358	−10.831	22.705	1.00	3.98
ATOM	1129	OH	TYR	A	191	15.770	−11.722	23.688	1.00	5.42
ATOM	1131	CE2	TYR	A	191	14.374	−9.904	22.956	1.00	3.96
ATOM	1133	CD2	TYR	A	191	13.976	−9.015	21.936	1.00	4.68
ATOM	1135	C	TYR	A	191	12.867	−7.717	17.548	1.00	5.86
ATOM	1136	O	TYR	A	191	13.442	−7.941	16.490	1.00	5.27
ATOM	1137	N	HIS	A	192	12.064	−6.680	17.733	1.00	5.52
ATOM	1139	CA	HIS	A	192	11.834	−5.683	16.695	1.00	5.42
ATOM	1141	CB	HIS	A	192	10.640	−6.082	15.840	1.00	5.81
ATOM	1144	CG	HIS	A	192	9.337	−6.131	16.581	1.00	7.52
ATOM	1145	ND1	HIS	A	192	8.968	−7.201	17.368	1.00	8.54
ATOM	1147	CE1	HIS	A	192	7.767	−6.981	17.874	1.00	8.22
ATOM	1149	NE2	HIS	A	192	7.340	−5.810	17.439	1.00	8.91
ATOM	1151	CD2	HIS	A	192	8.297	−5.263	16.618	1.00	8.65
ATOM	1153	C	HIS	A	192	11.604	−4.308	17.310	1.00	4.59
ATOM	1154	O	HIS	A	192	11.297	−4.196	18.500	1.00	4.80
ATOM	1155	N	PHE	A	193	11.814	−3.269	16.514	1.00	3.78
ATOM	1157	CA	PHE	A	193	11.499	−1.910	16.920	1.00	4.00
ATOM	1159	CB	PHE	A	193	11.713	−0.937	15.762	1.00	3.98
ATOM	1162	CG	PHE	A	193	11.543	0.513	16.132	1.00	4.65
ATOM	1163	CD1	PHE	A	193	12.275	1.085	17.162	1.00	5.34
ATOM	1165	CE1	PHE	A	193	12.114	2.427	17.484	1.00	5.11
ATOM	1167	CZ	PHE	A	193	11.224	3.201	16.773	1.00	6.20
ATOM	1169	CE2	PHE	A	193	10.492	2.641	15.759	1.00	6.35
ATOM	1171	CD2	PHE	A	193	10.654	1.307	15.440	1.00	6.00
ATOM	1173	C	PHE	A	193	10.043	−1.917	17.354	1.00	4.11
ATOM	1174	O	PHE	A	193	9.153	−2.237	16.552	1.00	3.97
ATOM	1175	N	ASP	A	194	9.794	−1.561	18.607	1.00	4.35
ATOM	1177	CA	ASP	A	194	8.458	−1.645	19.176	1.00	4.97
ATOM	1179	CB	ASP	A	194	8.290	−3.008	19.861	1.00	5.31
ATOM	1182	CG	ASP	A	194	6.876	−3.264	20.360	1.00	4.89
ATOM	1183	OD1	ASP	A	194	6.731	−3.777	21.498	1.00	4.65
ATOM	1184	OD2	ASP	A	194	5.855	−2.991	19.698	1.00	6.48
ATOM	1185	C	ASP	A	194	8.249	−0.494	20.162	1.00	5.45
ATOM	1186	O	ASP	A	194	8.101	−0.711	21.369	1.00	5.31
ATOM	1187	N	LYS	A	195	8.246	0.728	19.634	1.00	5.95
ATOM	1189	CA	LYS	A	195	8.067	1.932	20.444	1.00	6.42
ATOM	1191	CB	LYS	A	195	8.163	3.173	19.549	1.00	6.85
ATOM	1194	CG	LYS	A	195	8.499	4.463	20.274	1.00	7.53
ATOM	1197	CD	LYS	A	195	8.571	5.668	19.330	1.00	9.24
ATOM	1200	CE	LYS	A	195	8.671	6.977	20.117	1.00	10.07
ATOM	1203	NZ	LYS	A	195	8.535	8.203	19.303	1.00	10.82
ATOM	1207	C	LYS	A	195	6.718	1.897	21.167	1.00	6.73
ATOM	1208	O	LYS	A	195	5.701	1.507	20.582	1.00	5.99
ATOM	1209	N	SER	A	196	6.697	2.294	22.438	1.00	6.97
ATOM	1211	CA	SER	A	196	5.443	2.313	23.210	1.00	7.85
ATOM	1213	CB	SER	A	196	5.741	2.699	24.653	1.00	7.66
ATOM	1216	OG	SER	A	196	6.188	4.036	24.712	1.00	7.51
ATOM	1218	C	SER	A	196	4.375	3.286	22.654	1.00	8.71
ATOM	1219	O	SER	A	196	4.719	4.256	21.987	1.00	8.40
ATOM	1220	N	THR	A	197	3.100	3.017	22.971	1.00	10.30
ATOM	1222	CA	THR	A	197	1.936	3.843	22.568	1.00	11.43
ATOM	1224	CB	THR	A	197	1.071	3.161	21.458	1.00	11.80
ATOM	1226	OG1	THR	A	197	0.256	2.116	22.010	1.00	12.85
ATOM	1228	CG2	THR	A	197	1.933	2.464	20.416	1.00	11.59
ATOM	1232	C	THR	A	197	1.075	4.129	23.811	1.00	12.45
ATOM	1233	O	THR	A	197	1.409	3.702	24.907	1.00	12.65
ATOM	1234	N	SER	A	198	−0.051	4.818	23.658	1.00	13.61
ATOM	1236	CA	SER	A	198	−0.866	5.162	24.829	1.00	14.55
ATOM	1238	CB	SER	A	198	−1.735	6.376	24.549	1.00	14.51
ATOM	1241	OG	SER	A	198	−2.410	6.197	23.325	1.00	13.76
ATOM	1243	C	SER	A	198	−1.754	3.982	25.168	1.00	15.46
ATOM	1244	O	SER	A	198	−2.209	3.819	26.297	1.00	16.73
ATOM	1245	N	SER	A	199	−2.002	3.166	24.158	1.00	15.77
ATOM	1247	CA	SER	A	199	−2.797	1.972	24.318	1.00	16.24
ATOM	1249	CB	SER	A	199	−3.745	1.838	23.130	1.00	16.54
ATOM	1252	OG	SER	A	199	−3.053	1.414	21.970	1.00	17.04
ATOM	1254	C	SER	A	199	−1.869	0.749	24.425	1.00	16.21
ATOM	1255	O	SER	A	199	−2.332	−0.385	24.516	1.00	16.42
ATOM	1256	N	CYS	A	200	−0.559	0.976	24.438	1.00	15.86
ATOM	1258	CA	CYS	A	200	0.386	−0.137	24.428	1.00	15.68
ATOM	1260	CB	CYS	A	200	0.453	−0.723	23.012	1.00	15.84
ATOM	1263	SG	CYS	A	200	1.110	−2.412	22.884	1.00	17.21
ATOM	1264	C	CYS	A	200	1.799	0.229	24.868	1.00	14.77
ATOM	1265	O	CYS	A	200	2.528	0.896	24.140	1.00	15.85
ATOM	1266	N	ILE	A	201	2.199	−0.229	26.052	1.00	13.28
ATOM	1268	CA	ILE	A	201	3.565	−0.032	26.518	1.00	11.96
ATOM	1270	CB	ILE	A	201	3.689	−0.385	28.025	1.00	12.01
ATOM	1272	CG1	ILE	A	201	5.108	−0.137	28.534	1.00	12.80
ATOM	1275	CD1	ILE	A	201	5.162	0.134	30.028	1.00	13.95
ATOM	1279	CG2	ILE	A	201	3.284	−1.817	28.271	1.00	11.38
ATOM	1283	C	ILE	A	201	4.519	−0.889	25.680	1.00	10.34
ATOM	1284	O	ILE	A	201	5.630	−0.469	25.380	1.00	9.68
ATOM	1285	N	SER	A	202	4.057	−2.075	25.284	1.00	9.04
ATOM	1287	CA	SER	A	202	4.859	−3.027	24.519	1.00	8.50
ATOM	1289	CB	SER	A	202	5.929	−3.672	25.431	1.00	8.52
ATOM	1292	OG	SER	A	202	6.646	−4.704	24.774	1.00	6.90
ATOM	1294	C	SER	A	202	3.958	−4.114	23.917	1.00	8.85
ATOM	1295	O	SER	A	202	2.965	−4.520	24.529	1.00	8.96
ATOM	1296	N	THR	A	203	4.282	−4.557	22.703	1.00	8.53
ATOM	1298	CA	THR	A	203	3.553	−5.638	22.063	1.00	7.99
ATOM	1300	CB	THR	A	203	4.000	−5.799	20.604	1.00	8.51
ATOM	1302	OG1	THR	A	203	3.927	−4.539	19.917	1.00	9.13
ATOM	1304	CG2	THR	A	203	3.031	−6.653	19.837	1.00	9.16
ATOM	1308	C	THR	A	203	3.802	−6.953	22.780	1.00	7.35
ATOM	1309	O	THR	A	203	2.964	−7.850	22.759	1.00	6.77
ATOM	1310	N	ASN	A	204	4.983	−7.072	23.388	1.00	6.67
ATOM	1312	CA	ASN	A	204	5.358	−8.269	24.108	1.00	6.32
ATOM	1314	CB	ASN	A	204	6.430	−9.031	23.340	1.00	7.02
ATOM	1317	CG	ASN	A	204	6.076	−9.229	21.901	1.00	9.04
ATOM	1318	OD1	ASN	A	204	5.442	−10.222	21.545	1.00	12.06
ATOM	1319	ND2	ASN	A	204	6.473	−8.285	21.050	1.00	10.74
ATOM	1322	C	ASN	A	204	5.896	−7.849	25.476	1.00	5.34
ATOM	1323	O	ASN	A	204	7.112	−7.902	25.712	1.00	4.91
ATOM	1324	N	ALA	A	205	4.991	−7.414	26.355	1.00	4.25
ATOM	1326	CA	ALA	A	205	5.353	−6.895	27.687	1.00	4.45
ATOM	1328	CB	ALA	A	205	4.103	−6.433	28.415	1.00	4.36
ATOM	1332	C	ALA	A	205	6.107	−7.869	28.578	1.00	4.02
ATOM	1333	O	ALA	A	205	6.748	−7.445	29.545	1.00	4.26
ATOM	1334	N	LEU	A	206	5.996	−9.163	28.293	1.00	4.13
ATOM	1336	CA	LEU	A	206	6.639	−10.193	29.127	1.00	4.05
ATOM	1338	CB	LEU	A	206	5.651	−11.310	29.467	1.00	4.39
ATOM	1341	CG	LEU	A	206	4.540	−10.873	30.442	1.00	5.48
ATOM	1343	CD1	LEU	A	206	3.623	−12.031	30.791	1.00	6.08
ATOM	1347	CD2	LEU	A	206	5.105	−10.247	31.717	1.00	6.03
ATOM	1351	C	LEU	A	206	7.883	−10.780	28.476	1.00	3.35
ATOM	1352	O	LEU	A	206	8.445	−11.755	28.972	1.00	3.40
ATOM	1353	N	LEU	A	207	8.298	−10.190	27.363	1.00	2.61
ATOM	1355	CA	LEU	A	207	9.509	−10.600	26.677	1.00	2.48
ATOM	1357	CB	LEU	A	207	9.370	−10.388	25.167	1.00	2.30
ATOM	1360	CG	LEU	A	207	10.658	−10.610	24.363	1.00	2.38
ATOM	1362	CD1	LEU	A	207	11.119	−12.048	24.473	1.00	2.94
ATOM	1366	CD2	LEU	A	207	10.491	−10.235	22.889	1.00	2.26
ATOM	1370	C	LEU	A	207	10.639	−9.727	27.221	1.00	2.20
ATOM	1371	O	LEU	A	207	10.736	−8.557	26.881	1.00	2.36
ATOM	1372	N	PRO	A	208	11.487	−10.266	28.082	1.00	2.31
ATOM	1373	CA	PRO	A	208	12.541	−9.447	28.692	1.00	2.22
ATOM	1375	CB	PRO	A	208	13.158	−10.383	29.746	1.00	2.19
ATOM	1378	CG	PRO	A	208	12.238	−11.522	29.864	1.00	2.61
ATOM	1381	CD	PRO	A	208	11.525	−11.654	28.555	1.00	2.13
ATOM	1384	C	PRO	A	208	13.622	−9.002	27.729	1.00	2.17
ATOM	1385	O	PRO	A	208	13.744	−9.544	26.634	1.00	2.75
ATOM	1386	N	ASP	A	209	14.382	−7.993	28.133	1.00	2.07
ATOM	1388	CA	ASP	A	209	15.537	−7.558	27.370	1.00	2.07
ATOM	1390	CB	ASP	A	209	15.873	−6.108	27.671	1.00	2.16
ATOM	1393	CG	ASP	A	209	17.092	−5.642	26.921	1.00	2.83
ATOM	1394	OD1	ASP	A	209	18.215	−5.970	27.366	1.00	2.00
ATOM	1395	OD2	ASP	A	209	17.026	−4.987	25.858	1.00	3.37
ATOM	1396	C	ASP	A	209	16.696	−8.488	27.758	1.00	2.08
ATOM	1397	O	ASP	A	209	16.986	−8.667	28.940	1.00	2.17
ATOM	1398	N	PRO	A	210	17.378	−9.050	26.770	1.00	2.13
ATOM	1399	CA	PRO	A	210	18.411	−10.064	27.006	1.00	2.49
ATOM	1401	CB	PRO	A	210	18.719	−10.589	25.599	1.00	2.35
ATOM	1404	CG	PRO	A	210	18.212	−9.574	24.665	1.00	2.21
ATOM	1407	CD	PRO	A	210	17.258	−8.704	25.352	1.00	2.18
ATOM	1410	C	PRO	A	210	19.684	−9.538	27.651	1.00	2.93
ATOM	1411	O	PRO	A	210	20.321	−10.299	28.361	1.00	2.79
ATOM	1412	N	TYR	A	211	20.043	−8.283	27.398	1.00	3.18
ATOM	1414	CA	TYR	A	211	21.242	−7.682	27.950	1.00	3.33
ATOM	1416	CB	TYR	A	211	21.570	−6.388	27.200	1.00	3.46
ATOM	1419	CG	TYR	A	211	22.666	−5.539	27.817	1.00	2.30
ATOM	1420	CD1	TYR	A	211	23.995	−5.687	27.428	1.00	2.58
ATOM	1422	CE1	TYR	A	211	25.015	−4.900	28.010	1.00	2.00
ATOM	1424	CZ	TYR	A	211	24.685	−3.963	28.967	1.00	2.27
ATOM	1425	OH	TYR	A	211	25.673	−3.168	29.545	1.00	2.08
ATOM	1427	CE2	TYR	A	211	23.356	−3.791	29.346	1.00	2.01
ATOM	1429	CD2	TYR	A	211	22.371	−4.583	28.785	1.00	2.29
ATOM	1431	C	TYR	A	211	20.962	−7.403	29.419	1.00	3.70
ATOM	1432	O	TYR	A	211	21.770	−7.707	30.297	1.00	4.00
ATOM	1433	N	GLU	A	212	19.782	−6.845	29.670	1.00	3.95
ATOM	1435	CA	GLU	A	212	19.348	−6.519	31.018	1.00	4.61
ATOM	1437	CB	GLU	A	212	18.024	−5.773	30.929	1.00	4.52
ATOM	1440	CG	GLU	A	212	17.515	−5.155	32.202	1.00	4.94
ATOM	1443	CD	GLU	A	212	16.226	−4.392	31.966	1.00	4.99
ATOM	1444	OE1	GLU	A	212	15.347	−4.950	31.280	1.00	5.00
ATOM	1445	OE2	GLU	A	212	16.086	−3.249	32.445	1.00	5.13
ATOM	1446	C	GLU	A	212	19.214	−7.802	31.846	1.00	5.07
ATOM	1447	O	GLU	A	212	19.640	−7.862	33.002	1.00	4.83
ATOM	1448	N	SER	A	213	18.638	−8.830	31.228	1.00	5.54
ATOM	1450	CA	SER	A	213	18.421	−10.135	31.850	1.00	6.29
ATOM	1452	CB	SER	A	213	17.821	−11.080	30.797	1.00	6.89
ATOM	1455	OG	SER	A	213	17.892	−12.428	31.216	1.00	9.71
ATOM	1457	C	SER	A	213	19.702	−10.733	32.444	1.00	6.29
ATOM	1458	O	SER	A	213	19.665	−11.412	33.479	1.00	6.32
ATOM	1459	N	GLU	A	214	20.832	−10.472	31.796	1.00	6.12
ATOM	1461	CA	GLU	A	214	22.120	−10.969	32.278	1.00	5.99
ATOM	1463	CB	GLU	A	214	23.164	−10.915	31.166	1.00	6.73
ATOM	1466	CG	GLU	A	214	22.949	−11.904	30.036	1.00	9.30
ATOM	1469	CD	GLU	A	214	24.057	−11.830	28.999	1.00	12.66
ATOM	1470	OE1	GLU	A	214	24.949	−10.962	29.143	1.00	14.58
ATOM	1471	OE2	GLU	A	214	24.032	−12.631	28.041	1.00	14.18
ATOM	1472	C	GLU	A	214	22.679	−10.174	33.454	1.00	5.39
ATOM	1473	O	GLU	A	214	23.514	−10.687	34.206	1.00	4.38
ATOM	1474	N	ARG	A	215	22.222	−8.937	33.610	1.00	4.75
ATOM	1476	CA	ARG	A	215	22.830	−8.018	34.578	1.00	4.90
ATOM	1478	CB	ARG	A	215	23.306	−6.746	33.853	1.00	5.24
ATOM	1481	CG	ARG	A	215	24.713	−6.896	33.276	1.00	8.07
ATOM	1484	CD	ARG	A	215	25.145	−5.883	32.213	1.00	10.65
ATOM	1487	NE	ARG	A	215	24.801	−6.383	30.908	1.00	14.29
ATOM	1489	CZ	ARG	A	215	25.577	−7.088	30.089	1.00	15.26
ATOM	1490	NH1	ARG	A	215	26.820	−7.388	30.367	1.00	15.54
ATOM	1493	NH2	ARG	A	215	25.065	−7.491	28.943	1.00	17.12
ATOM	1496	C	ARG	A	215	21.957	−7.671	35.791	1.00	4.12
ATOM	1497	O	ARG	A	215	22.487	−7.282	36.806	1.00	3.33
ATOM	1498	N	VAL	A	216	20.629	−7.807	35.709	1.00	3.09
ATOM	1500	CA	VAL	A	216	19.809	−7.429	36.873	1.00	2.91
ATOM	1502	CB	VAL	A	216	19.230	−6.002	36.738	1.00	2.96
ATOM	1504	CG1	VAL	A	216	20.332	−4.974	36.602	1.00	3.75
ATOM	1508	CG2	VAL	A	216	18.252	−5.921	35.551	1.00	2.83
ATOM	1512	C	VAL	A	216	18.647	−8.355	37.189	1.00	2.98
ATOM	1513	O	VAL	A	216	18.168	−9.109	36.331	1.00	2.44
ATOM	1514	N	TYR	A	217	18.199	−8.289	38.440	1.00	2.76
ATOM	1516	CA	TYR	A	217	17.009	−9.020	38.865	1.00	2.74
ATOM	1518	CB	TYR	A	217	17.341	−10.412	39.382	1.00	2.54
ATOM	1521	CG	TYR	A	217	18.125	−10.454	40.662	1.00	2.38
ATOM	1522	CD1	TYR	A	217	17.486	−10.645	41.874	1.00	2.54
ATOM	1524	CE1	TYR	A	217	18.183	−10.712	43.040	1.00	2.32
ATOM	1526	CZ	TYR	A	217	19.553	−10.587	43.022	1.00	2.27
ATOM	1527	OH	TYR	A	217	20.236	−10.656	44.219	1.00	2.99
ATOM	1529	CE2	TYR	A	217	20.220	−10.409	41.826	1.00	2.26
ATOM	1531	CD2	TYR	A	217	19.507	−10.339	40.657	1.00	2.43
ATOM	1533	C	TYR	A	217	16.202	−8.208	39.881	1.00	2.77
ATOM	1534	O	TYR	A	217	16.737	−7.327	40.557	1.00	3.00
ATOM	1535	N	VAL	A	218	14.908	−8.497	39.961	1.00	2.44
ATOM	1537	CA	VAL	A	218	14.014	−7.831	40.890	1.00	2.69
ATOM	1539	CB	VAL	A	218	12.632	−7.579	40.228	1.00	3.00
ATOM	1541	CG1	VAL	A	218	11.610	−7.097	41.245	1.00	3.76
ATOM	1545	CG2	VAL	A	218	12.778	−6.577	39.140	1.00	3.43
ATOM	1549	C	VAL	A	218	13.833	−8.702	42.120	1.00	2.66
ATOM	1550	O	VAL	A	218	13.617	−9.907	42.005	1.00	3.28
ATOM	1551	N	ALA	A	219	13.917	−8.091	43.296	1.00	2.57
ATOM	1553	CA	ALA	A	219	13.739	−8.791	44.555	1.00	2.48
ATOM	1555	CB	ALA	A	219	15.054	−9.468	45.000	1.00	2.68
ATOM	1559	C	ALA	A	219	13.301	−7.758	45.585	1.00	2.60
ATOM	1560	O	ALA	A	219	13.221	−6.571	45.284	1.00	2.69
ATOM	1561	N	GLU	A	220	13.021	−8.204	46.800	1.00	2.80
ATOM	1563	CA	GLU	A	220	12.644	−7.286	47.867	1.00	3.50
ATOM	1565	CB	GLU	A	220	12.332	−8.043	49.165	1.00	4.18
ATOM	1568	CG	GLU	A	220	12.052	−7.104	50.330	1.00	5.43
ATOM	1571	CD	GLU	A	220	11.359	−7.774	51.506	1.00	7.31
ATOM	1572	OE1	GLU	A	220	11.761	−8.899	51.879	1.00	9.83
ATOM	1573	OE2	GLU	A	220	10.420	−7.163	52.069	1.00	6.12
ATOM	1574	C	GLU	A	220	13.792	−6.321	48.138	1.00	3.30
ATOM	1575	O	GLU	A	220	14.942	−6.747	48.291	1.00	3.39
ATOM	1576	N	SER	A	221	13.485	−5.032	48.215	1.00	3.07
ATOM	1578	CA	SER	A	221	14.500	−4.024	48.513	1.00	3.25
ATOM	1580	CB	SER	A	221	13.896	−2.637	48.422	1.00	3.15
ATOM	1583	OG	SER	A	221	14.888	−1.657	48.617	1.00	3.60
ATOM	1585	C	SER	A	221	15.103	−4.174	49.913	1.00	3.41
ATOM	1586	O	SER	A	221	14.425	−4.601	50.853	1.00	2.86
ATOM	1587	N	LEU	A	222	16.375	−3.790	50.034	1.00	3.90
ATOM	1589	CA	LEU	A	222	17.070	−3.766	51.321	1.00	4.56
ATOM	1591	CB	LEU	A	222	18.588	−3.834	51.130	1.00	5.30
ATOM	1594	CG	LEU	A	222	19.097	−4.976	50.249	1.00	7.15
ATOM	1596	CD1	LEU	A	222	20.607	−4.964	50.183	1.00	9.23
ATOM	1600	CD2	LEU	A	222	18.609	−6.315	50.772	1.00	8.38
ATOM	1604	C	LEU	A	222	16.723	−2.480	52.059	1.00	4.29
ATOM	1605	O	LEU	A	222	17.001	−2.343	53.254	1.00	4.06
ATOM	1606	N	ILE	A	223	16.138	−1.527	51.343	1.00	3.99
ATOM	1608	CA	ILE	A	223	15.724	−0.267	51.944	1.00	4.02
ATOM	1610	CB	ILE	A	223	15.547	0.816	50.886	1.00	3.79
ATOM	1612	CG1	ILE	A	223	16.865	1.041	50.150	1.00	5.03
ATOM	1615	CD1	ILE	A	223	16.706	1.847	48.893	1.00	4.83
ATOM	1619	CG2	ILE	A	223	15.073	2.118	51.527	1.00	3.14
ATOM	1623	C	ILE	A	223	14.411	−0.511	52.669	1.00	3.87
ATOM	1624	O	ILE	A	223	13.503	−1.110	52.119	1.00	2.80
ATOM	1625	N	SER	A	224	14.343	−0.082	53.923	1.00	3.63
ATOM	1627	CA	SER	A	224	13.162	−0.286	54.758	1.00	3.85
ATOM	1629	CB	SER	A	224	13.353	0.467	56.075	1.00	4.59
ATOM	1632	OG	SER	A	224	12.305	0.153	56.970	1.00	6.66
ATOM	1634	C	SER	A	224	11.834	0.150	54.131	1.00	3.32
ATOM	1635	O	SER	A	224	11.658	1.317	53.811	1.00	2.78
ATOM	1636	N	SER	A	225	10.913	−0.801	53.972	1.00	3.00
ATOM	1638	CA	SER	A	225	9.545	−0.514	53.494	1.00	3.09
ATOM	1640	CB	SER	A	225	8.874	0.469	54.462	1.00	2.88
ATOM	1643	OG	SER	A	225	8.729	−0.106	55.745	1.00	3.17
ATOM	1645	C	SER	A	225	9.470	0.031	52.068	1.00	3.22
ATOM	1646	O	SER	A	225	8.407	0.502	51.627	1.00	3.34
ATOM	1647	N	ALA	A	226	10.572	−0.066	51.331	1.00	3.38
ATOM	1649	CA	ALA	A	226	10.683	0.493	49.987	1.00	3.48
ATOM	1651	CB	ALA	A	226	12.139	0.766	49.672	1.00	3.48
ATOM	1655	C	ALA	A	226	10.060	−0.368	48.879	1.00	3.36
ATOM	1656	O	ALA	A	226	10.057	0.036	47.717	1.00	3.94
ATOM	1657	N	GLY	A	227	9.531	−1.534	49.244	1.00	3.22
ATOM	1659	CA	GLY	A	227	8.911	−2.445	48.299	1.00	2.87
ATOM	1662	C	GLY	A	227	9.944	−3.293	47.583	1.00	2.64
ATOM	1663	O	GLY	A	227	10.914	−3.763	48.189	1.00	2.43
ATOM	1664	N	GLU	A	228	9.747	−3.486	46.281	1.00	2.32
ATOM	1666	CA	GLU	A	228	10.693	−4.244	45.484	1.00	2.34
ATOM	1668	CB	GLU	A	228	10.039	−4.814	44.223	1.00	2.52
ATOM	1671	CG	GLU	A	228	8.887	−5.768	44.488	1.00	3.17
ATOM	1674	CD	GLU	A	228	8.461	−6.522	43.236	1.00	4.92
ATOM	1675	OE1	GLU	A	228	8.462	−5.922	42.145	1.00	5.91
ATOM	1676	OE2	GLU	A	228	8.141	−7.722	43.344	1.00	6.16
ATOM	1677	C	GLU	A	228	11.825	−3.310	45.083	1.00	2.31
ATOM	1678	O	GLU	A	228	11.652	−2.099	45.062	1.00	2.49
ATOM	1679	N	GLY	A	229	12.980	−3.887	44.771	1.00	2.30
ATOM	1681	CA	GLY	A	229	14.119	−3.135	44.286	1.00	2.20
ATOM	1684	C	GLY	A	229	14.778	−3.869	43.125	1.00	2.15
ATOM	1685	O	GLY	A	229	14.360	−4.973	42.754	1.00	2.15
ATOM	1686	N	LEU	A	230	15.812	−3.254	42.561	1.00	2.22
ATOM	1688	CA	LEU	A	230	16.549	−3.802	41.435	1.00	2.13
ATOM	1690	CB	LEU	A	230	16.623	−2.757	40.328	1.00	2.21
ATOM	1693	CG	LEU	A	230	17.162	−3.248	38.983	1.00	2.18
ATOM	1695	CD1	LEU	A	230	16.210	−4.268	38.363	1.00	2.50
ATOM	1699	CD2	LEU	A	230	17.388	−2.068	38.043	1.00	2.60
ATOM	1703	C	LEU	A	230	17.956	−4.182	41.901	1.00	2.15
ATOM	1704	O	LEU	A	230	18.621	−3.385	42.549	1.00	2.20
ATOM	1705	N	PHE	A	231	18.396	−5.394	41.580	1.00	2.05
ATOM	1707	CA	PHE	A	231	19.697	−5.875	42.041	1.00	2.38
ATOM	1709	CB	PHE	A	231	19.507	−7.041	43.007	1.00	2.23
ATOM	1712	CG	PHE	A	231	18.813	−6.666	44.269	1.00	2.69
ATOM	1713	CD1	PHE	A	231	17.443	−6.483	44.302	1.00	3.21
ATOM	1715	CE1	PHE	A	231	16.807	−6.139	45.480	1.00	3.94
ATOM	1717	CZ	PHE	A	231	17.542	−5.970	46.633	1.00	2.72
ATOM	1719	CE2	PHE	A	231	18.900	−6.141	46.607	1.00	3.21
ATOM	1721	CD2	PHE	A	231	19.534	−6.486	45.434	1.00	2.54
ATOM	1723	C	PHE	A	231	20.609	−6.336	40.921	1.00	2.43
ATOM	1724	O	PHE	A	231	20.168	−6.832	39.910	1.00	2.42
ATOM	1725	N	SER	A	232	21.909	−6.195	41.130	1.00	2.69
ATOM	1727	CA	SER	A	232	22.862	−6.677	40.158	1.00	3.10
ATOM	1729	CB	SER	A	232	24.242	−6.068	40.413	1.00	2.95
ATOM	1732	OG	ASER	A	232	24.570	−6.073	41.799	0.50	5.29
ATOM	1733	OG	BSER	A	232	25.105	−6.433	39.353	0.50	4.49
ATOM	1736	C	SER	A	232	22.989	−8.182	40.259	1.00	2.97
ATOM	1737	O	SER	A	232	23.054	−8.736	41.364	1.00	2.99
ATOM	1738	N	LYS	A	233	23.064	−8.838	39.106	1.00	3.09
ATOM	1740	CA	LYS	A	233	23.294	−10.273	39.050	1.00	3.64
ATOM	1742	CB	LYS	A	233	22.732	−10.849	37.748	1.00	3.60
ATOM	1745	CG	LYS	A	233	21.288	−11.149	37.782	1.00	4.20
ATOM	1748	CD	LYS	A	233	20.904	−12.027	36.601	1.00	4.67
ATOM	1751	CE	LYS	A	233	19.415	−12.173	36.504	1.00	4.71
ATOM	1754	NZ	LYS	A	233	19.004	−13.209	35.517	1.00	4.85
ATOM	1758	C	LYS	A	233	24.779	−10.585	39.057	1.00	3.83
ATOM	1759	O	LYS	A	233	25.189	−11.681	39.419	1.00	4.11
ATOM	1760	N	VAL	A	234	25.584	−9.607	38.657	1.00	4.42
ATOM	1762	CA	VAL	A	234	26.996	−9.819	38.406	1.00	4.40
ATOM	1764	CB	VAL	A	234	27.223	−10.020	36.886	1.00	4.65
ATOM	1766	CG1	VAL	A	234	26.545	−11.304	36.402	1.00	4.93
ATOM	1770	CG2	VAL	A	234	26.683	−8.840	36.103	1.00	4.52
ATOM	1774	C	VAL	A	234	27.836	−8.636	38.870	1.00	4.50
ATOM	1775	O	VAL	A	234	27.306	−7.553	39.115	1.00	4.51
ATOM	1776	N	ALA	A	235	29.141	−8.860	39.022	1.00	4.24
ATOM	1778	CA	ALA	A	235	30.074	−7.799	39.364	1.00	3.86
ATOM	1780	CB	ALA	A	235	31.387	−8.386	39.903	1.00	4.11
ATOM	1784	C	ALA	A	235	30.358	−6.973	38.120	1.00	3.50
ATOM	1785	O	ALA	A	235	30.673	−7.530	37.077	1.00	3.56
ATOM	1786	N	VAL	A	236	30.255	−5.653	38.235	1.00	3.07
ATOM	1788	CA	VAL	A	236	30.572	−4.751	37.131	1.00	2.74
ATOM	1790	CB	VAL	A	236	29.286	−4.217	36.449	1.00	2.68
ATOM	1792	CG1	VAL	A	236	28.513	−5.360	35.863	1.00	3.61
ATOM	1796	CG2	VAL	A	236	28.426	−3.439	37.437	1.00	2.43
ATOM	1800	C	VAL	A	236	31.426	−3.575	37.609	1.00	2.65
ATOM	1801	O	VAL	A	236	31.505	−3.284	38.807	1.00	2.46
ATOM	1802	N	GLY	A	237	32.080	−2.916	36.668	1.00	2.33
ATOM	1804	CA	GLY	A	237	32.831	−1.722	36.973	1.00	2.18
ATOM	1807	C	GLY	A	237	31.965	−0.487	36.807	1.00	2.29
ATOM	1808	O	GLY	A	237	30.770	−0.572	36.490	1.00	2.08
ATOM	1809	N	PRO	A	238	32.567	0.675	37.015	1.00	2.31
ATOM	1810	CA	PRO	A	238	31.876	1.948	36.840	1.00	2.21
ATOM	1812	CB	PRO	A	238	32.944	2.981	37.223	1.00	2.41
ATOM	1815	CG	PRO	A	238	34.019	2.248	37.840	1.00	2.81
ATOM	1818	CD	PRO	A	238	33.965	0.853	37.409	1.00	2.49
ATOM	1821	C	PRO	A	238	31.507	2.156	35.382	1.00	2.28
ATOM	1822	O	PRO	A	238	32.095	1.500	34.535	1.00	2.08
ATOM	1823	N	ASN	A	239	30.549	3.042	35.111	1.00	2.48
ATOM	1825	CA	ASN	A	239	30.204	3.416	33.749	1.00	2.91
ATOM	1827	CB	ASN	A	239	31.457	3.843	32.981	1.00	3.61
ATOM	1830	CG	ASN	A	239	31.214	5.010	32.013	1.00	7.42
ATOM	1831	OD1	ASN	A	239	30.074	5.447	31.779	1.00	10.92
ATOM	1832	ND2	ASN	A	239	32.302	5.510	31.430	1.00	11.07
ATOM	1835	C	ASN	A	239	29.508	2.279	32.992	1.00	2.43
ATOM	1836	O	ASN	A	239	29.484	2.301	31.763	1.00	2.65
ATOM	1837	N	THR	A	240	28.933	1.315	33.708	1.00	2.07
ATOM	1839	CA	THR	A	240	28.302	0.157	33.059	1.00	2.01
ATOM	1841	CB	THR	A	240	28.632	−1.143	33.799	1.00	2.12
ATOM	1843	OG1	THR	A	240	30.051	−1.268	33.983	1.00	2.28
ATOM	1845	CG2	THR	A	240	28.262	−2.351	32.948	1.00	2.11
ATOM	1849	C	THR	A	240	26.777	0.275	32.950	1.00	2.04
ATOM	1850	O	THR	A	240	26.073	0.443	33.935	1.00	2.06
ATOM	1851	N	VAL	A	241	26.262	0.166	31.738	1.00	2.00
ATOM	1853	CA	VAL	A	241	24.815	0.177	31.570	1.00	2.01
ATOM	1855	CB	VAL	A	241	24.419	0.335	30.105	1.00	2.05
ATOM	1857	CG1	VAL	A	241	22.902	0.169	29.941	1.00	2.07
ATOM	1861	CG2	VAL	A	241	24.863	1.684	29.579	1.00	2.18
ATOM	1865	C	VAL	A	241	24.262	−1.130	32.134	1.00	2.16
ATOM	1866	O	VAL	A	241	24.753	−2.217	31.809	1.00	2.29
ATOM	1867	N	MET	A	242	23.224	−1.036	32.958	1.00	2.59
ATOM	1869	CA	MET	A	242	22.672	−2.226	33.615	1.00	2.76
ATOM	1871	CB	MET	A	242	22.756	−2.078	35.126	1.00	2.81
ATOM	1874	CG	MET	A	242	24.163	−1.918	35.634	1.00	3.09
ATOM	1877	SD	MET	A	242	25.119	−3.426	35.424	1.00	3.66
ATOM	1878	CE	MET	A	242	24.649	−4.347	36.888	1.00	3.91
ATOM	1882	C	MET	A	242	21.224	−2.534	33.297	1.00	2.34
ATOM	1883	O	MET	A	242	20.839	−3.689	33.299	1.00	2.18
ATOM	1884	N	SER	A	243	20.428	−1.493	33.089	1.00	2.43
ATOM	1886	CA	SER	A	243	18.988	−1.644	32.937	1.00	2.80
ATOM	1888	CB	SER	A	243	18.353	−1.584	34.332	1.00	2.79
ATOM	1891	OG	SER	A	243	16.985	−1.910	34.357	1.00	3.90
ATOM	1893	C	SER	A	243	18.430	−0.532	32.059	1.00	2.74
ATOM	1894	O	SER	A	243	19.043	0.516	31.890	1.00	3.19
ATOM	1895	N	PHE	A	244	17.249	−0.764	31.516	1.00	2.66
ATOM	1897	CA	PHE	A	244	16.602	0.200	30.632	1.00	2.43
ATOM	1899	CB	PHE	A	244	16.358	−0.446	29.280	1.00	2.19
ATOM	1902	CG	PHE	A	244	17.611	−0.977	28.664	1.00	2.28
ATOM	1903	CD1	PHE	A	244	17.793	−2.334	28.481	1.00	2.21
ATOM	1905	CE1	PHE	A	244	18.984	−2.818	27.945	1.00	2.25
ATOM	1907	CZ	PHE	A	244	19.985	−1.948	27.588	1.00	2.16
ATOM	1909	CE2	PHE	A	244	19.814	−0.595	27.763	1.00	2.45
ATOM	1911	CD2	PHE	A	244	18.628	−0.111	28.298	1.00	2.35
ATOM	1913	C	PHE	A	244	15.324	0.716	31.253	1.00	2.17
ATOM	1914	O	PHE	A	244	14.640	−0.013	31.958	1.00	2.24
ATOM	1915	N	TYR	A	245	15.035	1.991	31.009	1.00	2.18
ATOM	1917	CA	TYR	A	245	13.862	2.651	31.560	1.00	2.15
ATOM	1919	CB	TYR	A	245	14.256	3.924	32.353	1.00	2.20
ATOM	1922	CG	TYR	A	245	13.301	4.321	33.471	1.00	2.00
ATOM	1923	CD1	TYR	A	245	13.712	4.344	34.795	1.00	2.00
ATOM	1925	CE1	TYR	A	245	12.848	4.708	35.812	1.00	2.07
ATOM	1927	CZ	TYR	A	245	11.548	5.070	35.516	1.00	2.37
ATOM	1928	OH	TYR	A	245	10.675	5.430	36.522	1.00	2.32
ATOM	1930	CE2	TYR	A	245	11.121	5.048	34.214	1.00	2.16
ATOM	1932	CD2	TYR	A	245	11.988	4.684	33.201	1.00	2.44
ATOM	1934	C	TYR	A	245	12.932	2.994	30.402	1.00	2.45
ATOM	1935	O	TYR	A	245	12.892	4.136	29.945	1.00	2.43
ATOM	1936	N	ASN	A	246	12.238	1.977	29.890	1.00	2.77
ATOM	1938	CA	ASN	A	246	11.219	2.175	28.862	1.00	3.04
ATOM	1940	CB	ASN	A	246	11.057	0.938	27.976	1.00	2.93
ATOM	1943	CG	ASN	A	246	10.037	1.154	26.861	1.00	2.79
ATOM	1944	OD1	ASN	A	246	10.093	2.157	26.148	1.00	2.29
ATOM	1945	ND2	ASN	A	246	9.086	0.220	26.721	1.00	2.93
ATOM	1948	C	ASN	A	246	9.895	2.460	29.556	1.00	3.31
ATOM	1949	O	ASN	A	246	9.744	2.209	30.747	1.00	3.44
ATOM	1950	N	GLY	A	247	8.944	3.003	28.814	1.00	3.66
ATOM	1952	CA	GLY	A	247	7.616	3.268	29.336	1.00	3.80
ATOM	1955	C	GLY	A	247	6.799	4.017	28.309	1.00	4.27
ATOM	1956	O	GLY	A	247	7.253	4.225	27.178	1.00	4.28
ATOM	1957	N	VAL	A	248	5.584	4.396	28.697	1.00	4.32
ATOM	1959	CA	VAL	A	248	4.708	5.179	27.852	1.00	4.50
ATOM	1961	CB	VAL	A	248	3.233	5.103	28.304	1.00	4.48
ATOM	1963	CG1	VAL	A	248	2.745	3.670	28.288	1.00	5.63
ATOM	1967	CG2	VAL	A	248	3.023	5.702	29.664	1.00	4.96
ATOM	1971	C	VAL	A	248	5.195	6.620	27.881	1.00	4.37
ATOM	1972	O	VAL	A	248	5.774	7.068	28.864	1.00	4.09
ATOM	1973	N	ARG	A	249	4.974	7.348	26.795	1.00	4.02
ATOM	1975	CA	ARG	A	249	5.419	8.733	26.726	1.00	4.38
ATOM	1977	CB	ARG	A	249	6.013	9.022	25.353	1.00	5.06
ATOM	1980	CG	ARG	A	249	7.450	8.604	25.238	1.00	6.52
ATOM	1983	CD	ARG	A	249	7.815	7.997	23.918	1.00	9.42
ATOM	1986	NE	ARG	A	249	8.843	6.985	24.094	1.00	11.70
ATOM	1988	CZ	ARG	A	249	10.093	7.116	23.696	1.00	13.30
ATOM	1989	NH1	ARG	A	249	10.475	8.216	23.070	1.00	15.18
ATOM	1992	NH2	ARG	A	249	10.965	6.143	23.922	1.00	13.35
ATOM	1995	C	ARG	A	249	4.248	9.675	26.983	1.00	4.18
ATOM	1996	O	ARG	A	249	3.199	9.560	26.346	1.00	3.34
ATOM	1997	N	ILE	A	250	4.429	10.615	27.902	1.00	3.39
ATOM	1999	CA	ILE	A	250	3.389	11.580	28.226	1.00	3.73
ATOM	2001	CB	ILE	A	250	2.611	11.120	29.460	1.00	4.31
ATOM	2003	CG1	ILE	A	250	3.553	10.933	30.639	1.00	4.63
ATOM	2006	CD1	ILE	A	250	2.844	10.570	31.927	1.00	5.32
ATOM	2010	CG2	ILE	A	250	1.887	9.813	29.164	1.00	5.16
ATOM	2014	C	ILE	A	250	3.992	12.972	28.438	1.00	3.77
ATOM	2015	O	ILE	A	250	5.213	13.161	28.334	1.00	3.89
ATOM	2016	N	THR	A	251	3.148	13.951	28.740	1.00	3.68
ATOM	2018	CA	THR	A	251	3.637	15.312	28.956	1.00	3.84
ATOM	2020	CB	THR	A	251	2.637	16.325	28.398	1.00	3.91
ATOM	2022	OG1	THR	A	251	1.476	16.366	29.245	1.00	2.98
ATOM	2024	CG2	THR	A	251	2.135	15.916	27.032	1.00	3.69
ATOM	2028	C	THR	A	251	3.874	15.648	30.430	1.00	4.23
ATOM	2029	O	THR	A	251	3.304	15.034	31.329	1.00	3.85
ATOM	2030	N	HIS	A	252	4.724	16.644	30.656	1.00	4.92
ATOM	2032	CA	HIS	A	252	4.997	17.135	31.987	1.00	5.37
ATOM	2034	CB	HIS	A	252	6.129	18.167	31.939	1.00	5.54
ATOM	2037	CG	HIS	A	252	7.471	17.579	31.608	1.00	5.74
ATOM	2038	ND1	HIS	A	252	8.365	17.169	32.572	1.00	6.59
ATOM	2040	CE1	HIS	A	252	9.454	16.699	31.990	1.00	5.78
ATOM	2042	NE2	HIS	A	252	9.301	16.796	30.683	1.00	6.87
ATOM	2044	CD2	HIS	A	252	8.066	17.336	30.417	1.00	6.09
ATOM	2046	C	HIS	A	252	3.730	17.755	32.590	1.00	5.91
ATOM	2047	O	HIS	A	252	3.529	17.740	33.783	1.00	6.19
ATOM	2048	N	GLN	A	253	2.858	18.287	31.748	1.00	6.66
ATOM	2050	CA	GLN	A	253	1.646	18.938	32.236	1.00	7.22
ATOM	2052	CB	GLN	A	253	0.923	19.618	31.094	1.00	7.93
ATOM	2055	CG	GLN	A	253	1.585	20.884	30.621	1.00	9.76
ATOM	2058	CD	GLN	A	253	2.804	20.650	29.728	1.00	11.24
ATOM	2059	OE1	GLN	A	253	3.202	21.534	28.981	1.00	12.89
ATOM	2060	NE2	GLN	A	253	3.384	19.472	29.800	1.00	13.47
ATOM	2063	C	GLN	A	253	0.683	17.970	32.877	1.00	6.97
ATOM	2064	O	GLN	A	253	0.187	18.204	33.982	1.00	7.62
ATOM	2065	N	GLU	A	254	0.418	16.887	32.168	1.00	6.45
ATOM	2067	CA	GLU	A	254	−0.470	15.849	32.654	1.00	7.11
ATOM	2069	CB	GLU	A	254	−0.530	14.696	31.648	1.00	7.42
ATOM	2072	CG	GLU	A	254	−1.409	13.521	32.075	1.00	9.67
ATOM	2075	CD	GLU	A	254	−1.514	12.426	31.008	1.00	12.85
ATOM	2076	OE1	GLU	A	254	−0.897	12.561	29.925	1.00	12.24
ATOM	2077	OE2	GLU	A	254	−2.230	11.423	31.249	1.00	15.26
ATOM	2078	C	GLU	A	254	0.045	15.333	33.988	1.00	6.48
ATOM	2079	O	GLU	A	254	−0.725	15.114	34.913	1.00	6.44
ATOM	2080	N	VAL	A	255	1.364	15.155	34.075	1.00	6.59
ATOM	2082	CA	VAL	A	255	2.005	14.650	35.278	1.00	6.49
ATOM	2084	CB	VAL	A	255	3.505	14.345	35.012	1.00	6.42
ATOM	2086	CG1	VAL	A	255	4.236	14.063	36.290	1.00	6.18
ATOM	2090	CG2	VAL	A	255	3.647	13.158	34.066	1.00	5.96
ATOM	2094	C	VAL	A	255	1.853	15.651	36.439	1.00	6.75
ATOM	2095	O	VAL	A	255	1.463	15.273	37.531	1.00	6.38
ATOM	2096	N	ASP	A	256	2.126	16.929	36.181	1.00	7.52
ATOM	2098	CA	ASP	A	256	2.012	17.982	37.199	1.00	8.01
ATOM	2100	CB	ASP	A	256	2.583	19.306	36.678	1.00	8.71
ATOM	2103	CG	ASP	A	256	4.066	19.221	36.343	1.00	10.13
ATOM	2104	OD1	ASP	A	256	4.731	18.286	36.812	1.00	11.21
ATOM	2105	OD2	ASP	A	256	4.660	20.027	35.596	1.00	13.23
ATOM	2106	C	ASP	A	256	0.565	18.216	37.629	1.00	7.94
ATOM	2107	O	ASP	A	256	0.317	18.769	38.702	1.00	8.89
ATOM	2108	N	SER	A	257	−0.382	17.788	36.802	1.00	7.19
ATOM	2110	CA	SER	A	257	−1.799	17.999	37.086	1.00	6.69
ATOM	2112	CB	SER	A	257	−2.549	18.295	35.789	1.00	6.90
ATOM	2115	OG	SER	A	257	−2.974	17.081	35.197	1.00	7.47
ATOM	2117	C	SER	A	257	−2.443	16.794	37.772	1.00	6.14
ATOM	2118	O	SER	A	257	−3.653	16.773	37.998	1.00	6.30
ATOM	2119	N	ARG	A	258	−1.650	15.783	38.113	1.00	5.33
ATOM	2121	CA	ARG	A	258	−2.224	14.601	38.751	1.00	4.73
ATOM	2123	CB	ARG	A	258	−2.178	13.397	37.822	1.00	4.74
ATOM	2126	CG	ARG	A	258	−0.801	12.948	37.443	1.00	4.66
ATOM	2129	CD	ARG	A	258	−0.806	11.964	36.291	1.00	4.23
ATOM	2132	NE	ARG	A	258	0.439	11.225	36.181	1.00	3.76
ATOM	2134	CZ	ARG	A	258	0.678	10.280	35.288	1.00	3.91
ATOM	2135	NH1	ARG	A	258	−0.253	9.948	34.393	1.00	3.83
ATOM	2138	NH2	ARG	A	258	1.857	9.672	35.282	1.00	4.26
ATOM	2141	C	ARG	A	258	−1.551	14.266	40.077	1.00	4.32
ATOM	2142	O	ARG	A	258	−0.455	14.729	40.356	1.00	3.68
ATOM	2143	N	ASP	A	259	−2.254	13.461	40.868	1.00	4.17
ATOM	2145	CA	ASP	A	259	−1.831	13.025	42.202	1.00	3.92
ATOM	2147	CB	ASP	A	259	−2.930	12.122	42.753	1.00	4.24
ATOM	2150	CG	ASP	A	259	−2.800	11.847	44.221	1.00	5.85
ATOM	2151	OD1	ASP	A	259	−1.852	11.160	44.626	1.00	6.94
ATOM	2152	OD2	ASP	A	259	−3.658	12.248	45.031	1.00	9.13
ATOM	2153	C	ASP	A	259	−0.514	12.255	42.188	1.00	3.64
ATOM	2154	O	ASP	A	259	−0.214	11.522	41.245	1.00	3.11
ATOM	2155	N	TRP	A	260	0.269	12.394	43.259	1.00	3.86
ATOM	2157	CA	TRP	A	260	1.550	11.696	43.325	1.00	3.80
ATOM	2159	CB	TRP	A	260	2.322	12.060	44.581	1.00	4.34
ATOM	2162	CG	TRP	A	260	3.204	13.248	44.416	1.00	5.06
ATOM	2163	CD1	TRP	A	260	2.993	14.485	44.936	1.00	5.61
ATOM	2165	NE1	TRP	A	260	4.011	15.332	44.573	1.00	5.32
ATOM	2167	CE2	TRP	A	260	4.916	14.639	43.812	1.00	5.59
ATOM	2168	CD2	TRP	A	260	4.443	13.320	43.695	1.00	4.92
ATOM	2169	CE3	TRP	A	260	5.196	12.406	42.945	1.00	5.71
ATOM	2171	CZ3	TRP	A	260	6.383	12.839	42.357	1.00	6.16
ATOM	2173	CH2	TRP	A	260	6.822	14.155	42.506	1.00	5.94
ATOM	2175	CZ2	TRP	A	260	6.103	15.066	43.222	1.00	6.33
ATOM	2177	C	TRP	A	260	1.374	10.193	43.279	1.00	3.37
ATOM	2178	O	TRP	A	260	2.280	9.476	42.883	1.00	4.00
ATOM	2179	N	ALA	A	261	0.215	9.715	43.702	1.00	2.79
ATOM	2181	CA	ALA	A	261	−0.050	8.292	43.691	1.00	2.81
ATOM	2183	CB	ALA	A	261	−1.418	8.005	44.207	1.00	3.00
ATOM	2187	C	ALA	A	261	0.115	7.752	42.270	1.00	2.68
ATOM	2188	O	ALA	A	261	0.342	6.565	42.093	1.00	2.83
ATOM	2189	N	LEU	A	262	0.022	8.633	41.270	1.00	2.70
ATOM	2191	CA	LEU	A	262	0.198	8.252	39.866	1.00	2.95
ATOM	2193	CB	LEU	A	262	−0.841	8.985	38.993	1.00	2.95
ATOM	2196	CG	LEU	A	262	−2.312	8.808	39.386	1.00	3.70
ATOM	2198	CD1	LEU	A	262	−3.220	9.716	38.576	1.00	4.17
ATOM	2202	CD2	LEU	A	262	−2.738	7.384	39.178	1.00	4.22
ATOM	2206	C	LEU	A	262	1.582	8.582	39.304	1.00	3.18
ATOM	2207	O	LEU	A	262	1.877	8.216	38.161	1.00	3.23
ATOM	2208	N	ASN	A	263	2.427	9.247	40.098	1.00	3.18
ATOM	2210	CA	ASN	A	263	3.719	9.748	39.623	1.00	3.19
ATOM	2212	CB	ASN	A	263	3.757	11.274	39.771	1.00	3.19
ATOM	2215	CG	ASN	A	263	2.767	11.976	38.847	1.00	3.20
ATOM	2216	OD1	ASN	A	263	2.454	11.479	37.762	1.00	3.60
ATOM	2217	ND2	ASN	A	263	2.263	13.132	39.273	1.00	2.78
ATOM	2220	C	ASN	A	263	4.956	9.112	40.279	1.00	3.27
ATOM	2221	O	ASN	A	263	6.022	9.740	40.386	1.00	3.08
ATOM	2222	N	GLY	A	264	4.821	7.874	40.742	1.00	3.23
ATOM	2224	CA	GLY	A	264	5.955	7.159	41.309	1.00	2.91
ATOM	2227	C	GLY	A	264	7.028	6.781	40.291	1.00	2.93
ATOM	2228	O	GLY	A	264	8.228	6.724	40.628	1.00	3.18
ATOM	2229	N	ASN	A	265	6.612	6.529	39.044	1.00	2.70
ATOM	2231	CA	ASN	A	265	7.515	6.059	37.998	1.00	2.83
ATOM	2233	CB	ASN	A	265	6.995	4.736	37.440	1.00	3.16
ATOM	2236	CG	ASN	A	265	7.070	3.609	38.466	1.00	4.64
ATOM	2237	OD1	ASN	A	265	7.723	3.733	39.519	1.00	6.97
ATOM	2238	ND2	ASN	A	265	6.423	2.499	38.158	1.00	5.90
ATOM	2241	C	ASN	A	265	7.782	7.030	36.854	1.00	2.63
ATOM	2242	O	ASN	A	265	8.411	6.670	35.868	1.00	3.13
ATOM	2243	N	THR	A	266	7.312	8.260	36.975	1.00	2.76
ATOM	2245	CA	THR	A	266	7.534	9.243	35.928	1.00	2.53
ATOM	2247	CB	THR	A	266	6.657	10.449	36.156	1.00	2.58
ATOM	2249	OG1	THR	A	266	6.755	10.851	37.536	1.00	2.28
ATOM	2251	CG2	THR	A	266	5.182	10.097	35.948	1.00	2.42
ATOM	2255	C	THR	A	266	8.988	9.687	35.950	1.00	2.81
ATOM	2256	O	THR	A	266	9.516	10.009	37.015	1.00	3.23
ATOM	2257	N	LEU	A	267	9.606	9.711	34.775	1.00	2.94
ATOM	2259	CA	LEU	A	267	10.987	10.109	34.596	1.00	3.68
ATOM	2261	CB	LEU	A	267	11.856	8.890	34.312	1.00	3.83
ATOM	2264	CG	LEU	A	267	13.291	9.198	33.862	1.00	3.83
ATOM	2266	CD1	LEU	A	267	14.115	9.914	34.943	1.00	4.78
ATOM	2270	CD2	LEU	A	267	13.946	7.910	33.437	1.00	4.52
ATOM	2274	C	LEU	A	267	11.056	11.061	33.421	1.00	4.61
ATOM	2275	O	LEU	A	267	10.514	10.764	32.334	1.00	3.96
ATOM	2276	N	SER	A	268	11.692	12.210	33.629	1.00	5.56
ATOM	2278	CA	SER	A	268	11.786	13.203	32.563	1.00	6.81
ATOM	2280	CB	SER	A	268	12.141	14.598	33.129	1.00	6.96
ATOM	2283	OG	ASER	A	268	11.251	14.979	34.133	0.50	7.90
ATOM	2284	OG	BSER	A	268	12.920	15.273	32.173	0.50	7.34
ATOM	2287	C	SER	A	268	12.801	12.694	31.527	1.00	7.87
ATOM	2288	O	SER	A	268	13.968	12.392	31.860	1.00	8.21
ATOM	2289	N	LEU	A	269	12.345	12.574	30.289	1.00	9.28
ATOM	2291	CA	LEU	A	269	13.168	12.087	29.190	1.00	10.67
ATOM	2293	CB	LEU	A	269	12.292	11.404	28.140	1.00	10.48
ATOM	2296	CG	LEU	A	269	12.909	10.303	27.274	1.00	11.51
ATOM	2298	CD1	LEU	A	269	12.263	10.333	25.897	1.00	11.38
ATOM	2302	CD2	LEU	A	269	14.419	10.399	27.144	1.00	12.54
ATOM	2306	C	LEU	A	269	13.918	13.255	28.554	1.00	11.61
ATOM	2307	O	LEU	A	269	15.148	13.263	28.471	1.00	11.86
ATOM	2308	N	ASP	A	270	13.152	14.239	28.114	1.00	12.80
ATOM	2310	CA	ASP	A	270	13.676	15.440	27.491	1.00	13.69
ATOM	2312	CB	ASP	A	270	13.689	15.311	25.962	1.00	13.95
ATOM	2315	CG	ASP	A	270	12.311	15.213	25.376	1.00	14.89
ATOM	2316	OD1	ASP	A	270	11.368	15.718	26.018	1.00	14.96
ATOM	2317	OD2	ASP	A	270	12.061	14.665	24.267	1.00	17.09
ATOM	2318	C	ASP	A	270	12.755	16.571	27.958	1.00	14.07
ATOM	2319	O	ASP	A	270	11.871	16.357	28.794	1.00	14.20
ATOM	2320	N	GLU	A	271	12.948	17.763	27.416	1.00	14.31
ATOM	2322	CA	GLU	A	271	12.154	18.915	27.816	1.00	14.56
ATOM	2324	CB	GLU	A	271	12.632	20.138	27.034	1.00	15.14
ATOM	2327	CG	GLU	A	271	12.577	21.432	27.821	1.00	16.67
ATOM	2330	CD	GLU	A	271	13.173	22.603	27.053	1.00	18.56
ATOM	2331	OE1	GLU	A	271	13.233	22.537	25.801	1.00	19.69
ATOM	2332	OE2	GLU	A	271	13.584	23.591	27.702	1.00	19.35
ATOM	2333	C	GLU	A	271	10.656	18.705	27.566	1.00	14.24
ATOM	2334	O	GLU	A	271	9.811	19.220	28.306	1.00	14.58
ATOM	2335	N	GLU	A	272	10.339	17.938	26.530	1.00	13.41
ATOM	2337	CA	GLU	A	272	8.964	17.740	26.095	1.00	12.91
ATOM	2339	CB	GLU	A	272	8.919	17.825	24.564	1.00	13.45
ATOM	2342	CG	GLU	A	272	7.646	17.287	23.930	1.00	15.09
ATOM	2345	CD	GLU	A	272	6.425	18.139	24.229	1.00	17.47
ATOM	2346	OE1	GLU	A	272	6.010	18.937	23.354	1.00	17.98
ATOM	2347	OE2	GLU	A	272	5.871	17.995	25.343	1.00	19.19
ATOM	2348	C	GLU	A	272	8.329	16.421	26.530	1.00	11.55
ATOM	2349	O	GLU	A	272	7.108	16.284	26.498	1.00	11.51
ATOM	2350	N	THR	A	273	9.134	15.452	26.944	1.00	9.75
ATOM	2352	CA	THR	A	273	8.585	14.129	27.218	1.00	8.69
ATOM	2354	CB	THR	A	273	9.075	13.153	26.159	1.00	8.76
ATOM	2356	OG1	TER	A	273	9.047	13.781	24.869	1.00	9.12
ATOM	2358	CG2	THR	A	273	8.126	11.978	26.041	1.00	9.77
ATOM	2362	C	THR	A	273	8.942	13.528	28.565	1.00	7.33
ATOM	2363	O	THR	A	273	10.073	13.621	29.005	1.00	7.19
ATOM	2364	N	VAL	A	274	7.953	12.863	29.151	1.00	6.08
ATOM	2366	CA	VAL	A	274	8.077	12.124	30.390	1.00	5.63
ATOM	2368	CB	VAL	A	274	7.038	12.603	31.427	1.00	5.35
ATOM	2370	CG1	VAL	A	274	7.064	11.752	32.668	1.00	5.23
ATOM	2374	CG2	VAL	A	274	7.260	14.059	31.782	1.00	6.17
ATOM	2378	C	VAL	A	274	7.804	10.658	30.066	1.00	5.28
ATOM	2379	O	VAL	A	274	6.843	10.333	29.349	1.00	4.93
ATOM	2380	N	ILE	A	275	8.673	9.779	30.545	1.00	4.74
ATOM	2382	CA	ILE	A	275	8.492	8.345	30.395	1.00	5.25
ATOM	2384	CB	ILE	A	275	9.845	7.644	30.146	1.00	6.00
ATOM	2386	CG1	ILE	A	275	10.254	7.791	28.685	1.00	7.09
ATOM	2389	CD1	ILE	A	275	9.124	7.536	27.688	1.00	8.89
ATOM	2393	CG2	ILE	A	275	9.778	6.160	30.517	1.00	6.24
ATOM	2397	C	ILE	A	275	7.843	7.847	31.682	1.00	5.16
ATOM	2398	O	ILE	A	275	8.244	8.252	32.778	1.00	4.51
ATOM	2399	N	ASP	A	276	6.821	7.003	31.550	1.00	4.93
ATOM	2401	CA	ASP	A	276	6.097	6.499	32.712	1.00	4.99
ATOM	2403	CB	ASP	A	276	4.781	7.268	32.855	1.00	5.23
ATOM	2406	CG	ASP	A	276	4.056	6.983	34.159	1.00	5.97
ATOM	2407	OD1	ASP	A	276	4.721	6.607	35.154	1.00	7.19
ATOM	2408	OD2	ASP	A	276	2.818	7.146	34.273	1.00	6.97
ATOM	2409	C	ASP	A	276	5.813	5.004	32.610	1.00	5.08
ATOM	2410	O	ASP	A	276	5.674	4.459	31.522	1.00	4.61
ATOM	2411	N	VAL	A	277	5.758	4.335	33.761	1.00	5.26
ATOM	2413	CA	VAL	A	277	5.382	2.928	33.811	1.00	5.55
ATOM	2415	CB	VAL	A	277	6.506	2.054	34.354	1.00	6.07
ATOM	2417	CG1	VAL	A	277	6.110	0.589	34.321	1.00	6.33
ATOM	2421	CG2	VAL	A	277	7.767	2.265	33.537	1.00	6.87
ATOM	2425	C	VAL	A	277	4.143	2.842	34.703	1.00	5.75
ATOM	2426	O	VAL	A	277	4.226	2.531	35.888	1.00	5.17
ATOM	2427	N	PRO	A	278	2.995	3.165	34.130	1.00	5.68
ATOM	2428	CA	PRO	A	278	1.717	3.192	34.842	1.00	6.20
ATOM	2430	CB	PRO	A	278	0.738	3.734	33.780	1.00	6.37
ATOM	2433	CG	PRO	A	278	1.493	3.937	32.561	1.00	6.28
ATOM	2436	CD	PRO	A	278	2.853	3.518	32.708	1.00	5.79
ATOM	2439	C	PRO	A	278	1.214	1.820	35.278	1.00	6.95
ATOM	2440	O	PRO	A	278	1.647	0.810	34.733	1.00	6.97
ATOM	2441	N	GLU	A	279	0.314	1.794	36.259	1.00	7.70
ATOM	2443	CA	GLU	A	279	−0.341	0.559	36.691	1.00	8.29
ATOM	2445	CB	GLU	A	279	−1.627	0.928	37.450	1.00	8.86
ATOM	2448	CG	GLU	A	279	−1.592	0.943	38.965	1.00	10.55
ATOM	2451	CD	GLU	A	279	−0.797	−0.198	39.546	1.00	11.50
ATOM	2452	OE1	GLU	A	279	−0.096	0.024	40.564	1.00	12.98
ATOM	2453	OE2	GLU	A	279	−0.874	−1.317	38.996	1.00	12.19
ATOM	2454	C	GLU	A	279	−0.786	−0.106	35.394	1.00	8.23
ATOM	2455	O	GLU	A	279	−1.127	0.658	34.486	1.00	8.51
ATOM	2456	N	PRO	A	280	−0.849	−1.424	35.159	1.00	8.03
ATOM	2457	CA	PRO	A	280	−0.438	−2.620	35.910	1.00	7.65
ATOM	2459	CB	PRO	A	280	−1.239	−3.753	35.191	1.00	7.99
ATOM	2462	CG	PRO	A	280	−1.963	−3.141	34.091	1.00	8.12
ATOM	2465	CD	PRO	A	280	−1.524	−1.783	33.914	1.00	8.30
ATOM	2468	C	PRO	A	280	1.043	−2.900	35.695	1.00	6.68
ATOM	2469	O	PRO	A	280	1.691	−3.577	36.482	1.00	7.93
ATOM	2470	N	TYR	A	281	1.575	−2.321	34.628	1.00	5.83
ATOM	2472	CA	TYR	A	281	2.948	−2.492	34.168	1.00	4.98
ATOM	2474	CB	TYR	A	281	3.143	−1.626	32.932	1.00	4.93
ATOM	2477	CG	TYR	A	281	1.998	−1.853	31.958	1.00	5.13
ATOM	2478	CD1	TYR	A	281	1.142	−0.824	31.599	1.00	6.00
ATOM	2480	CE1	TYR	A	281	0.082	−1.048	30.733	1.00	6.35
ATOM	2482	CZ	TYR	A	281	−0.126	−2.314	30.231	1.00	6.60
ATOM	2483	OH	TYR	A	281	−1.168	−2.555	29.374	1.00	7.98
ATOM	2485	CE2	TYR	A	281	0.697	−3.351	30.583	1.00	6.56
ATOM	2487	CD2	TYR	A	281	1.748	−3.119	31.445	1.00	5.49
ATOM	2489	C	TYR	A	281	4.061	−2.236	35.181	1.00	4.34
ATOM	2490	O	TYR	A	281	5.201	−2.564	34.898	1.00	4.10
ATOM	2491	N	ASN	A	282	3.744	−1.655	36.335	1.00	3.78
ATOM	2493	CA	ASN	A	282	4.756	−1.474	37.377	1.00	3.97
ATOM	2495	CB	ASN	A	282	4.402	−0.340	38.344	1.00	4.11
ATOM	2498	CG	ASN	A	282	3.066	−0.537	39.012	1.00	5.03
ATOM	2499	OD1	ASN	A	282	2.065	−0.819	38.361	1.00	5.68
ATOM	2500	ND2	ASN	A	282	3.043	−0.379	40.325	1.00	5.45	N
ATOM	2503	C	ASN	A	282	4.962	−2.793	38.130	1.00	3.55
ATOM	2504	O	ASN	A	282	5.766	−2.876	39.063	1.00	3.50
ATOM	2505	N	HIS	A	283	4.218	−3.820	37.729	1.00	3.14	N
ATOM	2507	CA	HIS	A	283	4.330	−5.155	38.302	1.00	2.99
ATOM	2509	CB	HIS	A	283	2.958	−5.680	38.729	1.00	3.26
ATOM	2512	CG	HIS	A	283	2.198	−4.747	39.619	1.00	3.72
ATOM	2513	ND1	HIS	A	283	2.212	−4.855	40.997	1.00	5.84	N
ATOM	2515	CE1	HIS	A	283	1.466	−3.896	41.517	1.00	5.78
ATOM	2517	NE2	HIS	A	283	0.967	−3.175	40.527	1.00	5.04	N
ATOM	2519	CD2	HIS	A	283	1.427	−3.673	39.336	1.00	4.01
ATOM	2521	C	HIS	A	283	4.959	−6.077	37.250	1.00	3.18
ATOM	2522	O	HIS	A	283	4.542	−6.077	36.083	1.00	2.66
ATOM	2523	N	VAL	A	284	5.962	−6.852	37.664	1.00	3.38	N
ATOM	2525	CA	VAL	A	284	6.691	−7.754	36.772	1.00	3.93
ATOM	2527	CB	VAL	A	284	7.902	−8.397	37.522	1.00	4.61
ATOM	2529	CG1	VAL	A	284	8.480	−9.561	36.733	1.00	6.36
ATOM	2533	CG2	VAL	A	284	8.951	−7.367	37.765	1.00	5.28
ATOM	2537	C	VAL	A	284	5.793	−8.835	36.177	1.00	3.60
ATOM	2538	O	VAL	A	284	6.077	−9.374	35.102	1.00	3.80
ATOM	2539	N	SER	A	285	4.690	−9.129	36.857	1.00	3.21	N
ATOM	2541	CA	SER	A	285	3.729	−10.112	36.374	1.00	3.59
ATOM	2543	CB	SER	A	285	2.665	−10.381	37.441	1.00	3.57
ATOM	2546	OG	SER	A	285	2.080	−9.175	37.898	1.00	3.13
ATOM	2548	C	SER	A	285	3.053	−9.624	35.091	1.00	3.14
ATOM	2549	O	SER	A	285	2.489	−10.423	34.338	1.00	4.00
ATOM	2550	N	LYS	A	286	3.093	−8.313	34.853	1.00	3.10	N
ATOM	2552	CA	LYS	A	286	2.439	−7.702	33.678	1.00	3.42
ATOM	2554	CB	LYS	A	286	1.438	−6.633	34.123	1.00	3.77
ATOM	2557	CG	LYS	A	286	0.123	−7.194	34.685	1.00	6.06
ATOM	2560	CD	LYS	A	286	−0.724	−7.896	33.666	1.00	8.22
ATOM	2563	CE	LYS	A	286	−1.925	−8.600	34.311	1.00	9.47
ATOM	2566	NZ	LYS	A	286	−2.793	−9.261	33.296	1.00	11.77
ATOM	2570	C	LYS	A	286	3.405	−7.077	32.670	1.00	3.19
ATOM	2571	O	LYS	A	286	3.067	−6.937	31.484	1.00	3.19
ATOM	2572	N	TYR	A	287	4.591	−6.686	33.135	1.00	3.08
ATOM	2574	CA	TYR	A	287	5.581	−6.043	32.283	1.00	2.92
ATOM	2576	CB	TYR	A	287	5.327	−4.534	32.227	1.00	3.01
ATOM	2579	CG	TYR	A	287	6.346	−3.785	31.403	1.00	2.82
ATOM	2580	CD1	TYR	A	287	6.227	−3.716	30.020	1.00	2.65
ATOM	2582	CE1	TYR	A	287	7.154	−3.039	29.258	1.00	3.46
ATOM	2584	CZ	TYR	A	287	8.239	−2.428	29.883	1.00	3.19
ATOM	2585	OH	TYR	A	287	9.179	−1.762	29.138	1.00	3.19
ATOM	2587	CE2	TYR	A	287	8.375	−2.474	31.262	1.00	3.12
ATOM	2589	CD2	TYR	A	287	7.438	−3.153	32.008	1.00	2.85
ATOM	2591	C	TYR	A	287	6.994	−6.291	32.781	1.00	3.16
ATOM	2592	O	TYR	A	287	7.328	−5.923	33.904	1.00	2.77
ATOM	2593	N	CYS	A	288	7.825	−6.899	31.943	1.00	3.14
ATOM	2595	CA	CYS	A	288	9.210	−7.146	32.319	1.00	3.38
ATOM	2597	CB	CYS	A	288	9.379	−8.530	32.957	1.00	3.55
ATOM	2600	SG	CYS	A	288	9.045	−9.938	31.904	1.00	4.82
ATOM	2601	C	CYS	A	288	10.167	−6.940	31.143	1.00	3.21
ATOM	2602	O	CYS	A	288	11.324	−7.371	31.199	1.00	3.03
ATOM	2603	N	ALA	A	289	9.694	−6.258	30.100	1.00	2.71
ATOM	2605	CA	ALA	A	289	10.523	−5.935	28.941	1.00	2.80
ATOM	2607	CB	ALA	A	289	9.680	−5.275	27.818	1.00	2.83
ATOM	2611	C	ALA	A	289	11.691	−5.033	29.332	1.00	3.28
ATOM	2612	O	ALA	A	289	12.757	−5.100	28.732	1.00	4.23
ATOM	2613	N	SER	A	290	11.496	−4.204	30.354	1.00	3.41
ATOM	2615	CA	SER	A	290	12.558	−3.353	30.882	1.00	3.17
ATOM	2617	CB	SER	A	290	12.535	−1.959	30.266	1.00	3.30
ATOM	2620	OG	SER	A	290	11.322	−1.293	30.525	1.00	2.87
ATOM	2622	C	SER	A	290	12.317	−3.286	32.377	1.00	3.07
ATOM	2623	O	SER	A	290	11.195	−3.478	32.823	1.00	2.76
ATOM	2624	N	LEU	A	291	13.349	−2.993	33.159	1.00	2.85
ATOM	2626	CA	LEU	A	291	13.206	−3.042	34.601	1.00	2.89
ATOM	2628	CB	LEU	A	291	13.931	−4.286	35.143	1.00	2.91
ATOM	2631	CG	LEU	A	291	13.374	−5.624	34.631	1.00	2.88
ATOM	2633	CD1	LEU	A	291	14.284	−6.783	34.977	1.00	3.99
ATOM	2637	CD2	LEU	A	291	11.955	−5.886	35.147	1.00	2.41
ATOM	2641	C	LEU	A	291	13.712	−1.810	35.332	1.00	2.94
ATOM	2642	O	LEU	A	291	13.742	−1.805	36.562	1.00	2.78
ATOM	2643	N	GLY	A	292	14.073	−0.766	34.587	1.00	2.64
ATOM	2645	CA	GLY	A	292	14.630	0.449	35.169	1.00	2.69
ATOM	2648	C	GLY	A	292	13.795	1.106	36.250	1.00	2.65
ATOM	2649	O	GLY	A	292	14.336	1.707	37.187	1.00	2.68
ATOM	2650	N	HIS	A	293	12.478	0.991	36.126	1.00	2.35
ATOM	2652	CA	HIS	A	293	11.550	1.619	37.055	1.00	2.26
ATOM	2654	CB	HIS	A	293	10.148	1.602	36.437	1.00	2.29
ATOM	2657	CG	HIS	A	293	9.712	0.229	36.055	1.00	2.25
ATOM	2658	ND1	HIS	A	293	10.181	−0.403	34.926	1.00	2.25
ATOM	2660	CE1	HIS	A	293	9.648	−1.609	34.848	1.00	2.36
ATOM	2662	NE2	HIS	A	293	8.885	−1.797	35.910	1.00	2.79
ATOM	2664	CD2	HIS	A	293	8.918	−0.666	36.690	1.00	2.34
ATOM	2666	C	HIS	A	293	11.504	0.929	38.421	1.00	2.56
ATOM	2667	O	HIS	A	293	10.796	1.395	39.313	1.00	2.98
ATOM	2668	N	LYS	A	294	12.240	−0.172	38.582	1.00	2.27
ATOM	2670	CA	LYS	A	294	12.264	−0.919	39.839	1.00	2.63
ATOM	2672	CB	LYS	A	294	12.376	−2.421	39.565	1.00	2.92
ATOM	2675	CG	LYS	A	294	11.067	−3.031	39.101	1.00	3.32
ATOM	2678	CD	LYS	A	294	10.086	−3.141	40.258	1.00	4.06
ATOM	2681	CE	LYS	A	294	8.697	−3.522	39.807	1.00	4.08
ATOM	2684	NZ	LYS	A	294	7.734	−3.623	40.939	1.00	4.41
ATOM	2688	C	LYS	A	294	13.399	−0.470	40.746	1.00	2.51
ATOM	2689	O	LYS	A	294	13.471	−0.868	41.922	1.00	2.44
ATOM	2690	N	ALA	A	295	14.293	0.366	40.230	1.00	2.47
ATOM	2692	CA	ALA	A	295	15.431	0.814	41.054	1.00	2.22
ATOM	2694	CB	ALA	A	295	16.548	1.337	40.185	1.00	2.36
ATOM	2698	C	ALA	A	295	14.970	1.893	42.034	1.00	2.25
ATOM	2699	O	ALA	A	295	14.358	2.889	41.637	1.00	2.76
ATOM	2700	N	ASN	A	296	15.253	1.682	43.313	1.00	2.13
ATOM	2702	CA	ASN	A	296	14.860	2.615	44.361	1.00	2.29
ATOM	2704	CB	ASN	A	296	14.725	1.873	45.678	1.00	2.09
ATOM	2707	CG	ASN	A	296	13.486	1.028	45.711	1.00	2.28
ATOM	2708	OD1	ASN	A	296	12.422	1.486	45.279	1.00	2.81
ATOM	2709	ND2	ASN	A	296	13.615	−0.221	46.121	1.00	2.55
ATOM	2712	C	ASN	A	296	15.786	3.816	44.496	1.00	2.15
ATOM	2713	O	ASN	A	296	16.853	3.860	43.893	1.00	2.45
ATOM	2714	N	HIS	A	297	15.344	4.798	45.271	1.00	2.20
ATOM	2716	CA	HIS	A	297	16.080	6.034	45.450	1.00	2.13
ATOM	2718	CB	HIS	A	297	15.121	7.173	45.807	1.00	2.21
ATOM	2721	CG	HIS	A	297	15.829	8.394	46.302	1.00	2.34
ATOM	2722	ND1	HIS	A	297	16.462	9.281	45.458	1.00	2.56
ATOM	2724	CE1	HIS	A	297	17.037	10.232	46.173	1.00	2.82
ATOM	2726	NE2	HIS	A	297	16.815	9.984	47.451	1.00	2.94
ATOM	2728	CD2	HIS	A	297	16.066	8.838	47.561	1.00	2.18
ATOM	2730	C	HIS	A	297	17.130	5.980	46.554	1.00	2.15
ATOM	2731	O	HIS	A	297	16.948	5.305	47.551	1.00	2.33
ATOM	2732	N	SER	A	298	18.216	6.721	46.364	1.00	2.19
ATOM	2734	CA	SER	A	298	19.215	6.914	47.405	1.00	2.49
ATOM	2736	CB	SER	A	298	20.243	5.783	47.431	1.00	2.80
ATOM	2739	OG	SER	A	298	21.287	6.091	48.325	1.00	2.20
ATOM	2741	C	SER	A	298	19.911	8.241	47.136	1.00	2.39
ATOM	2742	O	SER	A	298	20.109	8.615	45.982	1.00	2.37
ATOM	2743	N	PHE	A	299	20.277	8.943	48.207	1.00	2.46
ATOM	2745	CA	PHE	A	299	21.037	10.186	48.092	1.00	2.65
ATOM	2747	CB	PHE	A	299	20.745	11.104	49.279	1.00	2.42
ATOM	2750	CG	PHE	A	299	19.338	11.659	49.286	1.00	2.34
ATOM	2751	CD1	PHE	A	299	18.416	11.245	50.231	1.00	2.37
ATOM	2753	CE1	PHE	A	299	17.133	11.763	50.240	1.00	2.97
ATOM	2755	CZ	PHE	A	299	16.752	12.697	49.297	1.00	2.88
ATOM	2757	CE2	PHE	A	299	17.657	13.115	48.345	1.00	3.21
ATOM	2759	CD2	PHE	A	299	18.945	12.599	48.341	1.00	2.74
ATOM	2761	C	PHE	A	299	22.543	9.873	47.963	1.00	2.90
ATOM	2762	O	PHE	A	299	23.370	10.764	47.722	1.00	3.44
ATOM	2763	N	THR	A	300	22.901	8.605	48.151	1.00	2.84
ATOM	2765	CA	THR	A	300	24.260	8.135	47.903	1.00	2.81
ATOM	2767	CB	THR	A	300	24.960	7.752	49.219	1.00	3.19
ATOM	2769	OG1	THR	A	300	24.282	6.645	49.839	1.00	3.63
ATOM	2771	CG2	THR	A	300	24.845	8.865	50.233	1.00	3.94
ATOM	2775	C	THR	A	300	24.177	6.940	46.941	1.00	2.44
ATOM	2776	O	THR	A	300	24.554	5.827	47.265	1.00	2.31
ATOM	2777	N	PRO	A	301	23.657	7.180	45.737	1.00	2.43
ATOM	2778	CA	PRO	A	301	23.378	6.110	44.781	1.00	2.16
ATOM	2780	CB	PRO	A	301	22.571	6.820	43.687	1.00	2.48
ATOM	2783	CG	PRO	A	301	22.859	8.261	43.848	1.00	2.59
ATOM	2786	CD	PRO	A	301	23.355	8.504	45.187	1.00	2.30
ATOM	2789	C	PRO	A	301	24.612	5.508	44.146	1.00	2.19
ATOM	2790	O	PRO	A	301	25.667	6.142	44.118	1.00	2.11
ATOM	2791	N	ASN	A	302	24.473	4.280	43.663	1.00	2.08
ATOM	2793	CA	ASN	A	302	25.544	3.631	42.923	1.00	2.30
ATOM	2795	CB	ASN	A	302	25.760	2.176	43.368	1.00	2.54
ATOM	2798	CG	ASN	A	302	24.503	1.347	43.345	1.00	2.93
ATOM	2799	OD1	ASN	A	302	23.527	1.646	42.642	1.00	2.27
ATOM	2800	ND2	ASN	A	302	24.524	0.276	44.126	1.00	2.69
ATOM	2803	C	ASN	A	302	25.305	3.719	41.414	1.00	2.18
ATOM	2804	O	ASN	A	302	26.127	3.272	40.629	1.00	2.31
ATOM	2805	N	CYS	A	303	24.182	4.317	41.022	1.00	2.27
ATOM	2807	CA	CYS	A	303	23.833	4.451	39.602	1.00	2.49
ATOM	2809	CB	CYS	A	303	22.792	3.396	39.210	1.00	2.78
ATOM	2812	SG	CYS	A	303	23.339	1.693	39.246	1.00	3.80
ATOM	2813	C	CYS	A	303	23.254	5.829	39.291	1.00	2.73
ATOM	2814	O	CYS	A	303	22.880	6.575	40.195	1.00	2.38
ATOM	2815	N	ILE	A	304	23.175	6.144	37.997	1.00	3.20
ATOM	2817	CA	ILE	A	304	22.551	7.362	37.507	1.00	4.01
ATOM	2819	CB	ILE	A	304	23.589	8.352	36.962	1.00	4.63
ATOM	2821	CG1	ILE	A	304	22.900	9.662	36.546	1.00	6.24
ATOM	2824	CD1	ILE	A	304	23.714	10.929	36.824	1.00	7.94
ATOM	2828	CG2	ILE	A	304	24.294	7.762	35.735	1.00	3.91
ATOM	2832	C	ILE	A	304	21.615	7.005	36.356	1.00	3.90
ATOM	2833	O	ILE	A	304	21.779	5.967	35.706	1.00	3.61
ATOM	2834	N	TYR	A	305	20.620	7.851	36.115	1.00	4.27
ATOM	2836	CA	TYR	A	305	19.811	7.719	34.905	1.00	4.17
ATOM	2838	CB	TYR	A	305	18.446	8.396	35.049	1.00	4.27
ATOM	2841	CG	TYR	A	305	17.518	7.784	36.075	1.00	4.35
ATOM	2842	CD1	TYR	A	305	16.969	8.561	37.079	1.00	3.85
ATOM	2844	CE1	TYR	A	305	16.088	8.031	37.989	1.00	3.52
ATOM	2846	CZ	TYR	A	305	15.742	6.705	37.916	1.00	2.97
ATOM	2847	OH	TYR	A	305	14.899	6.178	38.864	1.00	3.40
ATOM	2849	CE2	TYR	A	305	16.272	5.905	36.938	1.00	3.18
ATOM	2851	CD2	TYR	A	305	17.145	6.445	36.009	1.00	3.93
ATOM	2853	C	TYR	A	305	20.594	8.424	33.793	1.00	4.33
ATOM	2854	O	TYR	A	305	21.046	9.556	33.979	1.00	4.86
ATOM	2855	N	ASP	A	306	20.757	7.766	32.646	1.00	4.34
ATOM	2857	CA	ASP	A	306	21.513	8.308	31.529	1.00	4.40
ATOM	2859	CB	ASP	A	306	22.849	7.584	31.422	1.00	4.75
ATOM	2862	CG	ASP	A	306	23.936	8.435	30.780	1.00	7.01
ATOM	2863	OD1	ASP	A	306	25.078	7.942	30.676	1.00	9.18
ATOM	2864	OD2	ASP	A	306	23.753	9.599	30.359	1.00	8.97
ATOM	2865	C	ASP	A	306	20.724	8.051	30.246	1.00	4.09
ATOM	2866	O	ASP	A	306	19.871	7.178	30.213	1.00	4.07
ATOM	2867	N	MET	A	307	21.019	8.816	29.205	1.00	4.07
ATOM	2869	CA	MET	A	307	20.347	8.664	27.912	1.00	4.21
ATOM	2871	CB	MET	A	307	20.783	9.786	26.977	1.00	5.32
ATOM	2874	CG	MET	A	307	20.489	11.178	27.519	1.00	8.07
ATOM	2877	SD	MET	A	307	18.720	11.457	27.739	1.00	14.04
ATOM	2878	CE	MET	A	307	18.218	11.779	26.162	1.00	13.82
ATOM	2882	C	MET	A	307	20.701	7.330	27.284	1.00	3.48
ATOM	2883	O	MET	A	307	21.779	6.778	27.512	1.00	3.03
ATOM	2884	N	PHE	A	308	19.800	6.798	26.472	1.00	2.95
ATOM	2886	CA	PHE	A	308	20.089	5.560	25.787	1.00	2.68
ATOM	2888	CB	PHE	A	308	19.816	4.342	26.658	1.00	2.48
ATOM	2891	CG	PHE	A	308	20.525	3.109	26.175	1.00	2.58
ATOM	2892	CD1	PHE	A	308	21.838	2.872	26.533	1.00	2.38
ATOM	2894	CE1	PHE	A	308	22.506	1.749	26.081	1.00	2.34
ATOM	2896	CZ	PHE	A	308	21.861	0.859	25.233	1.00	2.21
ATOM	2898	CE2	PHE	A	308	20.561	1.091	24.864	1.00	2.27
ATOM	2900	CD2	PHE	A	308	19.899	2.213	25.323	1.00	2.69
ATOM	2902	C	PHE	A	308	19.247	5.463	24.556	1.00	2.59
ATOM	2903	O	PHE	A	308	18.077	5.819	24.590	1.00	2.93
ATOM	2904	N	VAL	A	309	19.846	4.997	23.470	1.00	2.55
ATOM	2906	CA	VAL	A	309	19.084	4.741	22.238	1.00	2.34
ATOM	2908	CB	VAL	A	309	19.779	5.286	20.996	1.00	2.39
ATOM	2910	CG1	VAL	A	309	18.970	4.927	19.749	1.00	3.20
ATOM	2914	CG2	VAL	A	309	19.947	6.783	21.101	1.00	2.94
ATOM	2918	C	VAL	A	309	18.929	3.234	22.085	1.00	2.29
ATOM	2919	O	VAL	A	309	19.908	2.537	21.784	1.00	2.81
ATOM	2920	N	HIS	A	310	17.708	2.735	22.288	1.00	2.05
ATOM	2922	CA	HIS	A	310	17.437	1.302	22.283	1.00	2.05
ATOM	2924	CB	HIS	A	310	16.515	0.970	23.451	1.00	2.06
ATOM	2927	CG	HIS	A	310	16.542	−0.468	23.854	1.00	2.16
ATOM	2928	ND1	HIS	A	310	15.910	−1.456	23.133	1.00	2.24
ATOM	2930	CE1	HIS	A	310	16.094	−2.620	23.729	1.00	2.24
ATOM	2932	NE2	HIS	A	310	16.841	−2.424	24.804	1.00	2.07
ATOM	2934	CD2	HIS	A	310	17.129	−1.087	24.907	1.00	2.11
ATOM	2936	C	HIS	A	310	16.780	0.859	20.978	1.00	2.02
ATOM	2937	O	HIS	A	310	15.853	1.516	20.508	1.00	2.15
ATOM	2938	N	PRO	A	311	17.236	−0.253	20.404	1.00	2.00
ATOM	2939	CA	PRO	A	311	16.729	−0.708	19.113	1.00	2.03
ATOM	2941	CB	PRO	A	311	17.679	−1.853	18.779	1.00	2.05
ATOM	2944	CG	PRO	A	311	18.002	−2.396	20.074	1.00	2.00
ATOM	2947	CD	PRO	A	311	18.269	−1.178	20.901	1.00	2.25
ATOM	2950	C	PRO	A	311	15.305	−1.227	19.166	1.00	2.06
ATOM	2951	O	PRO	A	311	14.682	−1.344	18.121	1.00	2.04
ATOM	2952	N	ARG	A	312	14.825	−1.556	20.363	1.00	2.07
ATOM	2954	CA	ARG	A	312	13.457	−2.019	20.544	1.00	2.05
ATOM	2956	CB	ARG	A	312	13.451	−3.193	21.520	1.00	2.11
ATOM	2959	CG	ARG	A	312	12.081	−3.729	21.869	1.00	2.61
ATOM	2962	CD	ARG	A	312	12.183	−4.845	22.888	1.00	2.59
ATOM	2965	NE	ARG	A	312	10.909	−5.399	23.321	1.00	2.54
ATOM	2967	CZ	ARG	A	312	10.809	−6.309	24.281	1.00	2.35
ATOM	2968	NH1	ARG	A	312	11.910	−6.750	24.882	1.00	2.09
ATOM	2971	NH2	ARG	A	312	9.633	−6.785	24.651	1.00	2.21
ATOM	2974	C	ARG	A	312	12.555	−0.906	21.079	1.00	2.01
ATOM	2975	O	ARG	A	312	11.441	−0.707	20.585	1.00	2.03
ATOM	2976	N	PHE	A	313	13.048	−0.180	22.082	1.00	2.06
ATOM	2978	CA	PHE	A	313	12.272	0.852	22.768	1.00	2.15
ATOM	2980	CB	PHE	A	313	12.646	0.908	24.252	1.00	2.09
ATOM	2983	CG	PHE	A	313	12.593	−0.422	24.940	1.00	2.49
ATOM	2984	CD1	PHE	A	313	13.706	−0.932	25.595	1.00	2.43
ATOM	2986	CE1	PHE	A	313	13.649	−2.151	26.218	1.00	2.71
ATOM	2988	CZ	PHE	A	313	12.476	−2.890	26.186	1.00	3.14
ATOM	2990	CE2	PHE	A	313	11.374	−2.388	25.543	1.00	3.93
ATOM	2992	CD2	PHE	A	313	11.432	−1.170	24.924	1.00	3.07
ATOM	2994	C	PHE	A	313	12.411	2.260	22.202	1.00	2.21
ATOM	2995	O	PHE	A	313	11.577	3.113	22.496	1.00	2.40
ATOM	2996	N	GLY	A	314	13.465	2.515	21.430	1.00	2.22
ATOM	2998	CA	GLY	A	314	13.703	3.846	20.898	1.00	2.38
ATOM	3001	C	GLY	A	314	14.504	4.673	21.888	1.00	2.42
ATOM	3002	O	GLY	A	314	15.170	4.117	22.771	1.00	2.50
ATOM	3003	N	PRO	A	315	14.474	5.995	21.752	1.00	2.39
ATOM	3004	CA	PRO	A	315	15.205	6.863	22.682	1.00	2.53
ATOM	3006	CB	PRO	A	315	15.125	8.244	22.017	1.00	2.53
ATOM	3009	CG	PRO	A	315	14.561	8.011	20.631	1.00	2.82
ATOM	3012	CD	PRO	A	315	13.766	6.768	20.718	1.00	2.60
ATOM	3015	C	PRO	A	315	14.553	6.856	24.064	1.00	2.29
ATOM	3016	O	PRO	A	315	13.414	7.277	24.218	1.00	2.54
ATOM	3017	N	ILE	A	316	15.279	6.371	25.065	1.00	2.65
ATOM	3019	CA	ILE	A	316	14.766	6.267	26.421	1.00	2.47
ATOM	3021	CB	ILE	A	316	14.346	4.822	26.706	1.00	2.35
ATOM	3023	CG1	ILE	A	316	15.497	3.870	26.375	1.00	2.33
ATOM	3026	CD1	ILE	A	316	15.293	2.446	26.877	1.00	2.49
ATOM	3030	CG2	ILE	A	316	13.104	4.465	25.901	1.00	3.20
ATOM	3034	C	ILE	A	316	15.879	6.678	27.374	1.00	2.60
ATOM	3035	O	ILE	A	316	16.785	7.397	26.977	1.00	2.71
ATOM	3036	N	LYS	A	317	15.811	6.223	28.622	1.00	3.12
ATOM	3038	CA	LYS	A	317	16.918	6.422	29.560	1.00	3.53
ATOM	3040	CB	LYS	A	317	16.561	7.348	30.733	1.00	4.01
ATOM	3043	CG	LYS	A	317	16.618	8.849	30.330	1.00	5.08
ATOM	3046	CD	LYS	A	317	16.663	9.811	31.503	1.00	5.59
ATOM	3049	CE	LYS	A	317	16.792	11.261	31.003	1.00	5.93
ATOM	3052	NZ	LYS	A	317	16.702	12.281	32.080	1.00	5.69
ATOM	3056	C	LYS	A	317	17.334	5.033	30.034	1.00	3.26
ATOM	3057	O	LYS	A	317	16.600	4.056	29.832	1.00	3.14
ATOM	3058	N	CYS	A	318	18.520	4.937	30.615	1.00	3.10
ATOM	3060	CA	CYS	A	318	19.029	3.676	31.146	1.00	2.84
ATOM	3062	CB	CYS	A	318	20.146	3.121	30.260	1.00	2.61
ATOM	3065	SG	CYS	A	318	21.710	4.019	30.351	1.00	3.58
ATOM	3066	C	CYS	A	318	19.546	3.909	32.557	1.00	2.89
ATOM	3067	O	CYS	A	318	19.564	5.043	33.031	1.00	2.65
ATOM	3068	N	ILE	A	319	19.941	2.826	33.223	1.00	2.82
ATOM	3070	CA	ILE	A	319	20.562	2.902	34.537	1.00	3.48
ATOM	3072	CB	ILE	A	319	19.903	1.905	35.512	1.00	3.96
ATOM	3074	CG1	ILE	A	319	18.398	2.176	35.628	1.00	5.82
ATOM	3077	CD1	ILE	A	319	18.023	3.175	36.621	1.00	7.54
ATOM	3081	CG2	ILE	A	319	20.612	1.932	36.846	1.00	4.63
ATOM	3085	C	ILE	A	319	22.012	2.515	34.311	1.00	2.77
ATOM	3086	O	ILE	A	319	22.282	1.418	33.815	1.00	2.85
ATOM	3087	N	ARG	A	320	22.930	3.417	34.653	1.00	2.38
ATOM	3089	CA	ARG	A	320	24.357	3.199	34.461	1.00	2.26
ATOM	3091	CB	ARG	A	320	24.902	4.228	33.482	1.00	2.37
ATOM	3094	CG	ARG	A	320	26.360	4.064	33.145	1.00	2.44
ATOM	3097	CD	ARG	A	320	26.901	5.216	32.313	1.00	2.34
ATOM	3100	NE	ARG	A	320	26.315	5.275	30.983	1.00	2.76
ATOM	3102	CZ	ARG	A	320	26.774	4.615	29.933	1.00	2.66
ATOM	3103	NH1	ARG	A	320	27.827	3.820	30.046	1.00	2.29
ATOM	3106	NH2	ARG	A	320	26.164	4.746	28.761	1.00	2.49
ATOM	3109	C	ARG	A	320	25.070	3.362	35.792	1.00	2.24
ATOM	3110	O	ARG	A	320	24.845	4.335	36.511	1.00	2.42
ATOM	3111	N	THR	A	321	25.943	2.419	36.115	1.00	2.12
ATOM	3113	CA	THR	A	321	26.667	2.490	37.390	1.00	2.25
ATOM	3115	CB	THR	A	321	27.462	1.218	37.665	1.00	2.06
ATOM	3117	OG1	THR	A	321	28.545	1.097	36.736	1.00	2.59
ATOM	3119	CG2	THR	A	321	26.650	−0.039	37.490	1.00	2.06
ATOM	3123	C	THR	A	321	27.605	3.696	37.421	1.00	2.65
ATOM	3124	O	THR	A	321	28.131	4.132	36.388	1.00	2.48
ATOM	3125	N	LEU	A	322	27.791	4.227	38.628	1.00	3.11
ATOM	3127	CA	LEU	A	322	28.667	5.360	38.890	1.00	3.87
ATOM	3129	CB	LEU	A	322	28.016	6.264	39.937	1.00	4.48
ATOM	3132	CG	LEU	A	322	27.290	7.518	39.498	1.00	6.27
ATOM	3134	CD1	LEU	A	322	26.431	7.277	38.300	1.00	9.03
ATOM	3138	CD2	LEU	A	322	26.468	7.993	40.693	1.00	6.96
ATOM	3142	C	LEU	A	322	29.987	4.870	39.476	1.00	4.18
ATOM	3143	O	LEU	A	322	30.979	5.597	39.508	1.00	4.32
ATOM	3144	N	ARG	A	323	29.970	3.649	39.985	1.00	4.39
ATOM	3146	CA	ARG	A	323	31.132	3.070	40.646	1.00	4.63
ATOM	3148	CB	ARG	A	323	31.080	3.375	42.146	1.00	4.87
ATOM	3151	CG	ARG	A	323	29.824	2.867	42.875	1.00	6.06
ATOM	3154	CD	ARG	A	323	29.726	3.355	44.329	1.00	8.55
ATOM	3157	NE	ARG	A	323	28.606	2.801	45.088	1.00	10.17
ATOM	3159	CZ	ARG	A	323	27.802	3.516	45.885	1.00	12.22
ATOM	3160	NH1	ARG	A	323	27.966	4.828	46.029	1.00	11.79
ATOM	3163	NH2	ARG	A	323	26.815	2.918	46.539	1.00	14.22
ATOM	3166	C	ARG	A	323	31.090	1.571	40.424	1.00	4.50
ATOM	3167	O	ARG	A	323	30.161	1.064	39.814	1.00	5.16
ATOM	3168	N	ALA	A	324	32.084	0.846	40.915	1.00	4.31
ATOM	3170	CA	ALA	A	324	32.033	−0.602	40.779	1.00	4.08
ATOM	3172	CB	ALA	A	324	33.333	−1.223	41.129	1.00	3.70
ATOM	3176	C	ALA	A	324	30.902	−1.132	41.665	1.00	4.02
ATOM	3177	O	ALA	A	324	30.613	−0.573	42.718	1.00	3.97
ATOM	3178	N	VAL	A	325	30.235	−2.184	41.204	1.00	4.41
ATOM	3180	CA	VAL	A	325	29.097	−2.754	41.907	1.00	4.52
ATOM	3182	CB	VAL	A	325	27.782	−2.415	41.193	1.00	4.82
ATOM	3184	CG1	VAL	A	325	26.624	−3.204	41.766	1.00	5.53
ATOM	3188	CG2	VAL	A	325	27.496	−0.917	41.274	1.00	5.10
ATOM	3192	C	VAL	A	325	29.304	−4.263	41.968	1.00	4.28
ATOM	3193	O	VAL	A	325	29.699	−4.874	40.979	1.00	4.13
ATOM	3194	N	GLU	A	326	29.071	−4.862	43.130	1.00	4.39
ATOM	3196	CA	GLU	A	326	29.232	−6.304	43.270	1.00	4.62
ATOM	3198	CB	GLU	A	326	29.656	−6.670	44.685	1.00	5.39
ATOM	3201	CG	GLU	A	326	31.133	−7.007	44.791	1.00	6.97
ATOM	3204	CD	GLU	A	326	31.551	−8.095	43.807	1.00	9.48
ATOM	3205	OE1	GLU	A	326	30.686	−8.907	43.347	1.00	8.95
ATOM	3206	OE2	GLU	A	326	32.753	−8.133	43.478	1.00	11.36
ATOM	3207	C	GLU	A	326	27.952	−7.052	42.956	1.00	4.33
ATOM	3208	O	GLU	A	326	26.871	−6.472	42.948	1.00	4.21
ATOM	3209	N	ALA	A	327	28.089	−8.355	42.734	1.00	3.98
ATOM	3211	CA	ALA	A	327	26.940	−9.226	42.518	1.00	3.84
ATOM	3213	CB	ALA	A	327	27.418	−10.657	42.330	1.00	3.86
ATOM	3217	C	ALA	A	327	25.998	−9.155	43.719	1.00	3.85
ATOM	3218	O	ALA	A	327	26.454	−9.146	44.870	1.00	3.06
ATOM	3219	N	ASP	A	328	24.697	−9.120	43.453	1.00	3.85
ATOM	3221	CA	ASP	A	328	23.662	−9.100	44.490	1.00	4.37
ATOM	3223	CB	ASP	A	328	23.813	−10.313	45.399	1.00	4.71
ATOM	3226	CG	ASP	A	328	23.611	−11.610	44.651	1.00	4.46
ATOM	3227	OD1	ASP	A	328	24.460	−12.518	44.789	1.00	4.47
ATOM	3228	OD2	ASP	A	328	22.646	−11.801	43.882	1.00	5.41
ATOM	3229	C	ASP	A	328	23.600	−7.799	45.295	1.00	4.84
ATOM	3230	O	ASP	A	328	22.965	−7.740	46.351	1.00	5.11
ATOM	3231	N	GLU	A	329	24.256	−6.757	44.797	1.00	4.98
ATOM	3233	CA	GLU	A	329	24.176	−5.439	45.411	1.00	4.94
ATOM	3235	CB	GLU	A	329	25.431	−4.620	45.086	1.00	5.24
ATOM	3238	CG	GLU	A	329	25.329	−3.153	45.470	1.00	6.22
ATOM	3241	CD	GLU	A	329	26.680	−2.439	45.501	1.00	7.84
ATOM	3242	OE1	GLU	A	329	27.745	−3.107	45.497	1.00	6.56
ATOM	3243	OE2	GLU	A	329	26.659	−1.189	45.515	1.00	9.56
ATOM	3244	C	GLU	A	329	22.908	−4.745	44.876	1.00	4.42
ATOM	3245	O	GLU	A	329	22.546	−4.900	43.698	1.00	4.27
ATOM	3246	N	GLU	A	330	22.204	−4.002	45.723	1.00	3.90
ATOM	3248	CA	GLU	A	330	21.009	−3.293	45.234	1.00	3.66
ATOM	3250	CB	GLU	A	330	20.079	−2.861	46.373	1.00	3.79
ATOM	3253	CG	GLU	A	330	18.758	−2.288	45.866	1.00	3.60
ATOM	3256	CD	GLU	A	330	17.722	−2.054	46.950	1.00	4.19
ATOM	3257	OE1	GLU	A	330	18.039	−2.252	48.125	1.00	4.83
ATOM	3258	OE2	GLU	A	330	16.567	−1.680	46.626	1.00	4.44
ATOM	3259	C	GLU	A	330	21.439	−2.076	44.415	1.00	3.53
ATOM	3260	O	GLU	A	330	22.347	−1.328	44.822	1.00	3.55
ATOM	3261	N	LEU	A	331	20.796	−1.891	43.264	1.00	3.45
ATOM	3263	CA	LEU	A	331	21.040	−0.743	42.397	1.00	3.33
ATOM	3265	CB	LEU	A	331	20.753	−1.077	40.938	1.00	3.49
ATOM	3268	CG	LEU	A	331	21.633	−2.168	40.332	1.00	4.45
ATOM	3270	CD1	LEU	A	331	21.415	−2.275	38.821	1.00	4.93
ATOM	3274	CD2	LEU	A	331	23.105	−1.933	40.668	1.00	4.93
ATOM	3278	C	LEU	A	331	20.149	0.400	42.838	1.00	2.89
ATOM	3279	O	LEU	A	331	18.930	0.239	42.968	1.00	2.74
ATOM	3280	N	THR	A	332	20.752	1.552	43.089	1.00	2.38
ATOM	3282	CA	THR	A	332	19.992	2.721	43.498	1.00	2.55
ATOM	3284	CB	THR	A	332	20.241	3.074	44.958	1.00	2.23
ATOM	3286	OG1	THR	A	332	21.648	3.262	45.174	1.00	3.52
ATOM	3288	CG2	THR	A	332	19.851	1.934	45.860	1.00	2.12
ATOM	3292	C	THR	A	332	20.363	3.913	42.642	1.00	2.57
ATOM	3293	O	THR	A	332	21.450	3.969	42.082	1.00	2.47
ATOM	3294	N	VAL	A	333	19.447	4.871	42.560	1.00	2.89
ATOM	3296	CA	VAL	A	333	19.650	6.071	41.761	1.00	3.37
ATOM	3298	CB	VAL	A	333	18.935	5.964	40.381	1.00	3.63
ATOM	3300	CG1	VAL	A	333	19.195	7.192	39.540	1.00	4.18
ATOM	3304	CG2	VAL	A	333	19.375	4.712	39.631	1.00	4.44
ATOM	3308	C	VAL	A	333	19.063	7.272	42.494	1.00	3.05
ATOM	3309	O	VAL	A	333	18.110	7.138	43.250	1.00	2.77
ATOM	3310	N	ALA	A	334	19.626	8.448	42.258	1.00	2.99
ATOM	3312	CA	ALA	A	334	19.081	9.671	42.831	1.00	2.93
ATOM	3314	CB	ALA	A	334	20.136	10.765	42.851	1.00	3.06
ATOM	3318	C	ALA	A	334	17.890	10.075	41.973	1.00	2.63
ATOM	3319	O	ALA	A	334	18.049	10.352	40.787	1.00	3.30
ATOM	3320	N	TYR	A	335	16.695	10.076	42.547	1.00	2.12
ATOM	3322	CA	TYR	A	335	15.488	10.421	41.772	1.00	2.13
ATOM	3324	CB	TYR	A	335	14.226	10.153	42.591	1.00	2.12
ATOM	3327	CG	TYR	A	335	13.822	8.679	42.649	1.00	2.19
ATOM	3328	CD1	TYR	A	335	14.659	7.669	42.172	1.00	2.05
ATOM	3330	CE1	TYR	A	335	14.288	6.333	42.253	1.00	2.13
ATOM	3332	CZ	TYR	A	335	13.062	6.001	42.802	1.00	2.11
ATOM	3333	OH	TYR	A	335	12.679	4.679	42.880	1.00	2.37
ATOM	3335	CE2	TYR	A	335	12.227	6.983	43.280	1.00	2.00
ATOM	3337	CD2	TYR	A	335	12.605	8.302	43.201	1.00	2.00
ATOM	3339	C	TYR	A	335	15.537	11.863	41.250	1.00	2.06
ATOM	3340	O	TYR	A	335	14.941	12.187	40.210	1.00	2.37
ATOM	3341	N	GLY	A	336	16.249	12.730	41.965	1.00	2.07
ATOM	3343	CA	GLY	A	336	16.435	14.105	41.538	1.00	2.14
ATOM	3346	C	GLY	A	336	15.197	14.964	41.409	1.00	2.34
ATOM	3347	O	GLY	A	336	15.019	15.632	40.396	1.00	2.51
ATOM	3348	N	TYR	A	337	14.344	14.964	42.425	1.00	2.25
ATOM	3350	CA	TYR	A	337	13.200	15.861	42.424	1.00	2.45
ATOM	3352	CB	TYR	A	337	12.150	15.412	43.440	1.00	2.38
ATOM	3355	CG	TYR	A	337	11.528	14.084	43.097	1.00	2.24
ATOM	3356	CD1	TYR	A	337	11.490	13.046	44.013	1.00	2.21
ATOM	3358	CE1	TYR	A	337	10.916	11.828	43.694	1.00	2.44
ATOM	3360	CZ	TYR	A	337	10.367	11.648	42.449	1.00	2.60
ATOM	3361	OH	TYR	A	337	9.790	10.446	42.091	1.00	2.91
ATOM	3363	CE2	TYR	A	337	10.396	12.668	41.530	1.00	2.55
ATOM	3365	CD2	TYR	A	337	10.963	13.867	41.847	1.00	2.67
ATOM	3367	C	TYR	A	337	13.721	17.255	42.754	1.00	2.50
ATOM	3368	O	TYR	A	337	14.841	17.394	43.269	1.00	2.54
ATOM	3369	N	ASP	A	338	12.922	18.275	42.463	1.00	2.61
ATOM	3371	CA	ASP	A	338	13.279	19.658	42.726	1.00	3.24
ATOM	3373	CB	ASP	A	338	12.413	20.600	41.906	1.00	3.78
ATOM	3376	CG	ASP	A	338	12.916	22.029	41.916	1.00	4.73
ATOM	3377	OD1	ASP	A	338	13.709	22.399	42.804	1.00	4.71
ATOM	3378	OD2	ASP	A	338	12.539	22.873	41.070	1.00	6.96
ATOM	3379	C	ASP	A	338	13.128	19.964	44.214	1.00	3.59
ATOM	3380	O	ASP	A	338	12.020	19.993	44.750	1.00	3.63
ATOM	3381	N	HIS	A	339	14.262	20.207	44.865	1.00	3.16
ATOM	3383	CA	HIS	A	339	14.304	20.488	46.296	1.00	3.75
ATOM	3385	CB	HIS	A	339	15.695	20.166	46.843	1.00	3.35
ATOM	3388	CG	HIS	A	339	16.044	18.711	46.790	1.00	3.17
ATOM	3389	ND1	HIS	A	339	17.254	18.223	47.230	1.00	2.63
ATOM	3391	CE1	HIS	A	339	17.288	16.915	47.057	1.00	2.70
ATOM	3393	NE2	HIS	A	339	16.143	16.534	46.522	1.00	2.61
ATOM	3395	CD2	HIS	A	339	15.350	17.639	46.338	1.00	2.29
ATOM	3397	C	HIS	A	339	13.972	21.931	46.640	1.00	4.29
ATOM	3398	O	HIS	A	339	13.708	22.237	47.799	1.00	4.47
ATOM	3399	N	SER	A	340	13.989	22.813	45.642	1.00	4.86
ATOM	3401	CA	SER	A	340	13.725	24.228	45.875	1.00	5.67
ATOM	3403	CB	SER	A	340	15.034	24.966	46.119	1.00	5.47
ATOM	3406	OG	SER	A	340	14.765	26.299	46.505	1.00	5.21
ATOM	3408	C	SER	A	340	12.992	24.922	44.726	1.00	6.73
ATOM	3409	O	SER	A	340	13.558	25.757	44.031	1.00	6.15
ATOM	3410	N	PRO	A	341	11.735	24.570	44.514	1.00	8.49
ATOM	3411	CA	PRO	A	341	10.935	25.205	43.464	1.00	9.84
ATOM	3413	CB	PRO	A	341	9.548	24.564	43.621	1.00	9.67
ATOM	3416	CG	PRO	A	341	9.663	23.509	44.656	1.00	9.19
ATOM	3419	CD	PRO	A	341	11.008	23.538	45.251	1.00	8.47
ATOM	3422	C	PRO	A	341	10.906	26.729	43.636	1.00	11.40
ATOM	3423	O	PRO	A	341	11.054	27.212	44.752	1.00	11.46
ATOM	3424	N	PRO	A	342	10.702	27.460	42.539	1.00	13.36
ATOM	3425	CA	PRO	A	342	10.795	28.924	42.514	1.00	14.64
ATOM	3427	CB	PRO	A	342	10.413	29.298	41.083	1.00	14.54
ATOM	3430	CG	PRO	A	342	10.091	28.070	40.386	1.00	14.08
ATOM	3433	CD	PRO	A	342	10.255	26.912	41.264	1.00	13.41
ATOM	3436	C	PRO	A	342	9.692	29.343	43.362	1.00	15.96
ATOM	3437	O	PRO	A	342	9.633	30.393	44.022	1.00	16.30
ATOM	3438	N	GLY	A	343	8.735	28.442	43.240	1.00	17.38
ATOM	3440	CA	GLY	A	343	7.569	28.478	44.029	1.00	18.23
ATOM	3443	C	GLY	A	343	8.228	28.995	45.268	1.00	18.94
ATOM	3444	O	GLY	A	343	9.434	29.246	45.343	1.00	19.46
ATOM	3445	N	LYS	A	344	7.428	29.144	46.274	1.00	19.60
ATOM	3447	CA	LYS	A	344	7.914	29.735	47.463	1.00	20.09
ATOM	3449	CB	LYS	A	344	6.668	30.125	48.244	1.00	20.41
ATOM	3452	CG	LYS	A	344	6.315	29.099	49.302	1.00	21.21
ATOM	3455	CD	LYS	A	344	5.275	29.602	50.247	1.00	22.19
ATOM	3458	CE	LYS	A	344	4.668	28.474	51.058	1.00	22.78
ATOM	3461	NZ	LYS	A	344	3.561	28.978	51.917	1.00	22.97
ATOM	3465	C	LYS	A	344	8.632	28.654	48.255	1.00	20.09
ATOM	3466	O	LYS	A	344	9.787	28.762	48.682	1.00	20.34
ATOM	3467	N	SER	A	345	7.861	27.577	48.261	1.00	19.82
ATOM	3469	CA	SER	A	345	7.728	26.467	49.184	1.00	19.48
ATOM	3471	CB	SER	A	345	6.371	26.002	48.682	1.00	19.59
ATOM	3474	OG	SER	A	345	6.417	26.059	47.251	1.00	20.84
ATOM	3476	C	SER	A	345	8.360	25.117	49.402	1.00	18.72
ATOM	3477	O	SER	A	345	7.650	24.234	49.879	1.00	19.17
ATOM	3478	N	GLY	A	346	9.612	24.864	49.135	1.00	17.45
ATOM	3480	CA	GLY	A	346	10.055	23.530	49.496	1.00	16.41
ATOM	3483	C	GLY	A	346	9.892	22.517	48.382	1.00	15.40
ATOM	3484	O	GLY	A	346	9.197	22.747	47.397	1.00	15.23
ATOM	3485	N	PRO	A	347	10.529	21.369	48.560	1.00	14.06
ATOM	3486	CA	PRO	A	347	10.630	20.358	47.508	1.00	13.20
ATOM	3488	CB	PRO	A	347	11.447	19.236	48.160	1.00	13.19
ATOM	3491	CG	PRO	A	347	11.825	19.687	49.517	1.00	13.71
ATOM	3494	CD	PRO	A	347	11.199	20.970	49.801	1.00	14.23
ATOM	3497	C	PRO	A	347	9.322	19.797	46.988	1.00	12.24
ATOM	3498	O	PRO	A	347	8.428	19.461	47.754	1.00	12.46
ATOM	3499	N	GLU	A	348	9.227	19.698	45.669	1.00	11.28
ATOM	3501	CA	GLU	A	348	8.063	19.073	45.047	1.00	10.48
ATOM	3503	CB	GLU	A	348	7.728	19.695	43.700	1.00	11.42
ATOM	3506	CG	GLU	A	348	6.239	20.027	43.515	1.00	14.16
ATOM	3509	CD	GLU	A	348	5.301	19.258	44.447	1.00	17.81
ATOM	3510	OE1	GLU	A	348	5.099	18.042	44.248	1.00	20.08
ATOM	3511	OE2	GLU	A	348	4.749	19.879	45.386	1.00	19.94
ATOM	3512	C	GLU	A	348	8.448	17.609	44.902	1.00	8.57
ATOM	3513	O	GLU	A	348	9.138	17.214	43.968	1.00	7.67
ATOM	3514	N	ALA	A	349	8.041	16.810	45.874	1.00	7.53
ATOM	3516	CA	ALA	A	349	8.433	15.419	45.919	1.00	6.82
ATOM	3518	CB	ALA	A	349	9.829	15.300	46.541	1.00	6.96
ATOM	3522	C	ALA	A	349	7.430	14.658	46.753	1.00	6.14
ATOM	3523	O	ALA	A	349	6.677	15.252	47.524	1.00	5.39
ATOM	3524	N	PRO	A	350	7.427	13.339	46.618	1.00	6.01
ATOM	3525	CA	PRO	A	350	6.539	12.502	47.408	1.00	5.75
ATOM	3527	CB	PRO	A	350	6.814	11.089	46.884	1.00	6.19
ATOM	3530	CG	PRO	A	350	7.616	11.243	45.665	1.00	6.43
ATOM	3533	CD	PRO	A	350	8.290	12.542	45.737	1.00	6.39
ATOM	3536	C	PRO	A	350	6.958	12.613	48.865	1.00	5.09
ATOM	3537	O	PRO	A	350	8.127	12.904	49.136	1.00	4.77
ATOM	3538	N	GLU	A	351	6.025	12.392	49.777	1.00	4.61
ATOM	3540	CA	GLU	A	351	6.289	12.547	51.198	1.00	4.26
ATOM	3542	CB	GLU	A	351	5.007	12.350	52.004	1.00	4.18
ATOM	3545	CG	GLU	A	351	5.192	12.539	53.512	1.00	3.77
ATOM	3548	CD	GLU	A	351	5.700	13.918	53.922	1.00	3.90
ATOM	3549	OE1	GLU	A	351	5.729	14.847	53.088	1.00	3.41
ATOM	3550	OE2	GLU	A	351	6.079	14.078	55.111	1.00	4.18
ATOM	3551	C	GLU	A	351	7.399	11.637	51.723	1.00	3.94
ATOM	3552	O	GLU	A	351	8.212	12.067	52.542	1.00	3.91
ATOM	3553	N	TRP	A	352	7.439	10.386	51.268	1.00	3.48
ATOM	3555	CA	TRP	A	352	8.464	9.448	51.727	1.00	3.30
ATOM	3557	CB	TRP	A	352	8.244	8.051	51.132	1.00	3.23
ATOM	3560	CG	TRP	A	352	8.373	7.984	49.655	1.00	2.44
ATOM	3561	CD1	TRP	A	352	7.354	7.966	48.734	1.00	2.73
ATOM	3563	NE1	TRP	A	352	7.872	7.904	47.464	1.00	2.26
ATOM	3565	CE2	TRP	A	352	9.242	7.885	47.545	1.00	2.19
ATOM	3566	CD2	TRP	A	352	9.587	7.923	48.907	1.00	2.67
ATOM	3567	CE3	TRP	A	352	10.950	7.919	49.251	1.00	2.00
ATOM	3569	CZ3	TRP	A	352	11.888	7.860	48.247	1.00	2.01
ATOM	3571	CH2	TRP	A	352	11.510	7.818	46.900	1.00	2.08
ATOM	3573	CZ2	TRP	A	352	10.193	7.823	46.534	1.00	2.44
ATOM	3575	C	TRP	A	352	9.872	9.978	51.407	1.00	3.05
ATOM	3576	O	TRP	A	352	10.821	9.749	52.161	1.00	2.69
ATOM	3577	N	TYR	A	353	9.984	10.686	50.286	1.00	2.79
ATOM	3579	CA	TYR	A	353	11.239	11.243	49.798	1.00	2.97
ATOM	3581	CB	TYR	A	353	11.074	11.636	48.332	1.00	2.84
ATOM	3584	CG	TYR	A	353	12.258	12.302	47.667	1.00	2.38
ATOM	3585	CD1	TYR	A	353	13.044	11.602	46.758	1.00	2.40
ATOM	3587	CE1	TYR	A	353	14.092	12.210	46.110	1.00	2.38
ATOM	3589	CZ	TYR	A	353	14.346	13.539	46.339	1.00	2.34
ATOM	3590	OH	TYR	A	353	15.372	14.143	45.669	1.00	3.35
ATOM	3592	CE2	TYR	A	353	13.561	14.265	47.205	1.00	2.14
ATOM	3594	CD2	TYR	A	353	12.520	13.646	47.858	1.00	2.08
ATOM	3596	C	TYR	A	353	11.620	12.449	50.640	1.00	3.20
ATOM	3597	O	TYR	A	353	12.780	12.621	50.995	1.00	3.31
ATOM	3598	N	GLN	A	354	10.632	13.274	50.965	1.00	3.72
ATOM	3600	CA	GLN	A	354	10.862	14.427	51.829	1.00	4.18
ATOM	3602	CB	GLN	A	354	9.589	15.248	51.985	1.00	4.39
ATOM	3605	CG	GLN	A	354	9.064	15.734	50.649	1.00	5.35
ATOM	3608	CD	GLN	A	354	8.216	16.977	50.735	1.00	6.61
ATOM	3609	OE1	GLN	A	354	8.524	17.899	51.485	1.00	8.35
ATOM	3610	NE2	GLN	A	354	7.164	17.022	49.933	1.00	6.18
ATOM	3613	C	GLN	A	354	11.365	13.965	53.195	1.00	4.32
ATOM	3614	O	GLN	A	354	12.252	14.591	53.771	1.00	4.28
ATOM	3615	N	VAL	A	355	10.795	12.871	53.706	1.00	4.44
ATOM	3617	CA	VAL	A	355	11.211	12.316	55.001	1.00	4.83
ATOM	3619	CB	VAL	A	355	10.322	11.120	55.416	1.00	4.90
ATOM	3621	CG1	VAL	A	355	10.953	10.366	56.603	1.00	5.07
ATOM	3625	CG2	VAL	A	355	8.928	11.585	55.764	1.00	4.57
ATOM	3629	C	VAL	A	355	12.666	11.842	54.947	1.00	4.96
ATOM	3630	O	VAL	A	355	13.457	12.124	55.853	1.00	4.94
ATOM	3631	N	GLU	A	356	13.005	11.105	53.887	1.00	5.36
ATOM	3633	CA	GLU	A	356	14.367	10.585	53.709	1.00	5.54
ATOM	3635	CB	GLU	A	356	14.446	9.650	52.495	1.00	6.54
ATOM	3638	CG	GLU	A	356	15.780	8.917	52.429	1.00	9.22
ATOM	3641	CD	GLU	A	356	15.801	7.726	51.489	1.00	13.26
ATOM	3642	OE1	GLU	A	356	16.176	7.917	50.315	1.00	15.69
ATOM	3643	OE2	GLU	A	356	15.493	6.590	51.933	1.00	15.43
ATOM	3644	C	GLU	A	356	15.349	11.737	53.541	1.00	4.88
ATOM	3645	O	GLU	A	356	16.484	11.695	54.048	1.00	4.16
ATOM	3646	N	LEU	A	357	14.913	12.784	52.851	1.00	4.21
ATOM	3648	CA	LEU	A	357	15.751	13.967	52.671	1.00	4.57
ATOM	3650	CB	LEU	A	357	15.024	15.006	51.825	1.00	3.91
ATOM	3653	CG	LEU	A	357	15.813	16.279	51.499	1.00	3.60
ATOM	3655	CD1	LEU	A	357	17.210	15.951	51.005	1.00	3.39
ATOM	3659	CD2	LEU	A	357	15.093	17.144	50.480	1.00	4.35
ATOM	3663	C	LEU	A	357	16.112	14.579	54.032	1.00	4.95
ATOM	3664	O	LEU	A	357	17.270	14.937	54.294	1.00	5.53
ATOM	3665	N	LYS	A	358	15.108	14.694	54.897	1.00	5.80
ATOM	3667	CA	LYS	A	358	15.295	15.243	56.242	1.00	6.34
ATOM	3669	CB	LYS	A	358	13.954	15.311	56.986	1.00	6.79
ATOM	3672	CG	LYS	A	358	14.039	15.852	58.408	1.00	8.85
ATOM	3675	CD	LYS	A	358	12.667	15.963	59.081	1.00	11.56
ATOM	3678	CE	LYS	A	358	12.778	15.922	60.608	1.00	13.45
ATOM	3681	NZ	LYS	A	358	11.446	16.046	61.278	1.00	15.20
ATOM	3685	C	LYS	A	358	16.278	14.381	57.021	1.00	6.23
ATOM	3686	O	LYS	A	358	17.210	14.897	57.647	1.00	6.46
ATOM	3687	N	ALA	A	359	16.055	13.069	56.982	1.00	6.07
ATOM	3689	CA	ALA	A	359	16.879	12.101	57.687	1.00	6.00
ATOM	3691	CB	ALA	A	359	16.277	10.724	57.587	1.00	6.19
ATOM	3695	C	ALA	A	359	18.303	12.091	57.143	1.00	6.09
ATOM	3696	O	ALA	A	359	19.265	12.036	57.907	1.00	5.68
ATOM	3697	N	PHE	A	360	18.443	12.145	55.824	1.00	5.93
ATOM	3699	CA	PHE	A	360	19.774	12.143	55.219	1.00	6.25
ATOM	3701	CB	PHE	A	360	19.692	12.075	53.691	1.00	6.09
ATOM	3704	CG	PHE	A	360	21.035	12.164	53.015	1.00	5.08
ATOM	3705	CD1	PHE	A	360	21.974	11.152	53.164	1.00	5.53
ATOM	3707	CE1	PHE	A	360	23.222	11.241	52.557	1.00	5.05
ATOM	3709	CZ	PHE	A	360	23.541	12.349	51.800	1.00	5.36
ATOM	3711	CE2	PHE	A	360	22.616	13.362	51.643	1.00	5.78
ATOM	3713	CD2	PHE	A	360	21.371	13.270	52.258	1.00	5.37
ATOM	3715	C	PHE	A	360	20.549	13.395	55.642	1.00	6.88
ATOM	3716	O	PHE	A	360	21.688	13.311	56.106	1.00	7.37
ATOM	3717	N	GLN	A	361	19.913	14.553	55.504	1.00	7.57
ATOM	3719	CA	GLN	A	361	20.535	15.826	55.850	1.00	8.38
ATOM	3721	CB	GLN	A	361	19.603	16.971	55.489	1.00	7.94
ATOM	3724	CG	GLN	A	361	19.627	17.293	53.983	1.00	7.07
ATOM	3727	CD	GLN	A	361	21.036	17.618	53.478	1.00	5.92
ATOM	3728	OE1	GLN	A	361	21.496	17.078	52.467	1.00	7.96
ATOM	3729	NE2	GLN	A	361	21.702	18.503	54.166	1.00	3.18
ATOM	3732	C	GLN	A	361	20.932	15.897	57.325	1.00	9.69
ATOM	3733	O	GLN	A	361	21.821	16.664	57.692	1.00	9.62
ATOM	3734	N	ALA	A	362	20.273	15.099	58.159	1.00	11.55
ATOM	3736	CA	ALA	A	362	20.615	15.019	59.590	1.00	13.25
ATOM	3738	CB	ALA	A	362	19.511	14.306	60.361	1.00	13.47
ATOM	3742	C	ALA	A	362	21.944	14.302	59.788	1.00	14.65
ATOM	3743	O	ALA	A	362	22.567	14.414	60.852	1.00	15.14
ATOM	3744	N	THR	A	363	22.382	13.561	58.772	1.00	16.29
ATOM	3746	CA	THR	A	363	23.667	12.859	58.813	1.00	17.77
ATOM	3748	CB	THR	A	363	23.600	11.548	58.031	1.00	17.95
ATOM	3750	OG1	THR	A	363	22.493	10.765	58.497	1.00	18.76
ATOM	3752	CG2	THR	A	363	24.814	10.663	58.314	1.00	18.15
ATOM	3756	C	THR	A	363	24.732	13.750	58.195	1.00	18.76
ATOM	3757	O	THR	A	363	25.922	13.421	58.208	1.00	18.78
ATOM	3758	N	GLN	A	364	24.283	14.871	57.640	1.00	19.77
ATOM	3760	CA	GLN	A	364	25.158	15.851	57.022	1.00	20.96
ATOM	3762	CB	GLN	A	364	24.616	16.229	55.640	1.00	21.24
ATOM	3765	CG	GLN	A	364	25.490	15.801	54.446	1.00	22.43
ATOM	3768	CD	GLN	A	364	25.668	14.294	54.277	1.00	23.32
ATOM	3769	OE1	GLN	A	364	25.472	13.516	55.210	1.00	23.46
ATOM	3770	NE2	GLN	A	364	26.060	13.889	53.076	1.00	24.13
ATOM	3773	C	GLN	A	364	25.312	17.110	57.902	1.00	21.55
ATOM	3774	O	GLN	A	364	26.401	17.645	58.011	1.00	21.55
ATOM	3775	N	GLN	A	365	24.219	17.542	58.539	1.00	22.62
ATOM	3777	CA	GLN	A	365	24.114	18.807	59.294	1.00	23.44
ATOM	3779	CB	GLN	A	365	25.287	19.137	60.218	1.00	23.70
ATOM	3782	CG	GLN	A	365	24.879	19.207	61.721	1.00	24.10
ATOM	3785	CD	GLN	A	365	24.542	20.613	62.236	1.00	24.69
ATOM	3786	OE1	GLN	A	365	23.620	21.268	61.738	1.00	25.16
ATOM	3787	NE2	GLN	A	365	25.279	21.061	63.257	1.00	24.67
ATOM	3790	C	GLN	A	365	23.877	19.909	58.281	1.00	24.03
ATOM	3791	O	GLN	A	365	24.709	20.190	57.421	1.00	24.63
ATOM	3792	N	LYS	A	366	22.717	20.524	58.396	1.00	24.21
ATOM	3794	CA	LYS	A	366	22.284	21.522	57.454	1.00	24.37
ATOM	3796	CB	LYS	A	366	20.933	21.079	56.920	1.00	24.52
ATOM	3799	CG	LYS	A	366	20.046	20.537	58.053	1.00	24.53
ATOM	3802	CD	LYS	A	366	19.425	19.211	57.731	1.00	24.45
ATOM	3805	CE	LYS	A	366	18.536	18.713	58.859	1.00	24.03
ATOM	3808	NZ	LYS	A	366	17.310	18.004	58.315	1.00	23.21
ATOM	3812	C	LYS	A	366	22.183	22.861	58.160	1.00	24.51
ATOM	3813	O	LYS	A	366	22.939	23.126	59.107	1.00	24.62
ATOM	3814	O	SAH	E	501	8.297	−2.058	44.325	1.00	40.90
ATOM	3815	C	SAH	E	501	8.314	−0.968	43.757	1.00	41.24
ATOM	3816	CA	SAH	E	501	9.219	0.183	44.185	1.00	41.19
ATOM	3818	N	SAH	E	501	9.794	−0.121	45.501	1.00	41.18
ATOM	3819	CB	SAH	E	501	10.235	0.369	43.049	1.00	40.73
ATOM	3822	CG	SAH	E	501	10.669	1.774	42.642	1.00	40.21
ATOM	3825	SD	SAH	E	501	9.362	2.829	41.941	1.00	40.07
ATOM	3826	C5*	SAH	E	501	9.401	4.162	43.144	1.00	39.88
ATOM	3829	C4*	SAH	E	501	8.664	3.778	44.420	1.00	40.55
ATOM	3831	O4*	SAH	E	501	9.530	2.983	45.238	1.00	40.00
ATOM	3832	C1*	SAH	E	501	9.449	3.389	46.590	1.00	40.22
ATOM	3834	C2*	SAH	E	501	8.352	4.430	46.689	1.00	40.93
ATOM	3836	O2*	SAH	E	501	7.161	3.829	47.167	1.00	41.07
ATOM	3838	C3*	SAH	E	501	8.191	4.947	45.270	1.00	41.32
ATOM	3840	O3*	SAH	E	501	6.840	5.321	45.046	1.00	41.73
ATOM	3842	N9	SAH	E	501	10.788	3.906	46.999	1.00	40.52
ATOM	3843	C8	SAH	E	501	11.866	4.115	46.184	1.00	40.63
ATOM	3845	N7	SAH	E	501	12.911	4.552	46.930	1.00	40.77
ATOM	3846	C5	SAH	E	501	12.513	4.611	48.221	1.00	40.71
ATOM	3847	C6	SAH	E	501	13.174	4.980	49.395	1.00	41.16
ATOM	3848	N6	SAH	E	501	14.445	5.380	49.372	1.00	40.82
ATOM	3851	C4	SAH	E	501	11.186	4.199	48.278	1.00	40.49
ATOM	3852	N3	SAH	E	501	10.520	4.152	49.451	1.00	40.16
ATOM	3853	C2	SAH	E	501	11.180	4.520	50.620	1.00	41.78
ATOM	3855	N1	SAH	E	501	12.490	4.933	50.576	1.00	39.76
ATOM	3859	N	ALA	K	1	8.996	19.908	38.353	1.00	12.39
ATOM	3861	CA	ALA	K	1	8.059	18.939	37.729	1.00	12.32
ATOM	3863	CB	ALA	K	1	8.537	18.584	36.343	1.00	12.87
ATOM	3867	C	ALA	K	1	7.923	17.674	38.576	1.00	11.87
ATOM	3868	O	ALA	K	1	8.855	17.304	39.301	1.00	11.99
ATOM	3871	N	ARG	K	2	6.723	17.102	38.604	1.00	10.65
ATOM	3873	CA	ARG	K	2	6.470	15.840	39.291	1.00	10.19
ATOM	3875	CB	ARG	K	2	4.974	15.667	39.504	1.00	10.49
ATOM	3878	CG	ARG	K	2	4.415	16.668	40.510	1.00	11.49
ATOM	3881	CD	ARG	K	2	3.077	16.269	41.101	1.00	13.38
ATOM	3884	NE	ARG	K	2	2.519	17.280	41.994	1.00	14.59
ATOM	3886	CZ	ARG	K	2	1.339	17.177	42.589	1.00	16.21
ATOM	3887	NH1	ARG	K	2	0.571	16.115	42.374	1.00	16.66
ATOM	3890	NH2	ARG	K	2	0.918	18.135	43.406	1.00	17.20
ATOM	3893	C	ARG	K	2	7.094	14.579	38.700	1.00	9.34
ATOM	3894	O	ARG	K	2	6.421	13.555	38.530	1.00	8.70
ATOM	3895	N	THR	K	3	8.389	14.649	38.415	1.00	8.38
ATOM	3897	CA	THR	K	3	9.111	13.512	37.888	1.00	8.36
ATOM	3899	CB	THR	K	3	8.979	13.404	36.364	1.00	9.04
ATOM	3901	OG1	THR	K	3	10.130	13.974	35.730	1.00	11.22
ATOM	3903	CG2	THR	K	3	7.815	14.212	35.820	1.00	8.63
ATOM	3907	C	THR	K	3	10.587	13.644	38.268	1.00	7.71
ATOM	3908	O	THR	K	3	11.070	14.728	38.566	1.00	6.59
ATOM	3909	CM	M1L	K	4	11.009	5.204	39.930	1.00	2.73
ATOM	3910	NZ	M1L	K	4	11.719	6.209	39.159	1.00	2.32
ATOM	3911	CE	M1L	K	4	11.574	7.615	39.523	1.00	2.66
ATOM	3914	CD	M1L	K	4	12.364	8.512	38.589	1.00	2.45
ATOM	3917	CG	M1L	K	4	12.084	9.965	38.945	1.00	2.40
ATOM	3920	CB	M1L	K	4	12.904	10.873	38.053	1.00	2.54
ATOM	3923	CA	M1L	K	4	12.449	12.304	38.194	1.00	2.52
ATOM	3925	N	M1L	K	4	11.029	12.295	37.865	1.00	3.37
ATOM	3926	C	M1L	K	4	13.197	13.193	37.235	1.00	3.01
ATOM	3928	O	M1L	K	4	12.962	13.222	36.056	1.00	2.56
ATOM	3929	N	GLN	K	5	14.584	13.478	37.797	1.00	7.22
ATOM	3931	CA	GLN	K	5	15.450	14.271	36.884	1.00	8.17
ATOM	3933	CB	GLN	K	5	16.054	13.370	35.828	1.00	8.43
ATOM	3936	CG	GLN	K	5	16.970	12.351	36.383	1.00	8.88
ATOM	3939	CD	GLN	K	5	18.081	11.997	35.430	1.00	9.35
ATOM	3940	OE1	GLN	K	5	17.869	11.885	34.227	1.00	8.97
ATOM	3941	NE2	GLN	K	5	19.276	11.807	35.972	1.00	9.42
ATOM	3944	C	GLN	K	5	14.750	15.431	36.194	1.00	8.64
ATOM	3945	O	GLN	K	5	15.022	15.707	35.035	1.00	8.44
ATOM	3948	N	THR	K	6	13.745	15.998	36.835	1.00	9.60
ATOM	3950	CA	THR	K	6	13.138	17.229	36.381	1.00	10.73
ATOM	3952	CB	THR	K	6	12.040	17.631	37.363	1.00	10.90
ATOM	3954	OG1	THR	K	6	11.316	18.746	36.833	1.00	12.28
ATOM	3956	CG2	THR	K	6	12.600	18.116	38.676	1.00	11.76
ATOM	3960	C	THR	K	6	14.104	18.390	36.122	1.00	11.09
ATOM	3961	O	THR	K	6	14.998	18.679	36.930	1.00	10.66
ATOM	3962	N	ALA	K	7	13.884	19.030	34.973	1.00	11.81
ATOM	3964	CA	ALA	K	7	14.630	20.184	34.495	1.00	12.53
ATOM	3966	CB	ALA	K	7	14.059	20.649	33.157	1.00	12.47
ATOM	3970	C	ALA	K	7	14.556	21.319	35.484	1.00	13.22
ATOM	3971	O	ALA	K	7	13.501	21.601	36.053	1.00	13.11
ATOM	3972	N	ARG	K	8	15.686	21.985	35.664	1.00	14.21
ATOM	3974	CA	ARG	K	8	15.771	23.093	36.588	1.00	14.87
ATOM	3976	CB	ARG	K	8	17.199	23.225	37.085	1.00	15.34
ATOM	3979	CG	ARG	K	8	17.295	23.916	38.407	1.00	16.87
ATOM	3982	CD	ARG	K	8	18.715	24.179	38.833	1.00	18.48
ATOM	3985	NE	ARG	K	8	18.899	25.527	39.347	1.00	19.64
ATOM	3987	CZ	ARG	K	8	19.763	25.839	40.293	1.00	20.69
ATOM	3988	NH1	ARG	K	8	20.502	24.888	40.845	1.00	21.86
ATOM	3991	NH2	ARG	K	8	19.885	27.095	40.703	1.00	20.91
ATOM	3994	C	ARG	K	8	15.329	24.395	35.926	1.00	14.75
ATOM	3995	O	ARG	K	8	15.383	24.535	34.715	1.00	14.65
ATOM	3996	N	LYS	K	9	14.897	25.343	36.745	1.00	14.92
ATOM	3998	CA	LYS	K	9	14.466	26.644	36.275	1.00	14.95
ATOM	4000	CB	LYS	K	9	13.143	27.010	36.942	1.00	15.30
ATOM	4003	CG	LYS	K	9	12.515	28.277	36.408	1.00	15.99
ATOM	4006	CD	LYS	K	9	12.015	28.080	34.985	1.00	16.93
ATOM	4009	CE	LYS	K	9	11.418	29.347	34.407	1.00	17.56
ATOM	4012	NZ	LYS	K	9	10.839	29.172	33.040	1.00	18.06
ATOM	4016	C	LYS	K	9	15.529	27.676	36.635	1.00	14.60
ATOM	4017	O	LYS	K	9	16.025	27.681	37.755	1.00	14.59
ATOM	4018	N	TYR	K	10	15.874	28.546	35.689	1.00	14.19
ATOM	4020	CA	TYR	K	10	16.904	29.561	35.916	1.00	14.11
ATOM	4022	CB	TYR	K	10	18.127	29.273	35.050	1.00	13.87
ATOM	4025	CG	TYR	K	10	18.817	27.984	35.439	1.00	13.76
ATOM	4026	CD1	TYR	K	10	18.440	26.775	34.878	1.00	13.67
ATOM	4028	CE1	TYR	K	10	19.061	25.596	35.241	1.00	14.13
ATOM	4030	CZ	TYR	K	10	20.074	25.616	36.175	1.00	14.21
ATOM	4031	OH	TYR	K	10	20.694	24.442	36.532	1.00	15.41
ATOM	4033	CE2	TYR	K	10	20.462	26.800	36.751	1.00	13.59
ATOM	4035	CD2	TYR	K	10	19.836	27.976	36.386	1.00	13.60
ATOM	4037	C	TYR	K	10	16.349	30.958	35.649	1.00	14.14
ATOM	4038	O	TYR	K	10	15.294	31.125	35.050	1.00	14.51
ATOM	4039	OXT	TYR	K	10	16.895	31.990	36.032	1.00	14.07

Claims

1. A crystal comprising at least a catalytically active portion of a SET 7/9 histone methyltransferase.

2. A crystal according to claim 1, comprising at least residues 117-366, preferably residues 108-366, of SET 7/9.

3. A crystal according to claim 1, comprising SET 7/9 in complex with a lysine-containing substrate peptide or protein and/or a cofactor.

4. A crystal according to claim 3, comprising SET 7/9 in complex with a lysine-containing substrate peptide or protein and a cofactor, wherein the lysine of the substrate which interacts with the SET 7/9 active site is methylated and wherein cofactor is unmethylated at the site whence a methyl group is normally transferred to the substrate.

5. A crystal in accordance with claim 1, having the atomic co-ordinates set out in Annex 1 or having a structure in which the atomic co-ordinates vary by less than 0.2 Å in any direction from those set out in Annex 1.

6. A crystal in accordance with claim 1, comprising at least a catalytically active portion of SET 7/9 in complex with a lysine-containing substrate peptide or protein, wherein the complex comprises one or more of the following interactions:

7. A method of selecting or designing a ligand for SET 7/9, which method comprises use of at least part of the atomic co-ordinate data contained in Annex 1 or data derivable therefrom.

8. A method according to claim 7 comprising use of data relating to at least 50%, preferably 75% and most preferably 95% of the atoms detailed in Annex I, or data derivable therefrom, or data in which the atomic co-ordinates used vary by less than 0.2 Å (preferably less than 0.1 Å) in any direction from the co-ordinates given in Annex 1.

9. A method according to claim 7, which involves the use of a computer system and/or computer readable medium.

10. A method according to claim 7, which comprises at least use of the atomic co-ordinate data contained in Annex 1 in respect of some or all of the amino residues of the SET 7/9 domain selected from the group consisting of: Tyr 245, His 252, Asp 256, Asn 263, Gly 264, Thr 266, Leu 267, Ser 268, Gly 292, His 293, Ala 295, Tyr 305, Lys 317, Tyr 335, and Tyr 337.

11. A method according to claim 7, comprising the step of testing in vitro the selected or designed ligand for ability to bind to SET 7/9, typically by contacting the ligand with SET 7/9 and measuring the amount of ligand, if any, bound to the SET 7/9.

12. A method according to claim 7, comprising the step of testing in vitro the ability of the selected or designed ligand to modulate the methyltransferase activity of SET 7/9 HMT.

13. A method according to claim 7, comprising the step of forming a complex comprising the selected or designed ligand and SET 7/9.

14. A method according to claim 13, comprising the step of forming a crystal comprising the complex and subjecting the crystal to X-ray diffraction analysis to investigate the binding of the ligand to SET 7/9.

15. A method according to claim 14, wherein the structure of the ligand is modified in view of the results of the X-ray diffraction analysis in order to optimise the characteristics of its binding to SET 7/9.

16. A method according to claim 15, wherein the optimised ligand is retested in vitro for ability to bind to SET 7/9 and/or modulate methyltransferase activity of SET 7/9 HMT.

17. A computer system and/or a computer readable medium comprising positional data relating to, or derivable form, at least part of the atomic co-ordinate data contained in Annex 1.

18. A computer system and/or a computer readable medium according to claim 9, comprising at least atomic co-ordinate data from Annex 1 (or data derivable therefrom) in respect of some or all of the amino acid residues of SET 7/9 domain selected from the group consisting of: Tyr 245, His 252, Hsp 256, Asn 263, Gly 264, Thr 266, Leu 267, Ser 268, Gly 292, His 293, Ala 295, Tyr 305, Lys 317, Tyr 335, and Tyr 337.

19. A method of forming a crystal comprising at least part of a SET 7/9 domain, the method comprising the steps of: forming a complex comprising at least a catalytically active portion of a SET 7/9 domain and a lysine-containing substrate peptide or protein; and crystallising the complex.

20. A method according to claim 19, wherein the complex further comprises a cofactor.

21. A method according to claim 20, wherein the lysine-containing substrate peptide or protein comprises a target lysine residue which has a methylated side chain and wherein the cofactor is unmethylated.

22. A method of forming a crystal comprising at least part of a SET 7/9 domain, the method comprising the steps of: selecting or designing a ligand in accordance with claim 7; forming a complex comprising the ligand and at least a catalytically active portion of a SET 7/9 domain; and crystallising the complex.

23. A method according to claim 19, wherein the complex comprises at least residues 117-366 of SET 7/9.

24. A ligand for SET 7/9 selected or designed by the method of claim 7.

25. A ligand for SET 7/9 conforming to general formula I or II:

26. A ligand for SET 7/9 comprising a bis-bicyclooctane or a 1,4 diphenyl moiety.

27. A ligand for SET 7/9 in accordance with the structure shown in FIG. 5 or FIG. 6.

28. A ligand according to claim 24, comprising an analogue of AdoMet having a stabilised 5′ thioadenosine moiety, and optionally substituted at the 3′-OH of the ribosyl moiety and/or the —NH2 group at position 4 of the adenyl moiety.

29. A ligand for SET 7/9 according to claim 24 comprising a hydrophobic moiety which occupies the lysine access channel of SET 7/9, forming hydrophobic interactions with the amino acid residues of SET 7/9 which define the lysine access channel.

30. A ligand according to claim 24, comprising a moiety which alkylates the terminal amino group the target lysine side chain of the histone substrate.

31. A ligand according to claim 30, comprising a modified or unmodified 5′-aziridinyl adenosine alkylating agent.

32. A ligand according to claim 24, which modulates the methyltransferase activity of SET 7/9 HMT.

33. A pharmaceutical composition comprising a ligand according to claim 24, in admixture with a physiologically acceptable excipient, carrier or diluent.

34. Use of a ligand in accordance with claim 24 to prepare a pharmaceutical composition for modulating the methylation of histones.

35. A method of altering the substrate specificity of histone methyltransferases, the method comprising the steps of: obtaining a nucleotide sequence encoding at least a catalytically active portion of a SET HMT; and altering the nucleotide sequence so as to introduce a mutation at one or more residues selected from the group consisting of residue numbers; 245; 305; and 335.

36. A method according to claim 35 for altering the substrate specificity of a SET 7/9 HMT, the method comprising the step of introducing at least one of the mutations selected from the group consisting of Y245>A; Y305>; and Y305>P.

37. An SET HMT having altered substrate specificity as a result of alteration of the amino acid sequence of the protein by a method according to claim 35.